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Travel report from Palestine, 1873
“The men called the illness Jericho fever or malaria. They in fact were two
different diseases, the men probably had both.
Jericho fever accounted for the large sores that took months to heal.
Sergeant Black had been troubled by "a very bad place" on his hands;
Conder complained of an ulcerous sore that kept growing on one hand until
the whole arm was painful; Drake was so plagued by sores on his feet, at
times he could barely walk. Any newcomer would mistakenly think the sore
was a boil, or the result of irritation of some kind, but not a disease. When it
healed it left a large scar. Then you would notice among people in Riha* or
in dealings with the Bedouin, that almost everyone in the valley had on his




by Robert Ruby *Riha (Arabic) = Jericho
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The following passages will give a general overview on leishmaniasis worldwide and 
specifically in Israel and the West Bank. The disease will be presented in its various clinical 
forms, in relation to the different causative Leishmania species. This will provide a  background 
for understanding why sensitive and species-specific diagnosis is important.  Consecutively, the 
facts about the biology and ecology of the parasite will be presented, which will convey a more 
profound understanding of the complexity of the disease. This is intended to illustrate that 
improved diagnostic tools are required in order to understand the epidemiology of the disease, 
which is a prerequisite for effective control measures. In the review of diagnostic methods the 
most important methods from past to present will be presented, including comparative aspects. 
By understanding the benefits and limitations of each of the methods presented, the selection of 
the specific diagnostic tools for this study will be comprehensible.  
 
1.1. General facts about leishmaniasis: 
1.1.1. Epidemiology: 
Leishmaniasis is a vector borne disease caused by various members of the genus Leishmania, a 
protozoic parasite. The clinical presentation ranges from simple cutaneous lesions to life 
threatening visceral forms. The disease is endemic in many tropical and subtropical countries 
around the world (more than 80 countries according to the WHO). Leishmaniasis is not only 
widely distributed in warm countries, but it is also prevalent in very different topographic areas. 
It is endemic in rain forests (Bolivia, Brazil), deserts (Middle East, North Africa), in the 
countries bordering the Mediterranean Sea and also in elevations of several thousand meters 
(Peruvian Andes, Ethiopian highlands).  
According to WHO estimates 350 million people are at risk world wide and 12 million people 
are affected. The annual incidence is estimated at 1-1.5 million new cases of cutaneous 
leishmaniasis (CL) and 0.5 million cases of visceral leishmaniasis (VL). The disease is greatly 
underreported, with only 600,000 officially declared cases annually. In most of the endemic 
countries leishmaniasis is not a reportable disease (http://www.who.int/emc/diseases/ 
leish/leisdis1.html). The incidence worldwide is on the rise. New endemic foci have emerged 
over the past decades, epidemics are not controlled and endemic areas are spreading due to 
development and population shifts (Desjeux, 1999). In western countries the incidence is 
increasing due to HIV-Leishmania coinfection and tourism. In recent years coinfection with HIV 
became a serious threat in south-western Europe with 1.5-9.5% of AIDS patients being affected. 
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For the following passages on the parasite, the clinical picture, the transmission and control of 
leishmaniasis Manson’s Tropical Diseases (1987; 1996) served as the main source of 
information, if not cited otherwise. 
 
1.1.2. The parasite: 
The Leishmania parasite is a protozoa belonging to the order Kinetoplastida and the family of 
Trypanosomatidae. The genus Leishmania  includes more than 20 species. The parasite exists in 
two morphological forms: the nonflagellated amastigote (3-5 µm in diameter) living intracellular  
in  macrophages of the mammalian host, and the flagellated promastigote (15-30 µm in length, 
plus the flagella), living extracellular in the intestinal tract of the sandfly-vector. In the 
macrophages the amastigotes are able to survive and  multiply within the acidic phagolysosomes 
of the host cells (reviewed by Alexander et al., 1999). After multiplication in the host cell the 
amastigotes are released. Subsequently other macrophages are infected and the infection spreads 
(reviewed by Peters and Killick-Kendrick, 1987; Rittig and Bogdan, 2000). 
The parasite contains two prominent organelles, the nucleus and the kinetoplast. The kinetoplast 
is found in all protozoa of the order kinetoplastidae (eg. Leishmania, Trypanosoma, Crithidia). It 
is a rod-shaped mitochondrial structure consisting of a DNA network of about 10,000 minicircles 
and about 50 maxicircles, the kinetoplast-DNA (kDNA). The function of the kinetoplast has not 
been clear until recently. It was found that maxicircles encode for mitochondrial ribosomal 
RNAs. The minicircles play a role in the editing process of these mRNAs (reviewed by Shlomai, 
1994). Figure 1a and 1b show amastigotes in Giemsa stained smears, Figure 2 shows 
promastigotes in the sandfly gut (electron micrograph). 
 








a) amastigotes in group of macrophages   b) extracellular amastigotes with  
prominent kinetoplast  
















Electron micrograph by Alon Warburg 
 
1.1.3 Life cycle: 
The transmission cycle is maintained between the vector and the reservoir. Depending on the 
species of Leishmania the transmission is either zoonotic or anthroponotic, involving either 
animals or humans as reservoir. The parasite is transmitted by the bite of female sandflies of the 
genus Phlebotomus and Lutzomyia. During the blood meal Leishmania infected macrophages are 
ingested by the vector. In the gut of the sandfly the intracellular amastigotes develop into 
flagellated promastigotes at an ambient temperature of 24-28°C. During another blood meal the 
mature promastigotes are inoculated into a mammalian host. Macrophages ingest the parasites, 
which then transform into the amastigote form. The life cycle is shown in Figure 3. 
 
1.1.4. Clinical forms of leishmaniasis: 
The three distinct forms, cutaneous (CL), visceral (VL) and mucocutaneous leishmaniasis 
(MCL) are classically caused by a spectrum of different Leishmania species each. Even though 
there is a clear correlation between the causative species and the clinical presentation many 
variations are seen. Depending on the specific characteristics of species/strains and also on the 
immunocompetence of the host the clinical manifestation may vary to a great extent. Species 
causing typically CL may visceralize and visceral species may show dermatotropism. In many 
endemic areas of the world a few Leishmania species are prevalent simultaneously so that a 
species specific diagnosis can not rely on clinical findings alone. Species specific diagnosis is 










































































































































































Apart from the characteristics of species and strains, the host immunology influences the severity 
of the disease to a great extent. Genetically determined immunological patterns of reaction, the 
present health condition and the nutritional status play a decisive role in the course of the 
disease. The events responsible for resistance or susceptibility occur early in infection. 
Resistance depends on a Th1-type response resulting in the production of γ-interferon (IFN-γ) 
and nitric oxide (NO). A Th2-type response is related to susceptibility (Blackwell, 1996; 
reviewed by Alexander et al., 1999; reviewed by Solbach and Laskay et al., 2000). The severity 
of the disease depends as well on factors related to the causative agent itself and the sandfly 
vector. The antigenicity is variable among strains of the same species, leading to atypical clinical 
presentations (eg. visceralizing L.tropica strains and dermatotrophic L.d.infantum and 
L.d.chagasi strains). Apart from this also the composition of the sand fly saliva influences the 
severity of the infection (reviewed by Kamhawi, 2000).  
 
1.1.5.1. Cutaneous Leishmaniasis: 
Old World: 
In the Old World, cutaneous leishmaniasis (CL) is also known as “Oriental Sore”, “Baghdad 
boil”, “the little sister” (Aljebori and Evans, 1980), “Delhi boil” or “Rose of Jericho”. CL is 
usually caused by L.major, L.tropica and L.aethiopica (see Table 1). CL presents usually as a 
self-limited, ulcerative skin lesion. The uncovered parts of the body, especially the face, are 
affected. After an incubation time of several weeks to several months a papule develops at the 
site of the sandfly bite, which later evolves into an ulcer. The size of the ulcer can reach a 
diameter of several centimeters. It lasts normally for a few (3-4) months but it can also persist for 
more than one year before it resolves spontaneously. The lesion is usually painless unless a 
secondary bacterial infection is present. A slightly depressed and often hypopigmented scar 
remains. If left to self-cure, life-long immunity is usually  acquired against the same species. 
L.tropica infections tend to be more severe than those of L.major and have a potential to 
recidivate and also to visceralize (Magill et al., 1993; 1994; Sacks et al., 1995). As an unusual 
causative agent L.d.infantum has been reported to cause CL, eg. in Tunisia (Gramiccia et al., 
1991), in Lebanon (Nuwayri-Salti et al., 1994) and in Iran (Hatam et al. 1997). 
 
New World CL: 
In the New World, CL is caused by species of the L.mexicana and the L.braziliensis complexes 
(see Table 1). L.mexicana infections are normally uncomplicated and self-limited. If the ear is 
infected, a so-called Chiclero's ulcer may develop which is characterized by destruction of the 
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cartilage and disfigurement of the ear. The infections caused by species of the L.braziliensis 
complex primarily present as CL. Especially the L.braziliensis infections are related to a high 
risk for later progression to mucocutaneous disease. 
An atypical form of CL has been reported from Honduras (Ponce et. al., 1991; Noyes et al., 
1997) and from Nicaragua (Belli et al., 1999) caused by L.d.chagasi, which normally causes VL. 
In this atypical presentation the symptoms are confined to the skin. The lesions are nodular and 
long-lasting, resembling leprosy.  
 
Chronic forms of CL: 
Leishmaniasis recidivans or lupoid leishmaniasis is one chronic form of CL caused by L.tropica 
(Salman et al. 1999). Self-cure is not completed and new eruptions evolve at the border of the 
scarring lesion over many years. The appearance resembles lupus vulgaris. Parasites are scarce 
and the chronic skin lesion is mostly due to a hyperreactive immune response.  
Diffuse CL (DCL) is another chronic form of CL. The infection spreads over large areas of the 
body. It represents a condition of anergy with a failure of cell-mediated immune response 
(negative Leishmanin test) and an abundance of amastigotes. In the Old World it is associated 
with L.aethiopica infections and is mostly seen in Ethiopia. It resembles lepromatous leprosy,  
which often led to misdiagnosis in the past. As a result, DCL patients were often kept in 
leprosaria by mistake. In the New World DCL is caused mainly by L.amazonensis (30% of the 
infections result in DCL). DCL occurs also in immunodeficient patients with no species-specific 
relation; coinfection with HIV is the most common cause (Ramos-Santos et al., 2000; Gillis et 
al., 1995). 
 
1.1.5.2. Visceral leishmaniasis (kala azar): 
Visceral leishmaniasis (VL) or kala azar is usually caused by species belonging to the 
L.donovani complex (L.donovani, L.d.infantum, L.d.chagasi, see Table1). L.donovani is the 
causative agent in the highly endemic areas of India and Sudan. In Middle Eastern and 
Mediterranean countries L.d.infantum prevails. In this region of the world mostly infants and 
immunocompromised adults suffer from the disease. In the New World L.d.chagasi is the only 
known species causing VL.  
VL is a severe systemic disease presenting with fever, splenomegaly and cachexia. Typical 
laboratory findings are pancytopenia, albumin deficiency and hypergammaglobulinaemia. If not 
treated patients usually die after approximately two years. Often super-infections, typically 
tuberculosis, pneumonia or bacterial dysentery, are the lethal causes. Most infections are 
subclinical, only 3% of infections lead to the full picture of the kala-azar syndrome.  
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Rarely VL can be caused also by L.tropica. In India L.tropica has been isolated from 4 patients 
suffering from classical kala azar (Sacks et al., 1995). Visceral infections caused by L.tropica 
have been reported from veterans of Operation Desert Storm. The onset of symptoms was more 
acute, presenting with fever, abdominal pain, fatigue and cough (Magill et. al., 1993). No 
cutaneous manifestations were seen and the disease was described as being viscerotropic but not 
identical with kala azar (Kreutzer et. al., 1993). 
 
Cutaneous manifestations related to VL: 
The site of inoculation is often symptomatic and is known as leishmanioma. A small lesion 
appears about 3-4 months before the onset of kala azar, which should not be mistaken for CL 
(Adler, 1964).  
Post kala azar dermal leishmaniasis (PKDL) is a form of CL occurring in some patients after 
treatment and cure of VL, usually after a latent phase of several years. PKDL presents as a rash,  
which  may last for many years and may spread over large parts of the body. It can appear either 
as a macular, maculo-papular or nodular rash (Zijlstra and El-Hassan 2001). Often it begins with  
depigmented patches, which later turn to be nodular. PKDL is a serious condition which often is 
disfiguring the patient (social problem); it has to be differentiated from lepromatous leprosy and 
other skin diseases. It is mostly seen in the north-east of India (Bengal, Bihar) where 20% of the 
VL patients are affected. According to Manson’s Tropical Diseases, (1996) East African PKDL 
occurs in only 2-5% of the VL cases and it does not exist in any other endemic area of VL. 
Recently it was reported that PKDL affects a much higher percentage of VL patients in Sudan. 
Zijlstra and El-Hassan (2001) found that 55% of the VL patients in Sudan developed PKDL. In 
the African form of PKDL the rash appears much earlier than in the patients from India, either 
during active kala azar or within 6 months after cure.  
 
1.1.5.3. Mucocutaneous Leishmaniasis (Espundia): 
Mucocutaneous leishmaniasis (MCL) or Espundia is almost exclusively seen in Central and 
South America. It is a chronic and very serious condition, developing years after self-cure of 
cutaneous lesions. The infection causes a progressive destruction of the mucosa, the cartilage and 
bones of nose and pharynx, leading to a severe mutilation of the face. MCL is mainly caused by 
Leishmania species belonging to the L.braziliensis complex (see Table 1), predominantly by 
L.braziliensis. The risk of developing MCL after cure of CL is estimated to be up to 40%. MCL 
can be lethal, often by aspiration pneumonia. Infections caused by L.panamanensis and 
L.guyanensis rarely result in MCL, whereas L.peruviana is not associated with MCL. 
L.guyanensis infections are also known as ‘pian bois’, typically presenting with multiple lesions. 
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L.peruviana infections are known as ‘uta’ and are usually self-healing within a few months. 
Infections caused by the L.braziliensis complex are often associated with lymphadenopathy, 
especially infections with L.braziliensis (Barral et al., 1992). In Sudan a less invasive form of 
MCL is seen in patients infected with L.donovani. In contrast to the American form, mucosal 
involvement usually precedes the clinical signs of kala azar (El-Hassan and Zijlstra, 2001). 
 
1.1.5.4. Leishmaniasis and HIV-coinfection: 
Most cases of coinfection with HIV and Leishmania have been reported in south-western 
Europe, with L.d.infantum being the predominant causative species. In conditions of immune 
suppression the clinical picture of leishmaniasis is often atypical. The typical affiliation between 
species and clinical presentation does not exist in many cases. Not only can cutaneous 
Leishmania species lead to systemic visceral disease, but also parasites infiltrate tissues and 
organs which are normally not affected. VL in HIV-positive patients has also been reported to be 
caused also by species which normally do not visceralize, eg. L.braziliensis (Hernandez et al., 
1993), L.major (Gillis et al., 1995), L.mexicana (Ramos-Santos et al., 2000). Likewise, visceral 
disease (L.d.infantum) can be accompanied with unusual cutaneous lesions (Postigo et al., 1997). 
Alvar et al., (1997) have reported that L.d.infantum- HIV coinfections can present with all forms 
of leishmaniasis including MCL, PKDL and disseminated CL. In disseminated forms of 
leishmaniasis parasites have been repeatedly found in the digestive tract, namely in the colon 
(Sebastian et al., 1997), in the duodenum (Hamour et al., 1998) and in an anal ulcer (Perez-
Molina et al., 1997). A retrospecive study in 91 coinfected patients suggests the presence of 
Leishmania amastigotes in atypical locations to be related to the immunological status 
(Rosenthal et al., 2000). The following Table 1 gives an overview on the different Leishmania 
species, the most common clinical manifestations, the geographical distribution as well as the 
specific host and vector species. 
 
1.1.6. Treatment: 
Simple CL due to L.major is mostly left to self-cure. It is even preferable not to treat, so that 
long-term immunity can be acquired. This especially applies to patients living in endemic areas. 
Treatment is necessary when cosmetically or functionally important sites are involved. L.tropica 
infections generally require treatment. For local treatment, intralesional Pentostam (sodium-
stibogluconate), ketoconazol, cryotherapy with liquid nitrogen or heat can be applied. For 
systemic treatment, pentavalent antimonal compounds (Sb) eg. Pentostam and Glucantime are 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Infections caused by species of the L.braziliensis complex generally require treatment with 
pentavalent antimonal drugs. In cases of MCL early diagnosis is essential for effective treatment. 
Simple CL caused by the L.mexicana complex does not necessarily require treatment. For 
L.braziliensis infections, sodium-stibogluconate is the drug of choice. Relapses are not 
uncommon and require a second course of treatment, possibly also with another drug (eg. 
Amphotericin B). In contrast to L.braziliensis infections, L.mexicana infections respond only 
poorly to antimonal compounds, but do instead respond well to ketoconazol. Reversely, 
ketoconazol is not efficient for the cure of L.braziliensis infections (Navin et al., 1992). 
For the treatment of kala azar, pentavalent antimonial drugs have been the therapy of choice 
since 1916. Due to its toxicity the treatment has to be monitored carefully. Heart and liver are 
typically affected  (Hepburn, 2000). Resistance against pentavalent antimonals has become a 
serious problem, especially in India. As an alternative drug Amphotericin-B has proved to be 
effective too. Less toxic lipid-associated formulations of Amphotericin can be administered as 
well. The combinations of Paromomycin (Aminosidine) with Sb and interferon-γ with Sb are 
also efficient and may help to reduce side effects of Sb compounds (less Sb is required) 
(reviewed by Berman, 1997).  
The treatment of VL and MCL requires hospitalization for several weeks and the drugs are 
expensive. New hope for an oral treatment came with the discovery of Miltefosine, which 
appears to be highly efficient, less toxic, and can be administered orally. If clinical trials are 
successful, this drug will be very beneficial, especially in India and Sudan (Herwaldt, 1999 b). 
 
1.1.7. Transmission: 
The presence of leishmaniasis depends on a variety of ecological and biological factors. Since 
the various Leishmania species depend as much on specific reservoir as on specific vector 
species,  a Leishmania focus can only exist if suitable ecological conditions are present for both  
the host animal species and the sandfly species. The topography and the climate are essential for 
the maintenance of the life cycle. Only if the reservoir and the vector live close enough together 
is the transmission of the parasite possible and the infectious cycle maintained. 
 
CL: 
CL occurs either as a zoonotic or an anthroponotic infection. Zoonotic CL is caused by L.major,  
with rodents serving as the reservoir. These rodents live usually in colonies and are commonly 
found in vast uninhabited areas. The rodent burrows provide excellent breeding places for the 
sandflies. Through the coexistence of rodents and sandflies in the same habitat the natural 
transmission cycle of L.major is maintained. In zoonotic leishmaniasis humans are only 
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accidental hosts. New endemic foci of CL can emerge when developmental changes take place 
(eg. building, agriculture). In the Middle East and North Africa the fat sand rat (Psammomys 
obesus) is the main reservoir. Also jirds (Meriones sp.) were found to host the parasite (Schlein 
et al., 1982; 1984). In Central Asia, Iran and Afghanistan the great gerbil (Rhombomys opimus ) 
was identified as being the reservoir of L.major (Strelkova, 1996; Yaghoobi-Ershadi and 
Javadian, 1996). This gerbil species also hosts nonpathogenic species of Leishmania (L.gerbilli 
and L.turanica). L.major is transmitted predominantly by sandflies of the species Ph.papatasi. 
 
Anthroponotic CL has been attributed to L.tropica. Major urban centers of the Middle East 
(Aleppo, Damascus, Baghdad, Tashkent, Teheran and Kabul) were known to be highly endemic 
for L.tropica. Humans were the only known reservoir. The infections were so numerous as to 
maintain the transmission cycle. In recent years it became increasingly obvious that the classical 
transmission pattern of L.tropica infections has changed. Epidemics in densely populated areas 
became less common. A shift from an urban to a rural distribution took place. In some of the 
mentioned Middle Eastern cities, CL has been quite efficiently eradicated by systematic and 
repeated spraying of houses with insecticides and also as a result of spraying within anti-malaria 
campaigns. In the past decade the outskirts of cities and villages have been affected 
predominantly, and infections have occurred more sporadically. These characteristics suggest the 
existence of an animal reservoir and a zoonotic transmission of L.tropica. Until today the animal 
reservoir of L.tropica has not been identified, but several animal species are suspected to 
function as reservoir. L.tropica has been isolated from a hyrax (Procavia ssp.) in Kenya (Sang et 
al., 1992), from dogs in Morocco (Dereure, 1991) and from a rat (Aljeboori and Evans, 1980). 
Hyraxes are the proven reservoir of L.aethiopica in Ethiopia (Ashford et al., 1973). In Jordan 
hyraxes are abundant in endemic areas of L.tropica and are therefore suspected to be the 
reservoir (Saliba et al., 1997). This has been discussed also by Ashford, (2000). L.tropica is 
predominantly transmitted by sandflies of the species Ph.sergenti. 
 
VL: 
VL occurs either in a typical zoonotic or an anthroponotic pattern, depending on the species 
involved. L.donovani depends on interhuman transmission (Thakur, 2000). It occurs in 
epidemics in densely populated areas of India (Bengal, Bihar) and in Sudan. Subclinical 
infections are thought to exist at such a high number that this alone would be sufficient to 
maintain the infectious cycle. Besides, PKDL patients are suspected as serving as a reservoir, 
especially bridging long-term intervals between epidemics. The homophilic nature of the vector 
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of Indian kala azar, Ph.argentipes, supports the hypothesis that humans are the only reservoir in 
India. 
In other regions of the World (Mediteranean countries, the Middle East, Central Asia and China) 
VL is a zoonosis. The causative agent is L.d.infantum, which is transmitted by phlebotomine 
sandflies mainly of the subgenus Larroussius. Canids, predominantly dogs, serve as a reservoir 
(Adler, 1962). Dogs suffer from canine visceral leishmaniasis (CVL), a disease closely related to 
human VL. In addition, dogs suffer typically from various dermal symptoms. The distribution of 
the disease is typically rural. Wild canids (eg. foxes and jackals) seem to be an important factor 
for the distribution of the parasite over larger geographical areas (Baneth et al., 1998). The 
epidemiology of L.d.chagasi in the New World is very similar, causing VL in humans and CVL 
in canids.  
 
MCL: 
CL and MCL of the New World are zoonotic, with small forest rodents and sloths serving as 
reservoir. Forest workers, hunters and settlers on cleared forest land are especially at risk. 
Sandfly species of the genus Lutzomyia and Psychodopogus are the vectors. 
 
1.1.8. Antiepidemic measures: 
Control measures target the interruption of the transmission cycle. For efficient control, the  
ecology and epidemiology of the disease have to be understood (differences depending on 
species and local ecology). Depending on the circumstances (eg. zoonotic or anthroponotic 
transmission), the control of either the reservoir or the vector is advisable. The human link in the 
transmission cycle can be controlled by taking personal precautions. 
 
Prevention of human infections:  
As sandflies are only active at night, inhabitants of endemic areas or travellers in endemic areas 
can diminish the risk of exposure to sandfly bites by long sleeve clothing during evening hours, 
application of insect repellents and usage of bed nets. Fine mesh screens for windows are 
advisable as well. In the case of anthroponotic leishmaniasis, early case detection and treatment 
are the most important control measures. Despite various attempts to develop a vaccine no 
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Control of the reservoir: 
One effective measure for the control of zoonotic CL is the deep ploughing of the area around 
houses, in order to destroy the rodent burrows. In the northern Jordan Valley CL cases became 
rare in recent years due to extensive agriculture and development which had resulted in the 
destruction of the natural habitat of the Psammomys (personal communication with Dr. Alon 
Warburg). In order to control VL, different measures have been employed. It has been shown in 
a study in Brazil that the removal of infected dogs led to a lower incidence but did not eradicate 
the disease (Ashford et al., 1998). Vaccination of dogs might be an alternative approach for the 
future (Tesh, 1995). Another control measure has been presented by Killick-Kendrick et al., 
(1997), who found that deltamethrin impregnated collars protect dogs very efficiently from 
sandfly bites; biting activity was reduced by 96%. 
 
Vector control: 
One important goal is the destruction of breeding places. This involves the closure of cracks in 
walls and the removal of rubble. A common measure is the spraying of houses with insecticides 
(Alexander et al., 1995; Tayeh et al., 1997 a). Biological control measures seem to be effective 
as well (Robert et al., 1997). In India kala azar had been almost eradicated after an anti-malaria 
campaign. Since the spraying of houses has been stopped, the disease has returned. 
 
1.1.9. Leishmaniasis in the Middle East: 
The Middle East is endemic for CL and VL. In most countries of the Middle East the three Old 
World species, L.major, L.tropica and L.d.infantum are prevalent. Even though urban L.tropica 
infections became less frequent the overall picture is that CL and VL are emerging diseases in 
the region. Several new outbreaks were reported during the last decade. Besides developmental 
changes, the political instability is an important factor: non-immune population groups as 
military troops, workers and also refugees enter endemic areas. More than 50 nations provide 
peacekeeping forces in the Middle East. In some of the home countries of these multinational 
forces, leishmaniasis has never been diagnosed before and therefore might be misdiagnosed. An 
endemic focus of L.major emerged in the northeastern Sinai among the multinational peace- 
keeping forces stationed in this area (Fryauff et al. 1993). Norton et al., (1992) reported about 23 
Fijian members of an international observer force who had acquired CL. Visceral infections 
caused by L.tropica have been reported from veterans of Operation Desert Storm (Magill et al., 
1993). 
In recent years L.tropica infections have been reported in rural areas in the Middle East and 
North Africa. Either new endemic foci or a higher incidence in already known endemic areas 
 24  
were reported in Jordan (Saliba et al. 1993; 1997), Morocco (Dereure et al., 1991), Oman 
(Scrimgeour et al., 1999), an Afghan refugee camp in Pakistan (Rowland et al., 1999) and in  
Aleppo in Syria (Ashford et al., 1993; Tayeh et al., 1997 b).  
L.major, L.tropica and L.donovani ssp. have been reported in Iraq, Iran and Saudi Arabia 
(Aljeboori and Evans, 1980; Hatam et. al., 1997; Momeni and Aminjavaheri, 1994; Peters et. al., 
1985). VL has been reported in Jordan (Qubain et al., 1997), in Tunisia as an emerging disease 
(Ben Salah et al., 2000), and new foci were reported in Libya (Mehabresh, 1994). L.donovani 
infantum has been reported in Lebanon and Tunisia (Nuwayri-Salti et. al., 1994; Gramiccia et 
al., 1991) causing CL. In Iran, CL is endemic in many parts of the country. L.major and 
L.tropica are prevalent, partly in the same regions. In 1989, 15,757 cases of CL were reported, in 
some areas up to 70% of the population have scars from past infections, the incidence being 
1.4/1,000 in the Isfahan province of Iran (Momeni and Aminjavaheri, 1994). The disease is 
common in the cities as well as in the rural areas. Leishmaniasis is endemic also in Turkey 
(Uzun et al., 1999). 
 
Leishmaniasis in Israel and the West Bank: 
CL has first been reported in the area of Jericho in the beginning of the 20th century 
(Huntemueller, 1914; Canaan, 1916). Settling and development of arid and semiarid areas has 
taken place over the last few decades, which gave rise to the emergence of new foci of CL (see 
map, Figure 4). According to reports from residents of Jericho, the disease was not seen in the 
years before the Six Days War in June 1967. This was due to spraying against malaria with 
DDT. A survey of Israeli soldiers who had been in the greater Jericho area during the war, 
revealed that the disease was still hyperendemic, with an incidence of 50% during an average 
exposure time of 1 month (Naggan et al., 1970). The recent epidemiology of CL in the Jericho 
district has been profoundly studied by  Jawabreh (2000). The epidemiology of leishmaniasis in 
Israel has been reviewed by Greenblatt et al., (1985). Leishmania major accounts for the 
majority of infections with Leishmania in the country. It is endemic in the Jordan Valley, the 
Jericho area, along the Dead Sea, in the Arava and the Negev. CL caused by L.major has been 
thoroughly studied over many years, and the reservoir animal species (P.obesus, M.crassus) as 
well as the vector species (Ph.papatasi) have been identified (Schlein et al., 1982; 1984).  
Leishmania tropica is endemic in a number of semiarid hilly areas in central and northern Israel 
as well as in the northern West Bank (Samaria), the Jenin district being a major endemic area 
(Abdeen et al., 2000, in press). An outbreak has been reported in Salfit (Blum, 1978), an Israeli 
settlement north of Nablus. The species has never been finally confirmed, but the hilly 
environment was highly suggestive of a focus of L.tropica. Another L.tropica focus has been 
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reported by Klaus et al., (1994): since 1989, CL had been diagnosed in 19 residents of Kfar 
Adumim, a village between Jerusalem and the Dead Sea. In 6 patients the cultivation of 
promastigotes succeeded and L.tropica was identified. Oren et al., (1991) reported about a 21 
year old Israeli suffering from VL caused by a L.tropica variant who came from the area south of 
the Sea of Galilee. Hyraxes were found  to be abundant in the environment of several L.tropica 
foci. They are highly suspected as being the reservoir. According to Sawalha (2001) more than 
700 cases of CL have been reported from many single foci in the northern West Bank over the 
last 10 years. The causative species has not been identified, but the geographical area suggests 
L.tropica. 
 
VL caused by L.d.infantum is an emerging disease in the northern West Bank. More than one 
hundred (127) human VL cases have been recorded over the past 10 years. Most cases were 
reported in the Jenin district, followed by Hebron, Tulkarem and Ramallah. Predominantly 
children between 1 and 6 years of age were affected (Abdeen et al., 2000, in press, Greenblatt et 
al., 1985, Qubain et al., 1997). A serological survey in an Arab village in an endemic area of VL 
in western Galilee showed a prevalence of 10% (Ephros et al., 1994). CVL has been diagnosed 
in dogs in central Israel. In a village close to Tiberias (Wadi Hamam), 4% of the dogs were 
seropositive and L.donovani sensu lato was identified from cultured parasites (Jaffe et al., 1988). 
Wild canids are suspected of playing a major role in distribution of the disease over greater 
distances. More than 5% of the foxes and jackals have been found to be positive by serology. In 
two villages west of Jerusalem the prevalence was about 10% of the domestic dog population 
(Baneth et al., 1998). Some dogs showed severe signs of CVL. In the northern West Bank, 
where human VL is endemic, the L.tropica foci are adjacent or even overlapping.  
 
Leishmaniasis is by law a reportable disease in Israel, but nevertheless the disease seems to be 
greatly underreported. The number of cases reported to the Israeli Ministry of Health over the 
last few years did not exceed the number of patients seen in the Hadassah Hospital, which is only 
one of several hospitals where patients with CL are treated. The Bedouins of the Negev and the 
Judean Desert are familiar with the disease. Since the disease is well-known among the 
inhabitants in endemic areas, simple cutaneous lesions are often diagnosed by the patients 
themselves and are left for self cure. As many young Israelis tour Central and South America 
after military service, New World leishmaniasis is increasingly diagnosed among returners 
(Zlotogorski, 1998). 
Figures 4 and 5 show the distribution of CL and VL over the last decade (1990-2000) in Israel 
and the West Bank.  





























Figure 4: Cutaneous Leishmaniasis in Israel



















This map is based on the data of CL patients who visited the Dermatology clinic of the Hadassah
Hospital since 1990 and on information collected during the study period. The information, especially on
the West Bank, is not complete.















































Figure 5: Canine Visceral Leishmaniasis in Israel 













This map was created by Gad Baneth, School of Veterinary Medicine, Hebrew University, Rehovot.
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1.2. Review of the diagnostic methods for leishmaniasis: 
1.2.1 Direct identification by classical routine methods: 
Microscopy: 
Classically the diagnosis of leishmaniasis relies on direct microscopical identification of 
amastigotes. Its sensitivity is limited to about 60% (Rodriguez et al., 1994), which has been 
found by many others too. No species-specific diagnosis can be achieved. Smears from skin 
lesions, tissue biopsies or aspirates from bone marrow, spleen or lymph nodes are used. 
Microscopy is performed on Giemsa stained smears or sections of the named specimens. 
Typically round to oval amastigotes are seen inside of macrophages. Sometimes they are also 
found extracellular. The densely stained (violet) rod-shaped kinetoplast should be always 
identified. Biopsies have shown a greater sensitivity than smears for the diagnosis of CL 
(Rodriguez et al., 1994). Andresen et al., (1996) identified amastigotes in 76% of histological 
sections, but only in 55% of smears taken from CL lesions. To improve the microscopical 
sensitivity of smears it has been recommended that a superficial slit be made radially into the 
lesion and that some tissue be scraped off with a surgical blade (Herwaldt, 1999 a; Hepburn 
2000). This collection method is much less invasive than taking biopsies. For the microscopical 
diagnosis of VL, splenic aspirates proved to have the highest detection rate (96.4%, 84 out of 88 
patients), followed by bone marrow aspiration (70.2%) and lymph node aspiration (58.3%) as 
shown by Zijlstra et al., (1992) and also reported by others. Bleeding complications are feared, 
but are low (0.6%), if applied exclusively to patients with coagulation parameters within the 
normal range. In peripheral blood the detection rate by microscopy is very low.  
 
Culturing: 
Cultures are obtained from aspirates or biopsies from the above-named sources. Cultures are 
usually grown in NNN (Nicolle-Novy-McNeal) and in Schneider's Drosophila medium. 
Culturing of promastigotes is required for a number of diagnostic methods such as isoenzyme 
analysis, and some of the serological and DNA-based methods. The sensitivity of culturing is 
variable and depends on various factors, as for example the viability of collected parasites, the 
strain, the media (different requirements for different species), the presence of a superinfection, 
and the expertise of the investigator. Different success rates have been reported, ranging between 
4% in Nicaragua (6 of 143) (Belli et al., 1999) and 95% (61 of 64) in Switzerland (Grimm et al., 
1996). Mostly a sensitivity of 40-50% was found (Rodriguez et al., 1994). Culturing is expensive 
and time-consuming as cultures sometimes become positive only after two or more weeks 
(Gramiccia et al., 1991). It depends on adequate facilities, which are often not available in less-
developed countries. Furthermore, cultures are susceptible to contamination. In cases of double 
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infections one strain usually outgrows the other, so that misdiagnosis can occur (Klaus et al., 
1994).  
 
1.2.2. Indirect diagnosis: 
1.2.2.1. Cellular immunity: 
Leishmanin skin test (LST) or Montenegro skin test: 
The LST is widely used for the screening of the exposure to Leishmania parasites within 
endemic areas. Analogous to the tuberculin test, leishmanial antigen (killed promastigotes) is 
applied intradermally and a delayed hypersensitivity reaction is measured after 48-72 h. A 
reaction is seen in people with previous contact to the antigen who have developed cellular 
immunity. Conversion occurs after several weeks in CL, and in VL usually only after treatment 
and cure (Peters and Killick-Kendrick, 1987). Present and past infections can not be 
differentiated. 
 
Lymphocyte proliferation assay (LPA): 
Alternatively a lymphocyte proliferation test can be used to measure the cellular response 
(Alvarado et al. 1989). In contrast to the LST one patient contact is sufficient, which may 
facilitate larger field studies. On the other hand the LPA is more labour intensive. 
 
1.2.2.2. Serological methods: 
Serology is suitable for mass screening within epidemiological surveys on VL or CVL. It is 
limited in its use for the diagnosis of leishmaniasis since present, subclinical and past infections  
generally not be discriminated. It is not reliable in CL since antibodies are often not detectable 
(Herwaldt, 1999). Cross reactions often complicate the interpretation (Wilson, 1995). Another 
disadvantage of serology is the fact that it is generally not reliable in immuno-compromised 
patients (Pizzuto et al., 2001; Agostoni et al., 1998). 
 
Enzyme linked immunosorbent assay (ELISA): 
The ELISA technique has been adapted especially to the diagnosis of VL by Hommel et al., 
(1978). Monoclonal Antibodies have been developed and are widely used for the ELISA, 
Western Blot and immunofluorescence assays (Jaffe and McMahon-Pratt, 1983; 1987; Jaffe et 
al., 1984; Jaffe and Sarfstein, 1987; Baneth et al., 1998). A highly specific and sensitive ELISA 
was developed by Jaffe and McMahon-Pratt (1987) for the diagnosis of VL. The assay was 
based on specific antibodies competing with serum antibodies. This competitive assay proved to 
be superior to direct binding tests, since no cross reactivity was reported, but it is not generally 
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used. In a comparative study on different serological methods conducted on 49 patient sera from 
India, the ELISA using a recombinant antigen proved to be more sensitive (100%) than the 
regular ELISA (77%), and was more sensitive than the DAT (90%) (Raj et al., 1999). 
 
Immunofluorescence assay (IFA): 
Immunofluorescence assays can be employed to detect either antibodies in patient sera or to 
identify the antigen. The IFA has been adapted to detection of Leishmania antibodies in patient 
sera by Walton et al., (1972). Rachamim et al., (1991) found in a comparative study in dog sera 
that the ELISA yields the same qualitative diagnosis as the IFA. It was concluded that the 
ELISA can replace the IFA due to its better practicability and its advantage in examining many 
more sera simultaneously. Mancianti et al., (1995) found a slightly higher sensitivity with the 
ELISA (99.5%) than with the IFA (98.4%), but the IFA was more specific (100%) than the 
ELISA (97.1%). The study was conducted with 290 dogs (186 Leishmania infected and 104 
control animals).  
 
Direct agglutination test (DAT): 
The DAT is a comparatively simple and reliable screening test suitable for field work. It is based 
on the agglutination of positive sera with stained promastigotes and can be performed in 
microtiter plates (Allain and Kagan, 1975; Harith et al., 1986; Zijlstra et al., 1991; 1992). In a 
study on treated VL patients the DAT was reported to be to 100% sensitive and to 99.3% 
specific. Oskam et al., (1999) used a freeze-dried antigen which is more stable and therefore 
improves the usefulnes of the DAT for field studies.  
 
Western Blot: 
The Western Blot relies on the recognition of Leishmania antigens by anti-leishmanial 
antibodies. Antigenic proteins of the parasites are separated by electrophoresis and are incubated 
with patient sera. In the Western Blot several different antigenic products can be recognized by  
different antibodies simultaneously in one assay. It was found that the sera of PKDL patients 
consistently recognize a specific antigen which is not recognized in VL patients without PKDL. 
This could be utilized for the identification of PKDL patients (Salotra et al., 1999).  
 
A recent improvement in serological diagnosis is the development of the rK39 dipstick test. One 
antigen (rK39) with high antigenicity has been selected and is recognized by the serum of kala 
azar patients. It is successfully employed in the diagnosis of VL in Nepal. It was found to be 
100% sensitive and 100% specific when tested in 14 newly diagnosed VL patients and 113 
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controls (Bern et al., 2000). It is comparatively inexpensive and results are obtained within 
minutes. 
 
1.2.3. Identification of Leishmania species and subspecies: 
Isoenzyme analysis: 
The analysis of isoenzymes is a generally accepted reference method for the species-specific 
diagnosis of Leishmania strains. The electrophoretic mobility of soluble enzymes is examined on 
starch or cellulose acetate gels. Patterns of single or multiple bands are seen. A consistent profile 
of isoenzyme patterns is found in closely related strains, which is also referred to as zymodemes. 
Between 10-20 enzymes have to be examined in order to classify new strains into their 
zymodemes (Miles et al., 1980; Aljeboori and Evans, 1980; Peters et al., 1985; Oren et al., 1991; 
Barral et al., 1991; Kreutzer et al., 1993). Gramiccia et al., (1992) found that viscerotropic and 
dermatotropic L.d.infantum strains differed in their zymodemes.  Isoenzyme analysis is work- 
intensive, time-consuming and not feasible for a regular laboratory. It is usually performed in 
specialized laboratories which are also internationally acknowledged to label new strains with 
codes according to their zymodemes (eg. LON- for London School of Hygiene and Tropical 
Medicine, or MON- for University of Montpellier).   
 
Excreted Factor (EF): 
This method allows species specific diagnosis of Leishmania strains (some species can be 
distinguished, some not). The EF refers to soluble antigenic substances (glycoconjugate 
compounds) which are present in the medium of growing promastigotes. Culture media is used 
in a gel diffusion test in which the EF compounds are precipitated by antileishmanial antibodies 
of the same species (Schnur et al., 1972).  
 
1.2.4. DNA based methods: 
1.2.4.1. Classical methods: hybridization and restriction: 
Efforts have been made to develop hybridization methods. Before the introduction of PCR, 
Southern Blotting, using radiolabelled probes for hybridization, was one of the most sensitive 
detection methods. Smith et al., (1989) were able to routinely detect 10,000 promastigotes. 
Washed promastigotes were blotted on nitrocellulose filters and hybridized with radiolabelled, 
cloned fragments of minicircles (das Gupta et al., 1991). Gramiccia et al., (1992) have employed 
a kinetoplast probe specific for L.d. infantum. Laskay et al., (1991) introduced a dot blot 
hybridization method using squashed sandflies on nylon membranes and L.aethiopica DNA as a 
probe. The hybridization detected every infected sandfly and reached the same level of 
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sensitivity as microscopy on infected sandflies. A weak signal was obtained from  a minimum of  
100 promastigotes. Lambson et al., (2000) developed a probe based on a cloned fragment of a 
minicircle which hybridized with DNA from the L.donovani complex only. Dot blots of 




 parasites, as others had shown previously.  
Also the digestion of purified kDNA with analysis of the restricted fragments (RFLP-analysis) 
was used for diagnosis (Jackson et al., 1984). The sensitivity of these methods is not sufficient 
for direct diagnosis in clinical material. 
 
1.2.4.2. Modern methods based on the polymerase chain reaction (PCR): 
The polymerase chain reaction (PCR) provides an excellent tool for the diagnosis and 
characterization of various infectious agents. It proved to be very useful for the diagnosis of 
leishmaniasis too. The method is based on the enzymatic amplification of selected DNA 
sequences, which are made visible by gel electrophoresis. PCR has a high potential for 
sensitivity, up to the detection of single parasites (Rodgers et al., 1990; Lopez et al., 1993; 
Noyes et al., 1998; Harris et al., 1998). In many studies PCR was found to be more sensitive 
than microscopy (Osman et al., 1997 a), and it proved to be more sensitive (100%) when 
compared to serology (63%) (Ashford et al., 1995). So far, several different PCR approaches 
have been developed for the diagnosis of leishmaniasis. 
Depending on the objective, different targets for amplification are chosen: for diagnosis multi-
copy sequence repeats are usually selected, implying the potential for high sensitivity. For this 
purpose the sequences need to be highly conserved either within the genus or within the species, 
depending on the specific aim. For genetic characterization of individual strains, more variable 
regions are selected, which usually do not appear in high copy numbers and are therefore less 
sensitive targets. Culturing of promastigotes is usually required for genetic characterization. 
Sensitivity and specificity can be enhanced by the hybridization of PCR products (southern 
blotting). The specificity can be improved by restriction fragment analysis of the PCR-
amplificates. 
 
Targets for diagnostic PCR: Kinetoplast DNA (kDNA) 
The targets with the highest copy number (10,000) are the kDNA minicircles. The minicircles 
have a size of about 800 bp with specific differences in sizes among some of the Leishmania 
species. They divide into subclasses of different sequences, but all of them share the same 
conserved sequence of 120 bp. This fact has been utilised for a genus-specific diagnostic PCR 
approach introduced by Rodgers et al., (1990) and later employed by others (Rodriguez et al., 
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1994; Ashford et al., 1995; Laskay et al., 1995; Reale et al., 1999). The major part of the 
minicircles consists of variable sequences. The different subclasses show variations, which to 
some extent are shared among species and to another are even different among clones of the 
same strain. This can be explained by a fast rate of sequence evolution of the minicircles. In 
contrast, some minicircle classes are well preserved within the species, even from geographically 
distant origins. Gutiérrez-Solar et al., (1995) showed that minicircle sequences from a well 
preserved minicircle class can be almost identical, even if the strains are isolated in China or in 
Europe. These facts make the design of species-specific oligonucleotides and probes 
problematic. Nevertheless, several approaches were undertaken, which have proved to be useful 
for species-specific and comparatively sensitive diagnosis. One pair of oligonucleotides was 
introduced by Smyth et al., (1992) for the diagnosis of kala-azar patients, which amplified whole 
minicircles of different species. Bhattacharyya et al., (1996) developed genus specific kDNA 
primers able to amplify whole minicircles. Eresh et al., (1993) introduced primers with the 
purpose of amplifying the species from the Old World and specifically to differentiate between 
L.major and L.tropica. These oligonucleotides were applied to purified DNA, but the sensitivity 
has never been studied (Klaus et al., 1994).  
 
2.Nuclear targets: 
Two genomic targets have been preferably selected: The small subunit ribosomal RNA (ssu 
rRNA) and the spliced leader sequence or mini-exon gene. Both targets are present in about 200 
copies. Due to the fact that these gene repeats consist of both conserved and variable regions, 
which are often species-specific, these targets are suitable for the development of more specific 
diagnostic approaches. The ssu rRNA gene has been successfully used as a target (van Eys et al., 
1992; Campino et al., 2000). The internal transcribed spacer (ITS) within the ribosomal operons 
(ssurRNA) is another target which has been selected by Guevara et al., (1992), Cupolillo et al., 
(1995) Schönian et al., (2000) and El Tai et al., (2000). The latter showed that the PCR was 
highly sensitive using clinical material. Combined with restriction fragment analysis of the 
amplified ITS region all species complexes could be identified. Also the mini-exon gene was 
successfully used as a target (Fernandes et al., 1994, Ramos et al., 1996; Harris et al, 1998). 
Harris et al, (1998) developed a multiplex PCR which was able to discriminate between the New 
World complexes of Leishmania and which was also very  sensitive. 
 
PCR and hybridization: 
In order to enhance the sensitivity and also to confirm the specificity, PCR has been combined 
with hybridization. In recent years non-radioactive detection methods have been introduced. 
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Lopez et al., (1993) were able to increase the sensitivity of a kDNA based PCR 10 fold by 
hybridizing the PCR product to membrane-bound oligonucleotides. The PCR product was 
biotinylated and colorimetrically detected by a streptavidin-alkaline phosphatase (SAP). 
Rodriguez et al., (1994) developed kDNA probes able to distinguish between L.mexicana and 
L.braziliensis infections. The combination of PCR with primers 13A/13B and subsequent 
hybridization proved to be highly sensitive as well as highly specific. 233 biopsies of skin 
lesions suggestive of CL were examined. PCR products were seen in 226 (97%) of the patients. 
After hybridizing the 120 bp product, 117 samples hybridized to a L.mexicana specific probe and 
109 hybridized to a L.braziliensis specific probe. The results reflected the epidemiological 
situation in Venezuela very well, when the origin of the patients was compared to the results. 
Furthermore, the results were confirmed by restriction patterns found after digestion with Msp I 
on purified kDNA from 60 positive cultures. Nuzum et al., (1995) evaluated the usefulness of 
PCR on peripheral blood for the diagnosis of kala-azar. Peripheral blood mononuclear cells 
(PBMC) were separated and lysed. The PCR product was biotinylated and bound to a specific 
oligonuctleotide probe in a microtiter plate, followed by an enzymatic reaction, which could be 
detected by an ELISA reader. Laskay et al., (1995) chose a similar approach, combining PCR 
with primers 13A/13B and  Southern Blotting using L.aethiopica kDNA as a probe to confirm 
the specifity. The hybridization enhanced the sensitivity 10 fold so that DNA corresponding to 
0.01 promastigote was detectable. Also digoxigenin (DIG) labelled probes were used and 
hybridization was visualized by a chemiluminescent signal (Rodriguez et al., 1999; Reale et al., 
1999). The latter found the genus specific kDNA-PCR (13A/13B), to be sensitive up to 0.1 fg of 
purified DNA (corresponding to 0.01 parasite), when combined with hybridization. 
 
1.2.4.3. Molecular strain typing of Leishmania: 
For genetic characterization as well as for species-specific diagnosis several other PCR-based 
methods have been developed:  
 
Randomly amplified polymorphic DNA analysis (RAPD) or arbitrarily primed polymerase 
chain reaction (AP-PCR):  
For RAPD/AP-PCR non-specific oligonucleotides are employed, which yield highly 
polymorphic products (Bhattacharyya et al.,1993; Schönian et al., 1996). Characteristic patterns 
for PCR products of different sizes are obtained. Mimori et al., (1998) used single products 
obtained by the AP-PCR to develop species-specific primers for five Leishmania species of the 
New World. Eisenberger and Jaffe, (1999) employed a Leishmania-specific oligonucleotide in 
combination with a non-specific permissive oligonucleotide. Banding patterns were 
 35  
characteristic for each species complex, occasionally showing also regional differences within 
the species. RAPD/AP-PCR-methods are generally not suitable for direct diagnosis: the 
sensitivity is not sufficient and the conditions need to be highly standardized. The patterns show 
alterations if the PCR conditions or the amount of template is changed. Due to the characteristics 
mentioned these methods are limited to the use of purified DNA (Noyes et al., 1996; Eisenberger 
and Jaffe, 1999). 
 
Restriction fragment length polymorphism (RFLP) or Schizodeme analysis: 
Amplified minicircle DNA is restricted enzymatically into fragments, which are visualized by 
gel electrophoresis. The fragment patterns or schizodemes are specific, either for species or for 
individual strains. The polymorphism of patterns indicates differences in sequences. Schizodeme 
analysis is a valuable tool for epidemiology and for species-specific diagnosis, usually on the 
basis of purified kDNA (Noyes et al., 1998; Qubain et al., 1997). For L.d.infantum it was shown 
that the known zymodeme groups around the Mediterranean could be subclassified by 
schizodeme analysis into various other groups (Noyes et al., 1998). Also this method is sensitive 
to minor changes in the conditions. Apart from that, point mutations may change the pattern due 
to changed restriction sites. This is desirable for genetic characterization, but for direct diagnosis 
from clinical material the method is neither sensitive nor consistent enough. 
 
1.3. Objectives of the study: 
At the onset of this work, microscopy, serology (ELISA, IFA, EF) and PCR-based on cultured 
parasites (Eisenberger and Jaffe, 1999) were the standard diagnostic methods for leishmaniasis at 
the Kuvin Center, which is the most advanced and specialized center for the study of 
leishmaniasis in Israel and the West Bank. The methods followed in this institute therefore 
reflect the diagnostic standard of the whole country. No sensitive direct (without culturing and 
not serological) diagnostic method had been established so far. For the diagnosis of patients as 
well as for epidemiological studies on reservoir animal species there was need for a field 
applicable sensitive and specific PCR as a routine method. 
The prevalence of three Leishmania species in Israel and the West Bank, with overlapping 
clinical pictures and endemic areas, increasing numbers of patients and unidentified reservoir 
animal and vector species in some areas made the development of improved laboratory tests an 
urgent priority. In recent years new L.tropica foci are emerging, and L.d.infantum has been 
increasingly identified among canids in central Israel (see maps, Figures 4 and 5). Also the fact 
that some reservoir animals, eg. dogs, may harbour different species of Leishmania emphasizes 
the need of a directly applicable diagnosis method at the species level (Baneth et al.,1998; 
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Dereure et al. 1991). Furthermore, New World CL is a serious problem in the country, as many 
Israelis travel to Central and South America (Dan et al., 1985). There are a number of cases seen 
annually (~10 in the Tel Hashomer Hospital). These patients need to be diagnosed at least at the 
complex level, since only infections due to the L.braziliensis complex require a three-weeks 
course of antimonal treatment. Specifically L.braziliensis infections need to be distinguished 
from L.mexicana infections. Species of both complexes are prevalent in large parts of Central 
and South America and have an overlapping geographical distribution and clinical presentation 
(Eresh et al., 1994). Differential diagnosis within the New World species of Leishmania has not 
been performed in the country to date. Old World infections need to be excluded, since the 
infections might as well have been contracted in Israel either before or after the journey. Due to 
immigration from Ethiopia, infections caused by L.aethiopica also need to be considered, as a 
differential diagnosis of other skin diseases. Presumably in no other country is such a variety of 
causative agents of leishmaniasis seen on a regular basis as in Israel.  
Over the last decade many efforts have been made in many parts of the world to improve PCR 
diagnosis of leishmaniasis. It was emphasized in a recent article on leishmaniasis in the Lancet  
that field applicable, diagnostic methods including species identification are desparately needed 
(Herwaldt, 1999). Several sensitive PCR methods have been developed by various research 
groups, using extracted DNA directly from clinical material. It has been shown that clinical 
material, eg. dermal lesion scrapings (CL) or peripheral blood (VL) could be collected and 
preserved on filter paper (Osman et al., 1997 a; Harris et al., 1998; Färnert et al., 1999; Campino 
et al., 2000). PCR appeared to be the method of choice, for achieving sensitive and species-
specific diagnosis of leishmaniasis in Israel and in the West Bank. 
 
Specific aims: 
1.  To establish direct PCR diagnosis of leishmaniasis in Israel and the West Bank. This 
included: testing for the most effective DNA extraction method, developing a sampling 
strategy (which samples to be collected), optimization of the PCR approach, achievement 
of the highest possible sensitivity and adaption for routine use. 
2.  To differentiate between the endemic species L.major, L.tropica and L.d.infantum by 
direct PCR diagnosis. 
3.  To establish direct PCR diagnosis of New World leishmaniasis, especially of the 
L.braziliensis complex. 
4. To establish PCR methods for the screening of reservoir animals and sandfly vectors. 
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1. Material and Methods 
 
The polymerase chain reaction (PCR) was selected as the most appropriate method, with the best  
potential to achieve direct, sensitive and species specific diagnosis. In order to establish the 
methods, samples had to be collected first. It appeared that dermal scrapings from CL lesions, 
preserved on filter paper, would be a suitable sampling procedure for this purpose (Harris et al., 
1998; Färnert et al., 1999). Apart from dermal scrapings several other specimens were obtained 
too, as for example Giemsa stained smears, paraffin embedded biopsies, peripheral blood, 
aspirates, spleen and liver tissue and also cultures of promastigotes. Samples were collected from 
patients as well as from various animal species, which were either known or suspected reservoir 
species of leishmaniasis. The collected and processed samples are presented here as groups. 
Detailed description of the samples is given together with the results in Tables 5-10.  
 
2.1. Origin of samples: 
2.1.1. Reference strains: 
Preliminary studies were performed on purified DNA from various strains of all available  
species. These strains had been collected over many years and were preserved at the WHO-
reference center for Leishmania strains at the Kuvin Center, Jerusalem. The cultured strains had 
been characterized previously by EF, isoenzyme analysis and PPIP-PCR (Eisenberger and Jaffe, 
1999). The purified DNA of these strains was used for positive controls in every experiment. 
The New World strains were kindly provided by Linda Oskam, Royal Tropical Institute, 
Amsterdam. Table 2 shows the reference strains used in this study. 
 
Table 2 : Reference strains 
 
Species LRC WHO code Source Origin 
L.major* LRC-137 MHOM/IL/67/Jericho II human  Jericho 
L.major LRC-465 IPAP/IL/84/UVDA sandfly Israel (Uvda) 
L.major LRC-509 MHOM/IL/86/BLUM human Jordan Valley 
L.tropica* LRC-36 MHOM/IQ/66/L75 human Iraq 
L.tropica LRC-682 MHOM/TR/95/Urfa40 human Turkey (Urfa) 
L.tropica LRC-747 IL/98/LRC-L747 sandfly Israel (Kfar Adumim) 
L.donovani* LRC-133 MHOM/ET/67/HU3 human Ethiopia 
L.donovani LRC-661 MHOM/SD/??/Khartoum human Sudan 
L donovani LRC-751 MHOM/IN/93/BI2302 human India 
L.d.infantum*  MHOM/TN/80/IPT1 human Tunisia 
L.d.infantum LRC-716 MCAN/IL/97/LRC-L716 dog Israel (Nataf) 
L.d.infantum LRC-719 MCAN/IL/97/LRC-L719 dog Israel (Rishon le Zion) 
L.aethiopica* LRC-149 MHOM/ET/72/L102 human  Ethiopia 
L aethiopica LRC-495 MHOM/ET/85/Vasa human  Ethiopia 
L.gerbilli* LRC-652 MRHO/CN/60/LD3 Rhombomys opimus China 
L turanica LRC-654 MRHO/MN/83/MNR2 Rhombomys opimus Mongolia 
L arabica  MPSA/SA/83/JISH220 Psammomys Saudi Arabia 
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L killicki*  MHOM/TN/80/LEM 163 human Tunisia 
L.mexicana  MHOM/GT/86/GO22 Oskam/Evans  
L.braziliensis  MHOM/CO/81/MORO Oskam/Evans  
L.amazonensis* WR 669 MHOM/BZ/73/M2269 no information  
L.guyanensis* WR 677 MHOM/BR/75/M4147 Oskam/WR  
L.panamensis  MHOM/CR/87/NEL3 Oskam/lab  
L.chagasi  MHOM/BR/74/PP75 LF Schnur  
T.cruzi  - LF Schnur  
T.lewisi T22 - LF Schnur  
L.seymourii L524 - LF Schnur  
C.fasciculata L466 - LF Schnur  
P.davidii ATCC 50166 - LF Schnur  
All strains were part of the WHO Reference Center for Leishmania strains at the Kuvin Center. Parts of the 
collection had been cultivated at the Kuvin Center (coded with LRC- Leishmania reference center, animal or human 
source known). Other strains had been received from others, as for example the internationally used WHO-reference 
strains (*) (often no information on the source of collection). All strains were identified by isoenzyme 
electrophoresis, many of them also with additional methods (PCR, EF).  
 
2.1.2. Patients: 
Samples were collected from patients visiting the Dermatology clinic of the Hadassah Hospital 
with lesions suspected of CL. Over a period of more than one year 100 skin scrapings from 
Hadassah-patients were collected (by Flory Jonas). Skin scrapings and/or cultures were collected  
from 11 Patients of the Tel Hashomer Hospital, 6 of them had contracted the disease in the New 
World. Most of the examined patients were Israelis who either live in endemic areas, who had 
been travelling inside or outside the country or who had been stationed as soldiers in the Judean 
Desert or in the Negev.  
A new focus of CL was discovered in early spring 2000 in a village named Wadi Albethan (West 
Bank/Samaria), located between Nablus and the Jordan Valley. In 8 households skin scrapings 
and cultures were collected. Skin scrapings were taken from 23 patients on filter paper and on 
slides. Eleven lesion aspirates were collected for culturing in NNN and semi-solid media. The 
number of cultures was smaller since needle aspirations were not performed on facial lesions of 
infants, and some other individuals refused. Detailed information on single patients is presented 
in  in chapter 3 (Results). 
 
2.1.3. Animal samples: 
Desert rodents: 
An extensive field study on desert rodents was carried out by Gideon Wasserberg (PhD student 
of the Department of Life Sciences, Ben-Gurion-University of the Negev). Rodents were trapped 
in endemic areas of the Negev (Qziot and Nizana), and skin scrapings were collected from the 
ears for microscopical examination. With the beginning of the cooperation the tissue was 
collected on sterile filter paper as well (for PCR). 
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The predominant species was the fat sand rat (Psammomys obesus), besides gerbils (Meriones 
crassus and Gerbil dasyarus) were trapped and examined. This collection of animal tissue 
samples provided an excellent study group for testing the reliability of the PCR from tissue 
preserved on filter paper. DNA extraction and PCR was performed on ear scrapings of 28 
individuals of P.obesus, 6 M.crassus and 19 G.dasyarus.  
 
Canids: 
Blood of four infected dogs was examined for the presence of leishmanial DNA. A drop of 
collected peripheral EDTA-blood was preserved on filter paper (received from Dr. Gad Baneth, 
School of Veterinary Medicine of the Hebrew University, Rehovot). The dogs had been 
diagnosed previously by microscopy on Giemsa stained lymph node and spleen aspirates.  
In an earlier study by the same collegue jackals had been trapped in several areas in central 
Israel. The jackals had been previously screened for the presence of antibodies against 
L.d.infantum by ELISA and western blotting, partly with borderline positivity. No method for 
the detection of the antigen had been applied yet. Since PCR was available now it seemed to be 
worth-while to extract and amplify DNA from tissue of these animals in order to complete the 
survey. Ears and spleens were examined. The ears of 20 jackals were deep frozen at a 
temperature of –70°C. The spleens of 14 individuals had been preserved in buffered formalin. 
This was not very promising for good PCR results but it was worth-while to examine. 
 
Hyrax: 
Since hyraxes were highly suspected serving as reservoir for L.tropica (Photo 19), it was of 
interest to examine hyrax tissue. A parched body of a hyrax was found next to a cave in which a 
sandfly infected with L.tropica (LRC-747) had been trapped a few days earlier. The cave was 
close to Kfar Adumim, an Israeli settlement in the Judean Desert, one of the emerging L.tropica 
foci in the country. Most human cases had occurred in the periphery of the settlement, facing the 
slope with the caves (Photo 13). The presence of fecal remains of hyraxes as well as the corps 
indicated that these caves were inhabited by hyraxes. Several specimens of the hyrax were 
extracted, namely bone powder from the femur, tissue from the skin and nose. Ear tissue was not 
available. One ear sample from a living hyrax, which had been trapped in the Galilee (by 
Gunther Müller, Kuvin Center), was examined too.  
 
2.1.4. Cultivation of  Leishmania promastigotes: 
Cultures were obtained by Lionel Schnur (Kuvin Center, Hebrew University) and Flory Jonas 
(Dermatology Clinic, Hadassah Hospital), or collected during visits (Wadi Albethan, Tel 
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Hashomer Hospital). One culture derived from a sandfly trapped in a cave close to Kfar 
Adumim, one of the major L.tropica foci in the country (Alon Warburg, Kuvin Center).  
 
2.2. Laboratory work: 
2.2.1. Sampling: 
The study focused on dermal scrapings preserved on filter paper. Skin scrapings were obtained 
from patients with cutaneous lesions and from rodents. After desinfection with 70% ethanol a 
small incision was cut with a disposable surgical blade radially into the lesion, and some tissue 
was scraped off as described by Herwaldt, (1999). It was important to obtain tissue with as little 
blood as possible. The material was blotted on UV-radiated and autoclaved 3 mm filter paper 
(Schleicher and Schüll, Germany) and on glass slides for Giemsa staining. The tissue samples 
were wrapped with aluminium foil and stored at room temperature. Prior to extraction, the 
scraped tissue spots were cut off of the filter paper using sterile surgical blades. A new blade was 
used for each sample. The tissue samples were transferred to screw-cap 1.5 ml tubes containing 
either 500 µl NET buffer, 500 µl guanidine thiocyanate solution or 250 µl chelex (5%), 
depending on the extraction method used.  
 
2.2.2. Giemsa staining of smears: 
Smears were collected on glass slides, air dried and fixed with methanol for a few seconds. 
Giemsa stain was filtered and diluted 1:20 with phosphate buffer (pH 7.2). After 20 minutes of 
staining the slides were washed with tap water and air dried. The stained smears were examined 
under the microscope with a 40x lens and with a 100x oil immersion lens. If at least one intra- or 
extra-cellular amastigote with a distinctive kinetoplast was found the smear was declared 
positive. When no amastigotes were seen after 15 minutes the smear was declared negative. 
Microscopy of the smears of the Hadassah patients and of the desert rodents was performed by 
Flory Jonas and Gideon Wasserberg respectively. Many of the patient smears and some of the 
rodent smears were double checked, the observations were in concordance. All samples collected 
during visits (Wadi Albethan, Tel Hashomer Hospital) were stained and examined in our 
laboratory. 
 
2.2.3. Collection and cultivation of Leishmania strains: 
Cultures were obtained by needle aspiration from the border of the lesions. Usually it was 
necessary to inject about 0.1 ml of sterile 0.9% saline into the lesion in order to aspirate a drop of 
fluid as described by Herwaldt, (1999). The aspirated fluid was discharged into two culture 
tubes, one containing semisolid (SS) blood agar (Schnur and Jacobsen, 1987) and the other NNN 
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medium (Novy-MacNeal-Nicolle medium) overlayed with Schneider's (Gibco, Grand Island, 
NY; Biological Industries Beit Haemek, Israel) supplemented with 10% fetal calf serum, 2 mM 
L-glutamine, 200 µg/ml streptomycin, and 200 U/ml penicillin. The cultures were incubated at 
24-28°C. After a few days one drop of media was examined under the microscope. If 
promastigotes were found the cultures were transferred into Schneider’s Drosophila medium for 
further culturing. The parasites were cultivated in 5 ml of Schneider’s medium for 2-3 days 
before they were transferred to a larger volume (40 ml). Negative cultures were examined again 
several times and in case of no growth they were discarded only after 3 weeks. DNA-extraction 
was performed from 40 ml of densely grown parasites (see later). 
 
2.2.4. DNA extraction: 
Several different methods were tested, in order to find reliable and simple methods which could 
be adopted in a clinical laboratory and also be employed for epidemiological studies (high 
number of samples).   
 
Phenol-chloroform-extraction: 
1. Extraction from clinical samples, mostly dermal scrapings preserved on filter paper: 
Each tissue sample was transferred into a 1.5 ml tube and lysed with 500 µl of NET buffer (50 
mM NaCl; 10 mM EDTA; 50 mM Tris-HCl). Sodium dodecyl sulfat (SDS) was added to a final 
concentration of 5 %. RNAse was added to a final concentration of 100 µg/ml (5 µl of a 10 
mg/ml solution) and the samples were incubated at 37°C for 30 minutes. Proteinase K (10 µl of a 
10 mg/ml solution) was added to a final concentration of 200 µg/ml. The samples were digested 
over night, rotating in a hybridization oven at 60°C. Equal volumes of saturated phenol were 
added to each sample (500 µl). The samples were mixed gently for 5 minutes. After 
centrifugation at high speed (12000 rpm) for 5 minutes at room temperature the upper phase was 
carefully removed and transferred to new 1.5 ml tubes. A phenol and chloroform mix 
(chloroform/isoamylalcohol 25:1) was added in equal volumes to each sample (250+250 µl). The 
samples were mixed gently and centrifuged for 3 minutes. The upper phase was again transferred 
to a new tube. Equal volumes of chloroform were added and the samples were centrifuged for 1 
minute. The upper phase was once again  transferred. The DNA samples were precipitated with 
50 µl of 3M sodium actetate (NaAc 300 mM, pH 6.0) and one volume (500 µl) of cold (-20°C) 
isopropanol and then stored on ice for 30 minutes. Subsequently, the samples were centrifuged at 
14,000 rpm for 45 minutes at 4°C. The isopropanol was removed and the DNA pellets were 
washed with cold (-20°C) 70% ethanol (250 µl). The samples were centrifuged for 10 minutes. 
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The ethanol was removed, and the DNA pellets were vacuum dried. The DNA samples were 
then resuspended in 25 µl of sterile water and dissolved for one hour at 56°C. The fresh DNA 
samples were immediately subjected to PCR experiments. The remainder of the DNA was 
aliquoted and stored at -20°C. 
 
DNA extraction from cultures: 
The procedure routinely performed at the Kuvin Center has been described by Eisenberger and 
Jaffe, (1999). The reference strains used as positive controls had been extracted by this method 
as well as every newly collected strain which was cultivated during this research. Parasites were 
harvested at a density of about 2 x 107 parasites/ ml. The cells were centrifuged for 10 minutes at 
2500 rpm and washed three times with phosphate bufered saline (PBS). Proteinase K digestion 
and phenol-chloroform extraction followed. The protocol differed in some points from the 
extraction described above: Triton-X 100 (1%) was used instead of SDS. The proteinase K 
digestion was performed for 2h. The DNA was resuspended in 100 µl of TE buffer (1 mM 
EDTA; 10 mM Tris-HCl; pH 8.0). The DNA concentrations were determined photometrically at 
an absorbtion of 260 nm and stored at 4°C. Dilutions of 100 ng/µl and 20 ng/µl were prepared.  
 
Guanidine extraction:  
The method has been described by Boom et al., (1990). 
Preparation of silica beads: 
Six g of silica beads (Sigma) were washed in 50 ml of sterile ddH2O and mixed gently for 24 h at 
room temperature in a rotating hybridization oven. After a quick centrifugation the water was 
pipetted off. The silica beads were washed once again, the second time rotating for 5 h was 
sufficient. Sixty µl of HCl (1M) were added to the pellet. The consistency of the silica beads was 
viscous. The purified silica beads were transferred to a brown glass tube, autoclaved  and stored 
at room temperature. The prepared silica beads were stable for long term use. 
 
Extraction:  
The tissue samples were transferred to 1.5 ml tubes containing 500 µl of guanidinium 
thiocyanate solution (4M guanidinium thiocyanate (GTC), 0.1 M Tris-HCl pH 6.4; 0.02 M 
EDTA, pH 8; 1.3% Triton X-100) and incubated over night at 56°C under gentle agitation. One 
ml of 6 M sodium iodate (NaI) and 10 µl of resuspended silica beads were added. The samples 
were vortexed and kept on ice for one hour. After a quick centrifugation (3 seconds at 12,000 
rpm), the supernatant was carefully removed and discarded. Wash buffer (0.01M Tris-HCl, pH 
7.5; 0.05 M NaCl; 1 mM EDTA pH 8; Ethanol 50%) was added to each tube. The silica bead 
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pellets were vortexed until they were in suspension. Another quick centrifugation followed and 
the buffer was removed. The pellets were washed with 100% ethanol and vacuum dried. They 
were resuspended in 100 µl of sterile ddH2O and incubated for one hour at 56°C. The silica 
beads were spun down prior to PCR to avoid any inhibitory activity. The guanidine solution and 




A 5% Chelex solution was prepared by washing 500 mg of Chelex -100 (Biorad) in 10 ml of 
sterile ddH2O. The suspension was boiled for 10 minutes in a water bath. After centrifugation for 
5 minutes at 3000 rpm the water was removed. The washing step was repeated once. The 
purified chelex was resuspended in 10 ml of ddH2O and aliquoted to 250 µl volumes for 
subsequent use. The samples were incubated over night at 56° and then heated for 10 minutes to 
94 °C. After centrifugation of 1 minute at 12000 rpm the supernatant was directly used for PCR 
(Harris et al., 1998).  
 
Crude methods: 
Lysis of cultured parasites: 
PCR diagnosis from cultured strains was performed whenever new strains were cultivated in the 
laboratory and a differentiation between L.major and L.tropica was required. The density of 
parasites was not defined, since cultures were usually subjected to PCR as soon as there was a  
microscopical evidence of promastigotes. Cultures (100 µl) were transferred to 1.5 ml tubes and 
diluted 1:4 (300 µl) with ddH2O. The cultures were boiled for 5 minutes to increase cell lysis. 
One µl of the lysate was used as template.  
 
Crude preparation of dermal scrapings on filter paper: 
Dermal scrapings were processed as for the phenol-chloroform extraction. After the over night 
digestion with proteinase K the samples were only heated for 10 minutes to 95°C (or boiled for 5 
minutes) to inactivate the enzyme and then centrifuged shortly at high speed (12,000 rpm). The 
supernatant was directly used for PCR. 
 
2.2.4.1. Choice of extraction methods according to specimens: 
The patient samples (dermal scrapings on filter paper) were tested with each of the presented 
extraction methods. Some of the other sample groups were extracted with one specific method: 
The phenol-chloroform method was used for the jackal samples and the hyrax ear. A small part 
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(~0.5 g) of each jackal ear was chopped with a surgical blade and transferred to a 1.5 ml tube. 
Small pieces (~0.1 g) of the formalin fixed jackal spleens were cut out and were washed three 
times with sterile PBS prior to the extraction. Thorough purification was also required for 
Giemsa stained smears and paraffin embedded skin biopsies (phenol-chloroform). The guanidine 
extraction method was used for several series of patients samples (dermal scrapings on filter 
paper) and also for the parched hyrax tissues. The chelex extraction method was employed on 
dermal scrapings from patients and on the rodent samples. The crude extraction methods were 
used experimentally on filter paper samples from patients. 
 
2.2.4.2. Extraction from paraffin embedded biopsies: 
Four paraffin embedded skin biopsies of CL patients were proceeded. For deparaffinization,  
several slices were cut from each block and transferred into a 1.5 ml tube, containing 1 ml of 
xylene. The sample was vortexed and then left for 10 minutes at room temperature. After 
centrifugation for 5 minutes at 12,000 rpm the xylene was removed and the process repeated. 
One ml of absolute ethanol was added, the samples were mixed and centrifuged for 5 minutes 
and the ethanol was removed. The ethanol washing was repeated twice. Finally, the samples 
were vacuum dried, redisolved in ddH2O and submitted to phenol-chloroform extraction (Laskay 
et al., 1995). 
 
The 3 extraction methods (phenol-chloroform, guanidine and Chelex) were compared on 
infected mouse liver tissue, which had been evenly distributed on filter paper. Squares of 0.5 cm2 
were cut off the filter paper (6 pieces for each method, always 2 stored at a different temperature, 
see also the following passage). 
 
2.2.4.3. Storage conditions: 
The positive extraction control (mouse liver infected with L.donovani) was distributed 
homogenously on 3 pieces of filter paper. Each filter paper was stored at a different temperature 
(-20°C, 4°C and 20°C), in order to test the stability of the DNA in the tissue over a period of 1 
year under different conditions. Squares of the same size (0.5 cm square) were cut from each 




In the literature no primers were found which could achieve sensitive and species specific 
diagnosis for all species simultaneously. In order to adapt a diagnostic system to the specific 
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needs of the region, 3 different pairs of oligonucleotides were employed, which targeted at the 
kinetoplast minicircles (Uni21/Lmj4; 13A/13B and MP3H/ MP1L). The kinetoplast minicircles 
were selected as a suitable target due to the high copy number (10.000), implying the potential 
for high sensitivity. Close to the end of the study another pair of primers (LITSRn/L5.8S) was 
published (El Tai et al., 2000) and introduced also to this work. These primers target the 
intergenic transcribed spacer (ITS) and fulfill all the requirements (sensitive and species-specific 
diagnosis). 
 
1. Whole minicircle amplification with primers Uni21/Lmj4: 
The primer pair (Uni21/Lmj4) had been specifically designed for the purpose of direct diagnosis 
and the differentiation of L.major and L.tropica in Israel, which was had been the initial aim of 
this study. This primer pair had not been tested previously and was suggested by Prof. 
Greenblatt, Kuvin Center. The primer pair Uni 21 (5' -GGGGTT GGTGTAAAATAGGCC - 3') 
and Lmj4 (5' - CTAGTTTCCCGCCTCCGAG - 3') was designed by Eresh, Axelrod, Greenblatt 
and Barker (Eresh et al., 1993). The primer design was based on a published sequence from a 
L.major minicircle (Smith et. al., 1989). Primer Uni 21 was selected from a sequence within the 
conserved region. Primer Lmj4 was designed on the basis of the variable region of the same 
minicircle sequence.  
 
2. Genus specific kinetoplast primers 13A/13B: 
For the screening of desert rodents another PCR was employed, which needed to be primarily  
sensitive but not necessarily species specific. For this purpose kDNA primers 13A/13B (Rodgers 
et al., 1990) appeared to be suitable. Primers 13A (5'-GTGGGGGAGGGGCGTTCT-3') and 13B 
(5'-ATTTTCCACCAACCCC CAGTT-3') amplified a sequence of 120 bp of the kDNA 
minicircles. This sequence is conserved in all minicircle classes of all Leishmania species. Due 
to the small size of the sequence and its presence in all minicircles the PCR with primers 
13A/13B is highly sensitive and therefore suitable for screening. 
The following Figures demonstrate how primers Uni21/Lmj4 and primers 13A/13B relate to the 
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Figure 6: Section of the L.major minicircle 
                                                           50 
    L.major-original  AATTCCCCGA CCCACCCGGC CTATTTTACA CCAACCCCTA GTTTCCCGCC 
               Uni21  .......... .← 3'-CCG GATAAAATGT GGTTGGGG-5'.......... 
                Lmj4  .......... .......... .......... ....5'-CTA GTTTCCCGCC  
   13A  .......... .......... .......... .......... .......... 
                  13B .......... ......... 5'-ATTTTCCA CCAACCCCCA GTT-3'→... 
 
 
                      51                                                 100 
    L.major-original  TCCGAGCCCA AAAATGGCAA TTTTCGGCCA AAAATCGAAC GGGGTTTCTG 
               Uni21  .......... .......... .......... .......... .......... 
                Lmj4  TCCGAG-3'→.......... .......... .......... .......... 
                 13A  .......... .......... .......... .......... .......... 
                 13B  .......... .......... .......... .......... .......... 
 
 
                      101                                                150 
    L.major-original  CACCCATTTT TCGAATTTCG CAGAACGCCC CTACCCACGG GACCAGAAAA 
               Uni21  .......... .......... .......... .......... ..........     
    Lmj4  .......... .......... .......... .......... .......... 
                 13A  .......... .....← 3'- TCTTGCGGG GAGGGGGTG -5'......... 
                 13B  .......... .......... .......... .......... .......... 
 
 
151                                                 200 
    L.major-original  GTTTGAAATT TCGGGCATTT TTTGACCCCC ATAACCAAAA TACTCACATA 
               Uni21  .......... .......... .......... .......... .......... 
                Lmj4  .......... .......... .......... .......... .......... 
                 13A  .......... .......... .......... .......... .......... 



















L.braziliensis specific kinetoplast primers MP3H/ MP1L: 






                          13A/ 13B  →  120 bp
Uni21/ Lmj4  →  650 - 850 bp
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CCTCTG-3') were developed by Lopez et al., (1993) in order to distinguish between the species 
of the L.braziliensis and the L.mexicana complex. A 70 bp sequence specific of L.braziliensis 
minicircles is amplified. The L.mexicana complex as well as all Old World Leishmania species 
are not amplified.  
 
Amplification of the ITS-1 region with primers LITSRn/L5.8S: 
This non-kinetoplast based PCR has been recently published by El Tai et al., (2000). Primers 
LITSRn (5'- CTGGATCATTTTCCGATG - 3') and L5.8S (5'- AAGTGCGATAAGTGGTA-3') 
amplify a section of the intergenic transcribed region (ITS-1, about 300 bp) of all Leishmania 
species. In combination with the enzyme digestion of the PCR product using the restriction 
enzyme Hae III (= BsuRI) species specific diagnosis is achieved. ITS sequences of L.d.infantum, 
L.major, L.tropica, L.braziliensis, L.guyanensis, L.panamensis, L.mexicana, L.amazonensis and 
of other Leishmania species are published in the EMBL data base. These sequences are species 
specific and restriction sites could be identified that would allow the differentiation of all 
important Leishmania species, in the case of L.donovani and L.braziliensis the identification of 
the  complex. (G. Schönian, personal communication). Figure 8 shows the ITS region and how 
primers LITSRn/L5.8S relate to it. 
 
 







Restriction of the ITS-1 PCR-product: 
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The ITS-1 PCR products were digested with BsuRI (HaeIII) (MBI Fermentas, Lithuania). The 
amplified PCR products (8 µl) were mixed with 1 µl of enzyme and 1 µl of 10x buffer (10 mM 
Tris-HCl, pH 8.5; 10 mM MgCl2; 100 mM KCl; 0.1 mg/ml BSA) in 0.5 ml tubes, and were 
incubated for 2 hours at 37°C.  
 
2.2.5.2. PCR-conditions: 
The regular volume of each PCR reaction was 25 µl. Only the ITS-1 amplifications were either 
performed in 25 or in 50 µl. The reaction mixtures were prepared on ice. All  components were 
first pipetted into a 1.5 ml tube, well mixed and then aliquoted to 200 µl PCR tubes. For positive 
controls, 1 µl (20 ng/µl) of purified leishmanial DNA was used. When resuspended DNA from 
filter paper extractions was examined, 1 to 5 µl of extracted DNA were added. In case of lysed 
cultures 1 µl was sufficient as template. The reaction mix without DNA served as negative 
control.  
Several different polymerases were employed. The Promega Taq polymerase (Promega, 
Madison, WI) was used as a standard enzyme for most of the reactions. It was generally 
employed for the PCR with primers 13A/13B and MP3H/MP1L and for initial studies with 
primers Uni21/Lmj4 on purified DNA. For the studies on dermal scrapings with primers 
Uni21/Lmj4 a polymerase with a higher activity and stability was employed in order to increase 
the chances for positive results. In the beginning the TaKaRa Ex Taq polymerase (Takara Shuzo 
co., LTD., Japan) was used. Later the Fermentas Taq polymerase (MBI Fermentas, Lithuania) 
proved to be more reliable and was adopted in the laboratory. 
The reaction mix using the Promega Taq polymerase was composed of 50 mM KCl, 10 mM 
Tris-HCl (pH 9), 0.1 % Triton X-100, 1.5 mM MgCl2, 200 µM of each nucleotide (dATP, dGTP, 
dCTP, dTTP), 1µM of each primer, 1 U of polymerase and up to 5 µl of template DNA. Primers 
MP3H/ MP1L required only 0.625 U of the polymerase, since the amplified sequence was 
smaller (70 bp). PCR with the TaKaRa Ex Taq polymerase was performed in 10x Ex Taq buffer, 
2 mM MgCl2, 200 µM of each nucleotide, 1 µM of each primer, 0.5 U of TaKaRa Ex Taq 
polymerase and up to 5 µl of template DNA. The PCR with the Fermentas enzyme was 
performed in 75 mM Tris-HCl (pH 8.8), 20 mM (NH4)2SO4, 0.01% Tween 20, 1.5 mM MgCl2, 
200 µM of each nucleotide, 1 µM of each primer, 1 U of Fermentas Taq polymerase and 1-5 µl 




Table 3: PCR methods 
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1. PCR with primers Uni21/Lmj4: 
reagent original  conc. µl final conc. 
ddH2O  15.0-19.0  
buffer    10 x   2.5   1 x 
Mg 2+   25 mM   1.5   1.5 mM  
Primer Uni21  100 µMol   0.25   25 pmol/25 µl
Primer Lmj4 100 µMol   0.25   25 pmol/25 µl 
dNTP’s   20 mM    0.25   0.2 mM 
Taq-Polymerase     5 U/µl    0.25   0.625 U/ 25µl 
DNA    1-5  




2. PCR with primers 13A/13B: 
reagent original conc. µl final conc. 
ddH2O  13.5-17.5  
buffer    10 x   2.5   1 x 
Mg 2+   25 mM   1.5 1.5 mM 
Primer 13A 100 µMol   1.0 100 pmol/25µl 
Primer 13B 100 µMol   1.0 100 pmol/25µl 
dNTP’s   20 mM    0.25   0.2 mM 
Taq-Polymerase     5 U/µl    0.2   1U/ 25µl 
DNA    1-5  





3. PCR with primers MP3H/MP1L: 
reagent original conc. µl final conc. 
ddH2O  13.5-17.5  
buffer  10 x   2.5   1 x 
Mg 2+ 25 mM   1.5   1.5 mM 
Primer MP3H  100 µMol   1.0 100pmol/25µl 
Primer MP1L 100 µMol   1.0 100pmol/25µl 
dNTP’s 20 mM   0.25   0.2 mM 
Taq-Polymerase   5 U/µl    0.125   0.625 U/µl
DNA    1-5  






4. PCR ITS with primers LITSRn/L5.8S 
reagent original conc. µl final conc. 
 50  
ddH2O  33.0-37.0  
buffer (Promega)   10 x   2.5   1 x 
Mg 2+   25 mM   3   1.5.mM 
Primer LITSRn  100 µMol   1.0 25 pmol/50µl 
Primer L5.8S 100 µMol   1.0 25 pmol/50µl 
dNTP’s   20 mM    4.0   0.2 mM 
Taq-Polymerase     5 U/µl    0.4   2U/50µl 
DNA    1-5  
final volume  50  
 
Conc.= concentration. The volume of the water has to be adapted to the volume of the template used: 
more template DNA has to be balanced by using less water. The same has to be considered if additives 
are used. The final reaction volume has to be regarded. Other volumes can be used, if  concentrations stay 
the same. Eg.: PCR 4 was also used as a 25 µl mix, using exactly the half amount of every 
substance. 
 
Cycling was performed in a minicycler (M.J. Research, Watertown, USA). Mineral oil was not 
required because the machine was equipped with a heating device from above, in order to 
prevent evaporation within the PCR tubes. Table 4 shows the different cycling protocols for each 
PCR-method (as finally established). 
 
2.2.6 Agarose gels: 
1.5% or 2.5% agarose gels were prepared by dissolving 1.5 g respectively 2.5 g of agarose 
(Seakem LE agarose, FMC Bioproducts, Rockland, Maine, USA) in 100 ml of TAE buffer (0.04 
M Trisacetate; 0.0001 M EDTA) in an Erlenmeyer flask. The percentage of agarose depended on 
the size of the PCR product. For the amplificates with primers Uni21/Lmj4 (680-850 bp) a 1.5% 
agarose gel and for the amplificates with primers 13A/13B (120 bp) and MP3H/MP1L (70 bp) a 
2.5% gel was prepared. The agarose was dissolved by boiling in a microwave oven for 2-4 
minutes, until the solution was transparent. After cooling the agarose to about 60-70°C ethidium 
bromide (2.5 µl) was added. The well mixed fluid was poured into a gel-cast (DNA plus, USA 
Scientific) and was left to solidify.  
For higher resolution, 5 µl of Gel star stain (FMC BioProducts, Rockland, Maine) was used 
instead of ethidium bromid. Gel star stain was employed for the analysis of the restriction 
patterns obtained after digestion of the ITS-1 PCR-products (3% agarose gel) as well as for the 
amplification of filter paper samples with primers Uni21/Lmj4 (the least sensitive primers). 
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Table 4: Cycling 
 
1. PCR with primers Uni21/Lmj4:         
 
Preheating   5 min  94°C 
------------------------------------------------------------------------------------------------------------ 
Denaturation     1 min  94°C   
Annealing   80 sec  60°C  35-45 cycles 
Elongation     1 min  72°C 
------------------------------------------------------------------------------------------------------------ 




2. PCR with primers 13A/13B:         
 
Preheating   3 min  94°C 
------------------------------------------------------------------------------------------------------------ 
Denaturation   1 min  94°C   
Annealing   1 min  50°C  30 cycles 
Elongation   1 min  72°C 
------------------------------------------------------------------------------------------------------------




3. PCR with primers MP3H/MP1L:        
 
Preheating   3 min  94°C 
------------------------------------------------------------------------------------------------------------ 
Denaturation   1 min  94°C   
Annealing   1 min  54°C  35 cycles 
Elongation   1 min  72°C 
------------------------------------------------------------------------------------------------------------




4. PCR of the ITS-1 region with primers LITSRn and L5.8S:     
 
Preheating     4 min  95°C 
------------------------------------------------------------------------------------------------------------ 
Denaturation   40 sec  95°C   
Annealing   30 sec  53°C  36 cycles 
Elongation     1 min  72°C 
------------------------------------------------------------------------------------------------------------
Extension     6 min  72°C 
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Ten µl of each PCR product were loaded with 2.5 µl of 5x bromophenol blue loading buffer 
(BPB) on the gel. A few µl (2-3µl) of molecular size markers PGEM, φHAE or φHinf (100 
ng/µl) were loaded as controls. PGEM was used for the larger PCR-products, φHAE or φHinf 
were used for the small amplificates. Electrophoretic separation was performed at 120 V and 120 
mA for about 40 minutes. The PCR products were visualized under UV-light and photographed 
(ImageMaster VDS, Biotech Pharmacia). The pictures were captured with the NIH-Image 
program. 
 
2.2.7. Avoiding inhibition: 
Several experiments were performed using additives in the PCR, in order to reduce possible 
inhibition caused by substances, which were not sufficiently eliminated by the crude extraction 
(such as hemoglobin). Bovine serum albumin (BSA) or dimethyl-sulfoxyd (DMSO) in 
combination with formamide were used. BSA was sterile filtrated and used in a concentration of 
10 mg/ml. The effect of BSA was examined by adding 0, 1, 2 and 4 µl to 4 reactions performed 
with 1 µl of crude template.  
A similar experiment was performed using 2.5 % DMSO and 1% formamid in three reactions, 
containing 1, 2.5 and 5 µl of crude template. As a comparison, 3 reactions without additives,  
with 1, 2.5 and 5 µl of crude template were prepared and amplified. 
 
2.2.8. Avoiding contamination: 
The potential sensitivity of the PCR was theoretically up to less than one parasite. This implied a 
high risk for contamination, which had to be strictly avoided. As a general rule, the extraction of 
DNA, the preparation of the PCR and electrophoresis of the PCR products should be strictly 
separated. It is also recommended to use different sets of pipettes for the different parts of the 
work. Due to limitations of space and technical equipment this standard could not be met. 
Instead, extra precautions had to be taken: 
- DNA extraction from clinical material and preparation of the PCR was performed in a 
hood, located in a Leishmania-free room. The parts of the work, which were less 
sensitive and which were by themselves a potential source of contamination, were 
performed in a separate room (PCR-cycling, gel electrophoresis and also the extraction 
from cultured parasites) 
- Gloves were changed during the procedures from time to time. 
- The working surface in the hood was bleached with 5% bleach and UV-radiated prior to 
extraction or PCR. 
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- Before every new extraction or PCR the pipettes were wiped with 5% bleach and UV-
radiated from both sides for at least 15 min. This was necessary, because only one set of 
pipettes was available, which was used alternately for highly sensitive purposes and for 
very  concentrated DNA (PCR- amplified or extracted DNA from cultures).  
- The micro-centrifuge was bleached prior to extractions since the tops of the 1.5 ml tubes 
came in contact with the upper margin of the cups holding the tubes. Since normally 
highly concentrated DNA was centrifuged in the same centrifuge these cups were 
assumed to be a source of contamination. 
- A security distance between the 1.5 ml tubes was kept by placing the tubes in distances to 
each other. By this, the tops of neighbouring tubes did not touch each other when opened. 
- Filter tips were used for extraction and PCR. 
- Whenever possible 20 µl tips were used instead of 10 µl tips. Due to the length of the 20 
µl tips the shaft of the pipette could not touch the 1.5 ml tubes from inside. For volumes 
below 4 µl the 10 µl pipette was used to ensure accuracy.  
- For extraction tight tubes had to be used since they were to rotate in a hybridization oven. 
Only screw-cap 1.5 ml tubes proved to be tight enough for this purpose. 
 
2.2.9. Controls: 
1. Negative controls: 
The extraction as well as the PCR had to be monitored strictly for possible contamination. Two 
negative extraction controls were routinely used for every extraction series. A piece of sterile 
filter paper and a piece of filter paper with a drop of human blood (without history of previous 
infection with leishmaniasis) were extracted parallel to the samples. In order to exclude non-
specific results in the rodent samples, ear tissue from a negative Psammomys was used as  
negative control. The tissue was collected from a laboratory animal of the Diabetes Unit of the 
Hadassah Hospital, Ein Karem (received from Dr. Ehud Ziv). For the other animal species no 
suitable negative controls were available. The PCR itself was monitored by one reaction in every 
PCR, which contained only the reagents and no template. 
 
2. Positive controls: 
Liver tissue of a laboratory mouse, which had been infected with L.donovani, was blotted on 
filter paper. A piece of about 0.5 cm in diameter was used as a positive control for the  
extraction. As an amplification control and also as a reference, 20 ng of DNA from at least one 
of the Leishmania reference strains was amplified in every experiment. 
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2.2.10. Solutions: 
Agar    2.5 g agar-agar 
 1 g peptone 
 0.5 g NaCl 
 0.3 g Beef extract (Difco) 
    100 ml ddH2O 
 
Agarose gel (1.5-3%)  1.5/ 2.5/ 3 g agarose 
 100 ml of 1x TAE buffer 
 
Bromo-phenol-blue  
(1x BPB)  0.04% BPB 
    0.04% xylene cyanol 
    5% glycerol in H20 
 
Chelex (5%)   500 mg chelex-100 
 filled to 10 ml with ddH2O  
 
Chloroform 24 vol chloroform 
 1 vol isoamylalcohol 
 
EDTA (0.5M, pH 8.0) 186.1 g of disodium ethylendiaminetetraacetate 2H2O 
 add to 800 ml with ddH2O  
 pH-adjustment with NaOH pellets 
 
Ethidium bromide 10 mg/ml in ddH2O 
 
Guanidine solution 4 M GTC (mw 118.2), 47.28 g   
 0.1 M Tris-HCl (pH7.5), 10 ml (of a 1 M solution) 
 0.02 M EDTA (pH8.0), 4 ml (of a 0.5 M solution) 
 1.3% Triton x-100, 1.3 ml 
 filled up to 50 ml 
 
Locke’s solution  9.2 g NaCl 
 0.24 g CaCl2 
 0.15 g NaHCO3 
 0.42 g KCl 
 1 g dextrose 
 1000 ml ddH2O 
 
NNN medium 
    Solid phase: Agar 
  10% defibrinated rabbit blood 
    liquid phase: Schneider’s medium 
 overlaid on the solid phase 
 
NET-buffer   50 mM NaCl 
 10 mM EDTA 
 50 mM Tris (pH 7.4) 
 ddH2O made up to 100 ml 
 
Phosphat buffer for  0.7 g KH2PO4    
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Giemsa straining 1.0 g Na2HPO4    
 add ddH20 to 1 liter 
 
Phosphat-buffered saline  8 g NaCl     
(PBS) 0.2 g KCl     
 1.44 g Na2HPO4    
 0.24 g KH2PO4    
 adjust pH to 7.5 with HCl 
 add ddH20 to 1 l  
 
Schneider’s stock  1 package powered Schneider’s 
 4 l ddH2O 
 10 g yeastolate 
 134 mg L-cystine: diHCl 
 3.6 g L-tyrosine: Na(disodium) 
 250 ml 10 N NaOH 
 pH-adjustment to pH 6.9 with 1.0 N HCl (about 175 ml) 
 adjust volume to 5 liter 
 
Schneider’s drosophila 170 ml Schneider’s stock solution 
medium 30 ml fetal calf serum  
 4 ml L-glutamin 
 200 U/ml penicillin (20 µl of 200,000 U/ml penicillin) 
200 mg/ml streptomycin (20 µl of 200mg/ml) 
 
Semi-solid medium (SS) 7 parts of Locke’s solution 
 1 part of melted agar 
 10% defibrinated rabbit blood 
 Antibiotics (200 U/ml penicillin, 200 mg/ml streptomycin) 
 
Silica beads   3 g silica beads 
 30 µl of 1M HCl 
 resuspended in 1 ml ddH2O 
 (protocol of preparation in text) 
 
Sodium acetate (NaAc) 408.1 g NaAc 3H20     
3M, pH 6 for pH-adjustment glacial acetic acid  
 ddH20 filled up to 1 l     
 
Sodium iodate (NaI), 6 M  45 g NaI (mw 150)     
 ddH2O made up to 50 ml    
 
TAE (50x) 242 g tris base 
 57.1 ml glacial acetic acid 
 100 ml 0.5 M EDTA (pH 8.0) 
 
TAE (1x) 20 ml of 50x TAE 
 Made up to 1 liter with ddH2O 
 
TE (pH 7.4) 10 mM Tris HCl (pH 7.4) 
 1 mM EDTA (pH 8.0) 
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TE (pH 8)   10 mM Tris HCl (pH 8.0) 
 1 mM EDTA (pH 8.0) 
 
Tris (1M) 121 g tris base 
 in 800 ml of ddH2O 
 pH-adjustment with HCl 
 
Washing buffer (20 x) 0,2 M Tris-HCl (pH7.5)  20 ml ( of 1 M Tris-HCl) 
2. M NaCl   20 ml ( of 5 M NaCl) 
20 mM EDTA (pH 8.0)  4 ml ( of 0.5 M  EDTA) 
ddH2O made up to    100 ml  
 
Washing buffer (1x) 25 ml of 20x washing buffer 
 225 ml ddH2O 
 250 ml ethanol (100%) 
 
 
2.2.11. List of reagents: 
Agarose (LE agarose)   Seakem, Rockland Maine, USA 
BsuRI (HaeIII)      MBI Fermentas, Lithuania 
Chelex 100 Resin  Bio-Rad 
dNTP   MBI Fermentas, Lithuania 
Gelstar nucleic acid stain   FMC BioProducts, Rockland, Maine 
Giemsa's staining solution   Gurr, BDH, England 
Guanidine-thiocyanate   Fluka 
L-cystine dihydrochloride  Sigma 
L-tyrosine disodium  Sigma 
Molecular size markers (PGEM, φHAE, φHinf) Promega  
Oligonucleotides  Genset SA, France 
Proteinase K   Sigma 
RNase A   Sigma 
Schneider's Drosophila medium powder   Gibco  
Silica beads   Sigma 
Sodium iodate   Merck 
Taq polymerase    MBI Fermentas, Lithuania, Germany 
Taq polymerase   Promega, Madison, Wi 
Taq polymerase (TaKaRa Ex Taq)   TaKaRa Biomedicals, Shuzo CO.,  
    LTD, Japan 
Triton X-100   BDA 
Yeastolate (bacto-yeast-extract)   Difco 
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3. Results 
 
Several different extraction- and PCR-methods have been employed in this study. Methods have 
been changed and were even substituted as soon as better methods were available. Different 
sample groups have been studied, which were collected (or received) at different times during 
the study period, depending mainly on external circumstances. Some sample goups (eg. 
Psammomys, desert rodents) have been proceeded with the purpose of evaluating the quality of 
the method. As a "byproduct", interesting and sometimes unexpected results were found, as for 
example a new host species. Therefore technological findings or improvements are inseparably 
connected with the specific results obtained from different sample groups. This chapter is mainly 
structured according to the methods used.  
 
3.1. Efficiency of the tested DNA extraction methods: 
A major objective has been to find the most efficient and practicable extraction method with 
particular regard to the dermal scrapings on filter paper. It was important to find a reliable 
method which could be adopted to a clinical laboratory for routine diagnosis. The results with 
the different extraction methods are summarized here and will be thoroughly discussed in 
chapter 4 (Discussion).  
All tested extraction methods were successful. The classical phenol-chloroform method was 
applied on several series of dermal scrapings of patients (mostly the Hadassah patients at the 
beginning of the study). Differently preserved samples were occasionally received too (eg. 
Giemsa stained smears, paraffin embedded skin biopsies, formalin fixed jackal spleens). These 
samples were proceeded with the phenol-chloroform extraction, because this method had the 
greatest potential to remove inhibitory agents. The tested Giemsa stained smears (positive by 
microscopy) were PCR-positive (3 out of 3), as well as the paraffin embedded biopsies (4 out of 
4). The formalin fixed tissue was not amplified with Leishmania specific primers, but yielded a 
weak signal with mammalian primers (performed by Carney Mattheson). This proved that 
formalin fixed tissue can be theoretically proceeded, but that inhibition has to be expected. The 
phenol-cloroform extraction is labor-intensive and difficult to handle in a non-research oriented 
laboratory. Due to the frequent re-opening of the 1.5 ml tubes, the risk of sample cross-
contamination was highest with this method.  
For these reasons other extraction methods were tested too: At first, experiments with crude 
extractions were performed, using only the first steps of the phenol-chloroform extraction (lysis 
and digestion, concluded by a short boiling step). Experiments with this crude method were 
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performed on dermal scrapings from CL lesions in the initial phase of the study, when only the 
kDNA primers Uni21/Lmj4 were employed. The success rate was sometimes high, (up to 4 
positives out of 5 tested samples), and sometimes the results were poor (none, 1 or 2 positives in 
a series of 5-10 samples). Conditions were changed each time in order to finally introduce the 
best methodology (eg. amount of template, additives in the PCR, cycling temperatures). It was 
obvious that inhibition was the main cause for sub-optimal results: small amounts of template (1-
2 µl lysate) had a far better success rate than larger amounts (5 µl), the addition of BSA reduced 
the inhibition by hemoglobin.  
The guanidine extraction was tested as another potential alternative to the phenol-chloroform 
extraction. It also produced good results, on patient samples (mainly Tel Hashomer Hosital,   
Wadi Albethan) and on the dog peripheral blood spots (on filter paper). The guanidine method 
was easier to handle and also quicker than the phenol-chloroform extraction.  
The Chelex extraction was only “discovered” much later as another possible extraction method.  
It has been employed on the rodent samples (ear scrapings from Psammomys and Gerbilli). 
Since 28 out of 30 Psammomys samples (ear scrapings on filter paper) were strongly positive it 
can be stated that this method is highly efficient. These samples were characterized by a high 
tissue and a low blood content. The Chelex method was also employed on individual patients, 
but it has not been evaluated yet on a larger number of patient samples. One patient sample 
(dermal scraping) was incubated for 1 hour in Chelex (not overnight) and was amplified without 
problems. An experiment with one sample (infected mouse liver, spotted on filter paper) which 
was incubated for either 1, 2, 3 or 4 hours showed that a longer incubation was indeed more 
efficient (more PCR product, stronger bands on the gel). The Chelex method was even more 
simple than the previous crude method (lysis, digestion, boiling) so that it could replace the 
latter. 
No differences have been noticed between the 3 extraction methods (phenol-chloroform, 
guanidine and Chelex) when compared with practically identical samples (infected mouse liver 
spotted homogenously on filter paper, squares of 0.5.cm2, 6 pieces for each method).  
 
3.1.1 Suitability of different specimens for PCR diagnosis: 
It was examined whether dermal scrapings (preserved on filter paper) would in fact be suitable 
for direct PCR diagnosis of CL. The sampling method and way of preservation proved to be 
efficient, as seen in several study groups (Hadassah patients, rodent ear scrapings, dog blood, 
Wadi Albethan inhabitants, Tel Hashomer patients). Filter paper samples (infected mouse liver 
spotted on filter paper) were stable at all three temperatures (20°C, 4°C, -20°C) for more than 
one year and were amplified equally well. Dermal scrapings on filter paper were examined 
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predominantly, but it was also relevant to test other types of samples. It was especially of interest 
to obtain results from early cultures in which promastigotes had been just detected. A crude 
preparation from Schneider´s medium (lysis in H2O and boiling for 5´minutes) was amplified 
well (no inhibition seen). Inhibition was observed when blood containing media were used (eg. 
semisolid media). Peripheral blood spots on filter paper (from dogs with CVL), Giemsa stained 
smears and paraffin embedded skin biopsies proved to be suitable too.   
 
3.1.2 Experiments with crude samples: 
Inhibition was observed as a regular phenomenon when crudely extracted samples were 
subjected to PCR. The experiments with additives for the prevention of PCR-inhibition showed 
the following: bovine serum albumin (BSA) clearly helped to amplify crude samples containing 
hemoglobin. The crude template (1 µl) was amplified well in the presence of 4 µl BSA (10 
mg/ml), less amplified with 2 µl of BSA, very faintly amplified with 1 µl BSA and not amplified 
without BSA (results not shown). The experiment with 2.5 % DMSO and 1% formamid also 
showed a positive effect: When the additives were used the reaction tolerated 1, 2.5 and 5 µl of 
template. Without the additives the  reaction with 5 µl of crude template was inhibited. Results 
are shown in Figure 9. 
 












PCR with kDNA primers Uni21/Lmj4 with crudely extracted  
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3.2. Amplification of whole minicircle DNA with primers Uni21/Lmj4: 
3.2.1. Results with DNA purified from cultured reference strains: 
It was found that the size of the PCR product was consistent within each species. Whole 
minicircles of kDNA were amplified, the PCR products therefore reflected the size of the 
minicircles in each species, ranging from 680 bp (L.major), 800 bp (L.donovani complex), 820 
bp (L.tropica) to 850 bp (L.aethiopica). L.major could easily be differentiated from L.tropica 
and the L.donovani complex by the size of the PCR products, which had been one important aim 
of the study. L.tropica and the L.donovani complex could not be distinguished certainly since 
both produced similar sizes of bands. The minor bands were not always seen. The appearance of 
these bands depended on  the PCR conditions (eg. the Taq-polymerase). Even though some of 
them seemed to be related to the species they were not consistent enough to be used for species 
specific identification. The New World species  (L.mexicana, L.braziliensis, L.guyanensis, 
L.panamensis, L.amazonensis and L.d.chagasi) could be clearly distinguished from the Old 
World species either by not amplifying at all or yielding much smaller products. Only 
L.d.chagasi, as a species belonging to the L.donovani complex, was amplified (820 bp). Species 
of Leishmania that are not pathogenic to humans were amplified: L.gerbilli, L.turanica and 
L.killicki yielded a product of 800 bp. A 680 bp product was obtained from L.arabica. Results 
with reference strains are shown in Figure 10: 
 












Lane 1 DNA size marker PGEM; lane 2 neg. PCR-control; lane 3 L.major; lane 4 L.tropica; lane 5 
L.donovani; lane 6 L.d.infantum; lane 7 L.aethiopica; lane 8 L.m.mexicana; lane 9 L.braziliensis; lane 10 
L.b.guyanensis; lane 11 L.m.amazonensis; lane 12 L.d. chagasi; lane 13 L.gerbilli; lane 14 L.turanica; lane 15 
L.killicki; lane 16 L.arabica; lane 17 Leptomonas Seymourii; Lane 18 Crithidia; lane 19 T.cruzi; lane 20 
T.lousii; lane 21 P.davidii.    
 
1 2 3 5 6 7 8 9 10 11 124
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Kinetoplastidae other than Leishmania were not amplified with primers Uni21/Lmj4 
(Trypanosoma cruzi, Trypanosoma lewisii, Crithidia fasciculata, and Phytomonas davidi). The 
DNA of Leptomonas seymouri was amplified but the product was considerably smaller (500 bp). 
Primers Uni21/Lmj4 are specific for the Old World species of Leishmania, with the only 
exception of L.d.chagasi (identical to L.d.infantum in the Old World). 
The sensitivity of the PCR assay with primers Uni21/Lmj4 was examined with a serial dilution 
of L.major DNA. If PCR products were visualized with Gel star staining, maximum sensitivity 
was found to be at 25 fg of target DNA (less than one parasite). With regular ethidium bromide 
staining, dilutions of less than 1 pg were almost undetectable. The sensitivity study is shown in 
Figure 11: 
 













PCR with kDNA primers Uni21/Lmj4, purified L.major DNA: 
 
 
3.2.2. Results from lysed cultured isolates with primers Uni21/Lmj4: 
PCR proved to be reliable whenever cultures of promastigotes cultivated in Schneider´s medium 
were used as lysates. If the cultures were bloody because of the medium (NNN and semisolid 
medium contain rabbit blood), the PCR reaction sometimes failed. Most patients had CL, 
acquired in Israel, where L.major and L.tropica were expected to be the causative agents. The 
smaller product (680 bp) was identified as L.major, whereas the larger product (about 800 bp) 
was either amplified from L.tropica or from the L.donovani complex. Based on the patient 
history (CL or VL, origin of infection) and on additional tests (eg. EF), the species was 
determined as being either L.tropica or of the L.donovani complex. Culture 14 (Table 5, LRC-
10 pg 1 pg 100 fg 50 fg 25 fg 10 fg neg.75 fg
10 pg 1 pg 100 fg 50 fg 25 fg 10 fg neg.75 fg
A: staining with Gel star stain
B: staining with ethidium bromid
676 bp
676 bp
 62  
747) was derived from a sandfly trapped in a cave near Kfar Adumim (Photo 13) in the Judean 
Desert (trapped by Alon Warburg, Kuvin Center). It yielded a product of about 800 bp, which 
practically confirmed the suspected species of L.tropica. (The focus was already known to be 
endemic with L.tropica, since cutaneous infections by L.d.infantum have never been reported in 
the country). L.tropica was later confirmed by IFA, EF and PPIP-PCR (by colleagues at the 
Kuvin Center). Interestingly, L.major has also been identified from Kfar Adumim residents in 3 
patients (Tables 5 and 6). L.major transmission in this area is possible too, since the Jordan 
Valley with a high L.major incidence is very close and endemicity in the settlement itself can  
not be excluded.  
Culture 19 (LRC-744) was derived from a child with VL in Costa Rica. (The strain was brought 
to Israel by Lionel Schnur, Kuvin Center). It yielded a PCR product of 800 bp. L.d.chagasi was 
diagnosed since no other American Leishmania species would have been amplified. Table 5 and 
Figure 12 show the results from lysed cultures.  
 
 
Table 5: PCR results with Uni21/Lmj4 from lysed cultures: 
 
No. Sample Smear PCR Diagnosis Origin 
  1 P1092 + 680 bp L.major Negev  
  2 P1111 ++ 680 bp L.major Kfar Adumim 
  3 P1120 + 680 bp L.major Jericho  
  4 P1130 + 680 bp L.major Jericho  
  5 P1132 - 680 bp L.major Jordan Valley  
  6 P1135 + 680 bp L.major Jericho 
  7 P1136 - 680 bp L.major Jericho 
  8 P1125 - 680 bp L.major Jordan Valley? Negev? 
  9 P1161 + 680 bp L.major Israel 
10 P1165 - 680 bp L.major India?/Israel? 
11 P2001 n.a. 680 bp L.major Israel 
12 LRC-757 n.a. 820 bp L.tropica Kfar Adumim, sandfly 
13 LRC-768 n.a. 820 bp L.tropica Israel 
14 LRC-747 n.a. 820 bp L.tropica Kfar Adumim, sandfly 
15 LRC-765 n.a. 680 bp L.major India 
16 LRC-767 n.a. 680 bp L.major India 
17 LRC-773 n.a. 680 bp L.major Israel 
18 LRC-691 n.a. 680 bp L.major Israel 
19 LRC-744 n.a. 800 bp L.d.chagasi Costa Rica 
20 LRC-762 n.a. 680 bp L.major Uzbekistan 
 
The LRC-number is given to newly collected strains of the Leishmania Reference Center, Jerusalem.  
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Lane 1 L.major; lane 2 L.tropica; lane 3 L.donovani; lane 4 L.d.infantum; lane 5 L.aethiopica; lane 6 patient 
1120 (Jericho); lane 7 patient 1125 (Negev); lane 8 patient 1130 (Jericho); lane 9 patient 1132 (Jordan 
Valley); lane 10 patient 1135 (Jericho); lane 11 patient 1136 (Jericho); lane 12 neg. PCR-control; lane 13 
vaccination strain (Uzbekistan).    
 
 
3.2.3. Results with primers Uni21/Lmj4 with dermal scrapings on filter paper:  
This part of the work served to establish methods, which required experimental changes of 
conditions almost in every extraction series and PCR. This resulted in different success rates.  
Therefore the results of this part of the work are presented as a collection of positive results 
without a statistical evaluation.  
Skin scrapings of patient lesions (spotted onto filter paper) proved to be useful for the diagnosis 
of CL, in patients as well as in reservoir animals. Positive results helped in species diagnosis, 
negative results could not exclude infection. It turned out that a low success rate was often due to 
inhibition. Series in which 2 µl of template were used had a better success rate than 5 µl eg.. The 
DNA lost its quality quickly (resuspension in H2O), limiting the possibility of re-amplification of 
the relatively large PCR-product (680-850 bp). Out of this reason it was difficult to compare 
different PCR conditions with the same samples. The best possible DNA quality was necessary 
to obtain results, therefore freezing was not considered in this case (with smaller fragments no 
problem, see later). Out of filter paper samples from 100 suspected CL patients 24 were found 
positive with primers Uni21/Lmj4, either with the regular phenol-chloroform extraction or with 
the crude method (proteinase-K digestion, lysis and boiling). The first extractions yielded 
excellent results (also with the crude method!) as shown in Figures 13 and 14, whereas later 
extractions sometimes failed completely, with not even one single positive in 10 samples (mostly 
due to inhibition). The PCR from filter paper was usually successful when the corresponding 
smears contained a high number of amastigotes. When the smears (Giemsa stained) contained 
only single amastigotes the PCR with primers Uni21/Lmj4 (using the corresponding filter paper 
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sample) the method was often not sensitive enough. Most patients were diagnosed with L.major 
(23 out of 24), one patient was diagnosed with L.tropica (Figure 13 lane 10, Table No. 6, patient 
6). However, 6 patients with CL were diagnosed by PCR in whom microscopy and culturing had 
failed. Table No. 6 represents the results with whole amplified minicircles (Uni21/Lmj4) on 
dermal scrapings (preserved on filter paper).  
 
Table 6: Results with primers Uni21/Lmj4 from skin scrapings preserved on filter paper: 
 
No Patient Smear Culture PCR Diagnosis Origin of infection 
  1 1075 - - 680 bp L.major Ethiopia/ Israel ? 
  2 1077 + - 680 bp L.major Sinai, Arava  
  3 1078 - - 680 bp L.major Israel 
  4 1083 - - 680 bp L.major Dead Sea  
  5 1087 + - 680 bp L.major Dead Sea  
  6 1070 ++ - 820 bp L.tropica Hemdat 
  7 1088 ++ - 680 bp L.major Negev  
  8 1095 + - 680 bp L.major Jordan Valley  
  9 1100 ++ - 680 bp L.major Holon  
10 1101 ++ - 680 bp L.major Holon  
11  999 ++ - 680 bp L.major South America/Israel ? 
12 1102 + - 680 bp L.major South America/Israel ? 
13 1108 + - 680 bp L.major Jordan Valley? 
14 1124 - - 680 bp L.major Kfar Adumim 
15 1111 ++ + 680 bp L.major Kfar Adumim 
16 1113 + + 680 bp L.major Qziot, Negev  
17 1135 + + 680 bp L.major Jericho 
18 1150 ++ - 680 bp L.major  Jericho 
19 1152 + - 680 bp L.major  Jordan Valley  
20 1143 - - 680 bp L.major Baghdad/Israel ? 
21 1164 - - 680 bp L.major Sinai 
22 1181 + - 680 bp L.major Qziot, Negev  
23 1193 ++ - 680 bp L.major Sinai 
24 LRC-762  ? + 680 bp L.major Uzbekistan 
25 3 Psammomys + n.a. 680 bp L.major Qziot, Negev 
26 Mouse liver + + 800 bp L.donovani Infection in the laboratory 
n. a.- not available. For better understanding: The origin of infection relates to the patient history. It contains 
the information obtained from the patient before the diagnosis was made. 
 






Lane 1 T.cruzi; lane 2 L.aethiopica; lane 3 L.donovani; lane 4 L.tropica; lane 5 L.major; lane 6 negative PCR-
control; lane 7 patient 1084 (IL); lane 8 patient 1086 (Qziot, IL); lane 9 patient 1087 (Dead Sea, IL); lane 10 
patient 1070 (Hemdat, IL); lane 11 patient 1088 (Negev, IL); lane 12 neg. FP. TaKaRa-Ex-Taq polymerase 
was used and 5 µl of BSA (10mg/ml) was added to each reaction. The filter paper samples were lysed in 200 
µl NET-buffer, digested with proteinase K, 2 µl were used as template, annealing temperature was 50°C. 
1 2 3 4 5 6 7 8 9 10 11 12
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Lane 1-6 phenol-chloroform extracted, lane 7-10 crude experiment, lanes 11-17 controls. Lane 1 PGEM; lane 
2 patient 1075 (IL); lane 3 patient 1077a (Arava, IL); lane 4 patient 1077b (Arava, IL); lane 5 patient 1083 
(Dead Sea, IL); lane 6 positive extraction control, mouse liver infected with L.donovani; lane 7 patient 1077a 
crude 1µl; lane 8 mouse liver, crude 1 µl; lane 9 patient 1077a crude 1µl + 1µl BSA; lane 10 mouse liver crude 
1 µl + 1µl BSA; lane 11 L.donovani; lane 12 L.aethiopica; lane 13 L.major; lane 14 L.major; lane 15 L.tropica; 
lane 16 ? ; lane 17 neg. PCR-control. (Annealing of 48°C) 
 
 
3.2.4. Selected patient cases diagnosed with kinetoplast primers Uni21/Lmj4  
Results obtained from dermal scrapings on filter paper 
1. One patient suffered from a severe and prolonged infection of the nose (photo 1); he had a 
second lesion on his hand. He was a young man of 20 years coming from Hemdat, an Israeli 
settlement, located in a hilly area close to the Jordan Valley. The direct analysis from the skin 
scrapings on filter paper (1 of each lesion) revealed a band of 820 bp (Figure 13 lane 10, Table 
No. 6, patient 6) from one lesion, and two bands from the other lesion (680 bp and 820 bp, the 
latter band being weaker, not shown). The PCR performed on the culture some weeks later 
yielded a band of 680 bp . These contradictive results will be discussed in chapter 4. 
2. A married couple suffered from multiple lesions (12, respectively 9) distributed all over the 
body (Photo 5). They came from Holon, an urban center close to Tel Aviv and claimed they had 
not travelled either inside or outside the country for at least one year. It was the first case of CL 
in this part of the country and the origin of infection could not be identified. There was only a 
vague hypothesis that a sandfly might have been trapped in the car of a neighbour, who was 
travelling frequently to the Jordan Valley. PCR diagnosis succeeded from tissue scrapings in the 
couple from Holon (patients  9 and 10 in Table 6). L.major was diagnosed (680 bp product). The 
smears were positive but cultures failed to grow. 
3. A visiting researcher from Uzbekistan had been vaccinated with a viable L.major strain. A 
lesion had developed at the vaccination site, which had no tendency to heal even after several 
months and was forming also satellite lesions (Photo 4). Even though the cause of the infection 
was clear, a skin scraping was collected, to test if the PCR would in fact confirm the infection of 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
676 bp
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Leishmania major. The PCR confirmed L.major (patient 24 in Table 6; lane 13, Figure 12-PCR 
also from the culture). 
4. Ear scrapings from Psammomys (No. 25 in Table 6, Figure 16) were examined and a product 
of 680 bp was found in all 3 individuals, thus confirming the expected species, L.major. 
5. The positive extraction controls (infected mouse liver, No. 26 in Table 6) always yielded a 
800 bp product, as expected for the L.donovani complex.  
6. Patients 11 and 12 (Table 6) were diagnosed with L.major, and New World Leishmania 
species could be excluded as causative agent. The infections were therefore contracted in Israel 
and not during the journey in South America.  
 
3.3. Genus specific amplification with kDNA primers 13A/13B: 
All Kinetoplastidae (Leishmania, Trypanosoma, Crithidia) tested in the PCR with primers 
13A/13B yielded a product of 120 bp. The amplification of the positive extraction control 
indicated successful DNA extraction. The sensitivity with a serial dilution of purified DNA was 
at 10 fg (data not shown) with ethidium bromide staining (Gel Star staining not needed). This 
confirmed the sensitivity found by Rodgers et al., (1990) who had introduced the primers and 
had found a sensitivity corresponding to far less than one parasite. The negative extraction 
controls (negative filter paper, human blood on filter paper) of the first few extraction series 
were contaminated. Only after potential sources of contamination were eradicated, by following 
strictly the precautions mentioned in chapter 2 (Material and Methods), the problem was 
controlled. At the time the contamination problems were controlled with the more sensitive, 
genus specific PCR the patient samples (which had been mainly used to establish the diagnosis 
with primers Uni21/Lmj4) were used up. Primers 13A/13B were evaluated with new sample 
groups, which were received later (eg. animal samples). For species specific identification some 
of the PCR-positive samples were submitted to PCR with primers Uni21/Lmj4. This succeeded 
with 3 out of the 4 tested Psammomys samples, and L.major was confirmed (Figure 16).  
 
3.4. Studies on reservoir animals: 
1. Desert rodents: (Photo 18) 
The animal results are summarized in Table 7. As expected, the PCR proved to be more sensitive 
than microscopy on the Psammomys ear scrapings: Every microscopically positive smear was 
also positive by PCR. The genus specific PCR with primers 13A/13B detected Leishmania 
infections in 93.3 % (28 out of 30) of the tested P.obesus samples. Out of the 28 PCR-positive 
samples 20 were positive by microscopy (71.4%). Eight out of 10 smear-negative samples were 
thus positive by PCR. (Microscopy was performed by Gideon Wasserberg, Ben Gurion 
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University, Beer Sheva). Some of the smears were double checked in our laboratory, the 
microscopical results were in concordance between the two laboratories. The amplifications 
were highly efficient, as most samples showed intensive bands (Figure 15). The negative 
Psammomys control (laboratory animal from the Diabetes Unit, Hadassah Hospital) was always 
negative (as expected). As mentioned already L.major was confirmed with primers Uni21/Lmj4 
(Figure 16) and later also with ITS-1 amplification and RFLP-analysis (Figure 17). In the latter 
experiment non human pathogenic Leishmania species (reference strains) were amplified and 
restricted for comparison.  
According to PCR, 65% (11 out of 17) ear scrapings from Gerbillus dasyarus were positive 
(Figure 15). The PCR products were seen as faint bands. A new host species was identified 
(discussed in chapter 4). After positive PCR results the smears were examined once more. One 
single amastigote was finally detected in one of the smears and approved by three examinators, 
thus confirming the findings by PCR. The faint bands of the PCR products correlated with the 
scarcity of amastigotes in the smears. This explains also why the Gerbillus dasyarus sample 
failed to amplify in the ITS-1 PCR (Figure 17). The larger band (Figure 15, lane 15) may be a 
non-specific amplification seen sometimes also in amplifications from dog samples. A reliable 
negative control of the same animal species was not available which could have helped to clarify 
this non-specific amplification.   
 
Figure 15: Psammomys obesus and Gerbillus dasyarus 














Lane 1 negative filter paper; lane 2 neg. blood; lane 3 negative Psammomys control; lane 4-13 
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Lane 1-4 Psammomys; lane 5 L.major; lane 6 L.tropica 
 
 












Lane 1-3 P.obesus, Qziot (IL); lane 4 G.dasyarus, Qziot (IL);  
lane 5 L.major; lane 6 L.tropica; lane 7 L.arabica; lane 8 L.gerbilli; 
lane 9 L.turanica. 
 
2. Canids: 
The 4 tested dogs (Photo 20) were positive by PCR with primers 13A/13B (results not shown). 
Interestingly, a repeated extraction and PCR performed by a collegue showed the same 
intensities of bands on the gel. This indicated a positive correlation between antigen load and the 
quantity of amplified product. The 21 jackal ears were all negative. The extraction and the PCR 
had been successful as shown by the positive extraction- and positive PCR-controls. The 14 
extracted jackal spleens in formalin were PCR-negative too. In order to test, if the negative 
results were due to inhibition or poor DNA quality mammalian primers were tested on 3 of the 
jackal samples (by Carney Matheson, guest scientist at the Kuvin Center, University of 
Queensland, Australia). Faint signals were seen, meaning that amplification was principally 
possible from formalin fixed samples, but that this preservation method was probably not 
680 bp
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suitable for sensitive diagnosis. It remains unclear, if any of the jackals were Leishmania-
positive. 
3. Hyrax: 
All hyrax samples (parched and fresh tissue samples) were PCR-negative. A hyrax is shown in 
Photo 19.  
 
Table 7: Results from animal samples: 
 
species Specimen No. of samples PCR + smear + 
Psammomys ear scrapings 30 28 20 
Gerbillus dasyarus ear scrapings 17 11 1 
Meriones crassus ear scrapings 4 0 0 
dogs with CVL EDTA blood 4 4 n.a. 
Jackal ear biopsies, frozen 20 0 n.a. 
Jackal spleens in formalin 14 0 n.a. 
Hyrax  nose, skin, bone 6 0 n.a. 
Hyrax ear biopsy, frozen 1 0 n.a. 
mouse liver tissue  positive control always positive positive 
hamster foot pad aspirate 1 positive n.a. 
CVL =canine visceral leishmaniasis 
n.a. =not available 
 
 
3.5. Specific detection of Leishmania braziliensis with kDNA primers MP3H/MPL1: 
Results obtained from dermal scrapings preserved on filter paper: 
It was important to establish PCR diagnosis also for Leishmania infections contracted in the New 
World. Since especially L.braziliensis infections are feared due to the risk of MCL the most 
important aim was to identify L.braziliensis. The PCR with primers MP3H/MPL1 was 
successfully employed on the reference strains as well as on the patient samples. All tested 
Leishmania species of the L.braziliensis complex (L.braziliensis, L.guyanensis, L.panamanensis) 
were amplified and yielded a product of 70 bp (in Figure 18 the band appears to be slightly 
larger, the band was usually exactly at 72 bp of the marker). L.mexicana and the Leishmania 
species of the Old World did not amplify, as expected. The method proved to be highly specific 
with the only exception that L.amazonensis (L.mexicana complex) was sometimes amplified 
with a very faint signal, which was not expected. A carry-over contamination between the New 
World reference DNA strains can not be excluded. The DNA had been handled by several 
different persons previously. Contamination could have occurred by pipetting the different 
species into PCR tubes for one experiment, keeping in mind that this PCR method is capable of 
detecting DNA of far less than one parasite (Lopez et al., 1993). No other L.amazonensis strain 
was available. The sensitivity was known to be at least as high as with the genus specific primers 
13A/13B, according to the literature (Belli et al., 1998). Serial dilutions with purified DNA give 
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generally only theoretical sensitivities, which are not necessarily reproduced with clinical 
samples. Therefore it was preferred to directly evaluate the sensitivity on the clinical samples, in 
comparison with the genus specific primers (13A/13B). The sensitivity was 6/6 (100%) of the 
patients who had visited Tuiji in Bolivia and who were suspected to be infected with 
L.braziliensis. The genus specific primers gave positive results in all 11 patients who were 
examined (4 patients infected in the Old World, 1 in Guatemala). The follow-up study (repeated 
PCR with the genus specific and the L.braziliensis specific primers directly after and months 
after treatment) indicated that the L.braziliensis specific primers MP3H/MPL1 were even 
slightly more sensitive than the genus specific primers 13A/13B (eg. patients 1, 2 in Table 8).  
 
Patients of the Tel Hashomer Hospital: 
Skin scrapings and cultures were taken from 11 patients who were admitted to the Tel Hashomer 
Hospital (Tel Aviv) for systemic treatment with Pentostam. Species specific diagnosis especially 
of the L.braziliensis complex was required since 7 patients had contracted CL in the New World 
(Photos 15-17). Six patients had visited Tuiji, an attractive tourist site in the Bolivian rain forest, 
1 patient had been travelling in Guatemala. The other 4 patients had been infected in the Old 
World, 1 patient in Turkmenistan, 1 patient in Afula (Galilee), 1 in Korazim, a village on the 
northern slope of the lake of Galilee and another patient had been infected in the Negev. The 
patient from Afula was suffering from a severe infection of the nose (Photo 2), the patient from 
Korazim suffered from a lesion, which involved one eyelid (Photo 3). Both cases were of special 
interest, since L.tropica was expected to be the causative agent, and both places had not been  
identified as being L.tropica foci previously. The diagnosis of CL had been made in all 11 
patients beforehand in the hospital, by microscopy of skin biopsies. All 11 patients yielded 
positive results with the genus-specific primers 13A/13B. The results are specified together with 
the results of primers MP3H/MPL1 in Table 8.  
The patient who was infected in Guatemala (patient 12) was negative with the L.braziliensis 
specific primers MP3H/MPL1 and positive with the genus specific primers 13A/13B, which was 
suggestive of an infection with L.mexicana. Patients 4, 5, 8 and 9 were infected in the Old 
World. All were positive with the genus specific primers and negative with the L.braziliensis 
specific primers, thus confirming the specificity of the primers.  
Repeated PCR, directly after treatment with pentostam and also several months after completing 
the therapy, was still positive in most cases, though weaker. In some cases only one of the two 
PCR methods reproduced signals after repeated sampling (after treatment). Specific results are 
documented in Table No 8 and Figures 18-20. Cultures were positive in patients 1 (from 2 
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different lesions), 4, 7 and 9 (collected before treatment). This was the first time that 
L.braziliensis has been diagnosed in Israel. 
 













Dermal scrapings on filter paper, phenol-chloroform extraction. Lane 1 DNA size marker φHAE ; lane 2 neg. 
FP; lane 3 neg. blood; lane 4 patient 1a (BO), relapse?; lane 5 patient 1b (BO), relapse?; lane 6 patient 6a 
(BO) before treatment; lane 7 patient 6b (BO) before treatment; lane 8 patient 6a (BO) after treatment; lane 
9 patient 4 Afula, IL); lane 10 L.braziliensis; lane 11 L.guyanensis; lane 12 L.amazonensis (contamination?); 














Patients 1, 2, 4  before treatment, patient 3 after systemic treatment with pentostam. 
Dermal scrapings on filter paper, guanidine extracted. Lane 1 neg. FP; Lane 2 neg. blood; lane 3 patient 1a 
(BO); lane 4 patient 1b (BO), (taken from another lesion); lane 5 patient 2 (BO); lane 6 patient 3 (BO); lane 7 
patient 4 (Afula, IL); lane 8 patient 1201 (IL); lane 9 patient 1203 (IL); lane 10 patient 1204 (IL); lane 11 
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Patients 1-4 after treatment with pentostam. Lane 1 negative filter paper; lane 2 negative blood, lane 3 
patient 1 (BO); lane 4 patient 2 (BO); lane 5 patient 3 (BO); lane 6 patient 4 (Afula, IL); lane 7 and 8 patient 
5a, 5b (Korazim, IL), (2 paraffin embedded skin biopsies taken from two lesions); lane 9 and 10 paraffin 
embedded skin biopsies from Tchechia, patient infected in Jordan; lane 11 Hyrax ear; lane 12 sandfly (West 
Bank); lane 13 L.major; lane 14 negative PCR control; lane 15 L.mexicana; lane 16 L.braziliensis 
Table 8: Results of patients from the Tel Hashomer Hospital: 
 
Patient Nr. 1 2 3* 4** 5** 6 
Origin of infection Tuiji, Bolivia Tuiji, Bolivia Tuiji, Bolivia Afula, IL Korazim, IL Tuiji, Bolivia 
1st Sampling  8.5.00 8.5.00 8.5.00 8.5.00 1.6.00 11.7.00 
1st PCR genus +/+ + + + + +/+ 
1st PCR L.braz. +/+ + + - - +/+ 
Culture +/+ n.d. n.d. + - - 
Identification L.braziliensis L.braziliensis L.braziliensis L.tropica? L.tropica? L.braziliensis 
2nd sampling 1.6.00 1.6.00 1.6.00 1.6.00  5.9.00 
2nd PCR genus - - +  weak + + + 
2nd PCR L.braz. +  weak +  weak + - - ++ 







3rd PCR genus - -  +  + 
3rd PCR L.braz. +  weak -  -  + 
4th sampling relapse?  9.1.01   19.11.00 
4th PCR genus -/-/+  weak     +/- weak 
4th PCR L.braz. +/+/+  -   -/- 
5th sampling 19.11.00 
2ndtreatment 
    23.01.01 
5th PCR genus +/+ weak      




Patient Nr. 7 8 *** 9*** 10 11 
Origin of 
infection 
Tuiji, Bolivia Negev, IL Turkmenistan Tuiji, Bolivia Guatemala 
1st Sampling  23.10.00 12.11.00 12.11.00 21.11.00 10.10.00 
1st PCR genus n.d. +/+ +/+/- -/+/+ weak + 
1st PCR L.braz. + ? -/-/- +/+/+ weak - 
Culture + - +   
Identification L.braziliensis L.major ? L.major ? L.braziliensis L.mexicana? 
2nd sampling 19.10.00 12.11.00  24.12.00  
2nd PCR genus +? +/+  +  
2nd PCR L.braz. -     
3rd sampling 19.11.00   march 2001  
3rd PCR genus + weak     
3rd PCR L.braz. + weak   +/+  
4th sampling 9.1.01     
4th PCR genus      
4th PCR L.braz. +     
5th sampling march /01     
5th PCR genus      
5th PCR L.braz. +     
 
L.braz. =means L.braziliensis.  *Patient 3 had already had treatment before the first visit. ? indicates that the 
species was suspected, according to the patient history and the results obtained so far. Species were 
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confirmed later with ITS-1 PCR: **Patient 4 and 5 later were confirmed with L.tropica,***Patients 8 and 9 
were confirmed with L.major, patient 9 with kinetoplast primers Uni21/Lmj4 from the early culture. 
 
 
Figures 19 and 20 represent diagnostic PCR experiments (from dermal scrapings on filter paper) 
at two different times. Several patients are identical in both figures, with the difference that 
Figure 19 shows results before treatment and Figure 20 shows results after the 3 weaks course of 
treatment with pentostam: Bands in lanes 3 and 4 are derived from two different lesions of 
patient 1. Figure 20 shows that  no amplification was seen after treatment in patient 1 (lane 3, 
only one lesion re-examined). The same was found in patient 2 (lane 5 Figure 19, lane 4 Figure 
20). Patient 3 (lane 6 in Figure 19) was examined only after treatment and then re-examined later 
(lane 5 Figure 20). This patient had just completed the treatment when the sampling was 
performed  for the first time. As seen in this patient and also in patient  4 (lane 7 in Figure 19, 
lane 6 in Figure 20) DNA was amplified also after the treatment, though weaker. This will be 
discussed in chapter 4. The other patients are not identical in the two figures, because it was 
naturally the case that new cases were added to the series whenever diagnosis was required in 
new patients visiting the outpatient clinic for travellers.  
 
3.6. Amplification of the ITS-1 region and RFLP analysis: 
All tested species (purified DNA of WHO reference strains) were amplified. The products had a 
size of about 300 bp, with minor differences seen between some of the species, eg. L.braziliensis 
products appeared to be slightly smaller (not shown). The sensitivity was up to 1 pg when tested 
with purified DNA. Out of 36 previously positive extractions (thawed for reuse in this PCR) 25 
were successfully amplified and submitted to restriction with the enzyme BsuRI. The tested 
samples showed the restriction patterns as it was expected (species specific diagnosis had been 
made previously in most cases). Out of 5 patients from the Hadassah-Hospital 4 were infected 
with L.major and 1 patient with L.tropica. The recently discovered endemic sites Wadi Albethan 
(Photos 10, 11) and Korazim were confirmed as being L.tropica foci, as well as the infection 
seen in patient 4 from Afula (Galilee) (Table 8, Figure 21 lane 2). Some L.tropica amplifications 
have been comparatively weak, the smaller expected band at 57 bp is therefore not seen (in lanes 
3 and 5, compared to lane 10, reference strain). Therefore these  L.tropica results appear to be 
similar to the L.d.infantum reference (lane 11). The patients who were infected in Tuiji (Bolivia) 
were once more confirmed with an infection due to L.braziliensis. Table 9 shows the expected 
sizes of restriction fragments of each species and the results obtained from dermal scrapings on 
filter paper. Figure 21 shows one example of ITS-1 amplification and BsuRI-digestion. 
 

















Lane 1 patient 1 (BOL; lane 2 patient 4, Afula (IL); lane 3 patient 1201 (IL); lane 4 patient 1202 (IL); lane 5 
patient 5, Korazim (IL); lane 6 hamster liver infected with L.d.infantum; lane 7 patient 1175 (IL); lane 8 
patient 1168 (IL); lane 9 L.major; lane 10 L.tropica; lane 11 L.d.infantum; lane 12 L.braziliensis; lane 13 
L.mexicana; lane 14 L.amazonensis.   
 
 
Table 9: BsuRI restriction fragments of ITS-1 amplificates: 
 
 
Species Fragments after Restriction 














Wadi Albethan No.19 
P 4 Afula (IL)  
P1201 (IL) 
P5 Korazim (IL) 
L.donovani complex 184 
72 
54 
hamster liver on fp 









P1 (BOL) (2x) 
P2 (BOL) 
P7 (BOL) 
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3.7. A new focus of L.tropica in Wadi Albethan, West Bank: 
One major purpose of the project was the study of the endemic sites in the West Bank, since 
most of them were not sufficiently understood and some of them were not documented yet. A 
new L.tropica focus has been identified in the country, in an Arab village named Wadi Albethan.  
The area of Wadi Albethan is mountainous, declining towards the Jordan Valley (Photos 10 and 
11). Wadis (dry riverbeds) are connecting with the Jordan Valley. A brook is running through 
the village. In the center of the village settlement is dense, in the periphery houses are more 
isolated, surrounded by meadows with various kinds of trees and bushes (predominantly almond 
trees). Animals (predominantly goats) are kept in open sheds. The inhabitants claimed the 
infections only occurred for about one year. The characteristic lesions were not known before to 
the local population. Nevertheless, one young man had been suffering from leishmaniasis 
recidivans (lupoid leishmaniasis) for 9 years (Photo 8). He presented with a scarring lesion on 
his cheek, with active eruptions on the border of the lesion, and with one separate lesion on the 
nose. Another youth had an old scar (Photo 9). Interestingly, the inhabitants reported that 
hyraxes (Photo 19) had become abundant over the past two years. Due to the altitude of this area 
a focus of L.tropica was suspected. Several visits to this village were undertaken. In some houses 
several family members suffered from cutaneous lesions, some of them had multiple lesions 
(Photo 6). The lesions had appeared between 1 to 4 months before, in one person the lesion had 
evolved earlier (8 months before). Adults and children were equally affected. The severity of the 
lesions ranged from small papules to extensive and deep ulcers. Ulcers located on the nose 
tended to be severe. Some of the ulcerative lesions were obviously super-infected with bacteria 
(Photo 7). Some of the patients had received treatment with either liquid nitrogen or intralesional 
pentostam. Some infected residents had not seen a doctor and were left untreated. A visit to a 
doctor and subsequent treatment appeared to depend on the income of the family. Some families 
could not afford medical care. The information presented here is based on observations made 
during sporadic visits; a systematical epidemiological survey has not been carried out yet. 
 
 76  
The preservation of skin scrapings on filter paper proved to be a suitable preservation method for 
PCR-diagnosis in this field study. The PCR with primers 13A/13B succeeded at first in 12 out of 
23 guanidine extracted samples. This provided a very good result, considering that the methods  
were applied for the first time in a real field study in an unknown focus. A second extraction and 
re-amplification using only 2 µl template instead of 10 µl showed that all patients were positive, 
indicating inhibition by some components in the DNA-extract (the repeat was performed by 
Kefaya Azmi, Al-Quds-University). Primers Uni21/Lmj4 failed to directly prove the species, but 
later L.tropica was confirmed in one tested sample by ITS-1 amplification (Figure 20, Table 9) 
and BsuRI-digestion. L.tropica was also confirmed by other methods based on the successfully 
cultured strains (EF, Lionel Schnur and PPIP-PCR, Carol Eisenberger). The microscopical 
examination of the smears of 23 patients from Wadi Albethan revealed amastigotes in 9 smears, 
which is a sensitivity of 39%. Four smears had to be classified as negative, even though the 
microscopical picture was highly suggestive of a leishmanial infection: structures in the size of 
amastigotes were seen in groups either intracellular in macrophages or extracellular, but no 
nuclei and kinetoplasts could be identified. The following table shows epidemiological data and 
diagnostic results of the examined residents of Wadi Albethan. 
 
 
Table 10: Results from patients from Wadi Albethan: 
 
 







Culture Smear Therapy? 
1 f ~12 2 2 + n.d. ++  
2 f ~11 1 1 + n.d. ++  
3 f 13 1 1 + - - 1 P 
4 f 10 1 1 + - -  1 P 
5 m 25 8 2 + - -  no 
6 m 48 3 6 + - -  N 
7 f 12 1 1 + - -  N 
8 f 35 2 4 + n.d. + N 
9 m 13 4 3 + - - 3 P 
10 m 50 3 2 + - - 4 P 
11  m   3 4 1 + n.d. + 1 P 
12 m   3 3  weeks 1 + n.d. -  no 
13 m 23 2 4 + n.d. ++ no 
14 m 43 4 3 + n.d. - 4 P 
15 m 27 1 1 + - + no 
16 m 15 1 1 + - ++ ? 
17 m 44 4 5 + + + 2 P 
18 m 19 3 1 + n.d - 2 N 
19 f 18 1 1 + n.d - no 
20 m   4 3 3 + n.d - 3 P 
21 m   1 3 1 + n.d + ? 
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22 m   4 1 3 + n.d - no 
23 f 23 1 7 + + - 1 P 
f =female; m =male; n.d. =not done; contam. =culture contaminated with bacteria; P =intralesional 








3.8. The aims of the study have been achieved:  
1. Direct PCR diagnosis has been established in the laboratory and is ready to be used in 
clinical laboratories. The tested sampling procedure (dermal scrapings on filter paper) proved 
to be a highly suitable method which can be recommended for future applications. Diagnosis 
of CVL(VL) is available too, using peripheral blood spots on filter paper. Many observations 
have been made, related to preservation, extraction and amplification. This may help to select 
methods according to different purposes. Extraction methods have been simplified with 
regard to the application in clinical laboratories (eg. Chelex extraction). 
2. 2. The differentiation of L.major and L.tropica has been achieved. Primers Uni21/Lmj4 were 
able to make the distinction but the diagnosis from dermal scrapings did not always succeed.  
With the recent introduction of the ITS-1 primers a sensitive system was established for the 
differentiation of nearly all species. The latter is also able to distinguish L.d.infantum 
infections, the third endemic species in the country. 
3. PCR diagnosis directly from lesions has been established also for the L.braziliensis complex 
specifically, using kinetoplast primers MP3H/MPL1. This can help to decide if patients with 
New World leishmaniasis need to be hospitalized for 3 weeks or not. Species-specific 
diagnosis of the New World Leishmania species had not been available in the country before. 
The introduction of the ITS-1 method improved the quality of diagnosis, because it could 
also positively identify the L.mexicana complex (including the distinction of L.mexicana and 
L.amazonensis). 
4. It has been shown that the methods employed (DNA extraction and PCR) were suitable for 
screening of reservoir animals. PCR was far more sensitive than microscopy, which clearly 
justified the method for diagnosis and for epidemiological studies. 
In addition, some important results have been obtained: A new host species has been 
discovered (Gerbillus dasyarus) and a new focus of L.tropica has been identified (Wadi 
Albethan, West Bank).  
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Wadi Albethan, West Bank (Samaria), outbreak of L.tropica: 
 
Photo 9 
CL scar Photo 10 
Wadi Albethan, 
view to the east,  
towards the Jordan
Valley (behind  
mountain range) 81  
Photo 11 
Area of high incidence 
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4. Discussion 
 
The achievement of this research has been the selection of appropriate methods for the specific 
requirements of the Middle East. Many others have worked on the improvement of PCR-
diagnosis of leishmaniasis in other regions of the world, and much has been achieved in the past 
decade. Based on the experiences made within this research, different aspects of extraction- and 
PCR-methods will be discussed, which can be used as a basis for future applications. 
The PCR methods are discussed chronologically, as they have been gradually established in the 
laboratory. The results are mainly discussed within the sections of the PCR-methods by which 
they were obtained. This proceeding was favoured because it reflects the actual situation as it 
was, where neither the methods nor the samples were available at the beginning.  
The collection of samples depended greatly on the contacts made during the study. Sometimes 
coincidences led to the collection of new sample groups, as was the case with the new L.tropica 
focus in the West Bank (Wadi Albethan): A dermatologist in Nablus had invited us to visit. The 
same day he had treated a patient with CL from Wadi Albethan. Through the initiative and help 
of Samir Sawalha (Masters student of the Al Najar University, Nablus), the first visit to families 
in the village was arranged immediately and more visits followed. 
 
4.1. Sampling and preservation: 
4.1.1. Collection of dermal scrapings: 
The detection rate of leishmanial DNA by PCR in dermal scrapings proved to be higher than in 
microscopical smears, as especially seen in two study groups (desert rodents and patients from 
Wadi Albethan) The detection rate of PCR exceeded the detection rate of microscopy on dermal 
scrapings and skin biopsies also in previous studies (Belli et al., 1998; 1999; Rodriguez et al., 
1994). It is important that the sampling be performed correctly, according to the instructions 
given by Herwaldt, (1999) (chapter 2.2.1.). Belli et al., (1998) found the PCR on dermal 
scrapings (Chelex-extracted) to be 100% sensitive and also to 100% specific. Since dermal 
scrapings are less invasive and much easier to collect, he suggests that they can fully replace skin 
biopsies. This was also maintained by Rodgers et al., (1990), who suggested that patients should 
be spared from skin biopsies, especially if lesions are located in the face. Instead of sterile 
surgical blades, sterile wooden toothpicks can be used as well for sampling (Belli et al., 1998; 
Harris et al., 1998). It is known that skin biopsies have a higher detection rate than dermal 
scrapings if examined microscopically (Andresen et al., 1996), but with PCR the sensitivity is 
high enough using dermal scrapings. 
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4.1.2. Specimens other than dermal scrapings for direct PCR-diagnosis: 
Apart from dermal scrapings, peripheral blood has been successfully used for diagnosis in this 
study. Others have previously shown that many different kinds of specimens can be used for 
PCR-diagnosis of leishmaniasis. Extracts from tissue samples, smears, lymph node and bone 
marrow aspirates and peripheral blood have been used successfully (Smyth et al. 1992; Lopez et 
al., 1993; Eresh et al., 1994; Wilson et al., 1995; Laskay et al., 1995; Bhattacharyya et al., 1996; 
Osman et al., 1997; Belli et al., 1998; Noyes et al. 1998). PCR has also been performed on 
sandflies (Rodriguez et al., 1999; Aransay et al., 2000).  
 
4.1.3. Preservation on filter paper: 
Blotting of tissue scrapings on filter paper is an excellent method for long-term preservation. The 
preservation on filter paper proved to be especially suitable for field studies due to very good 
conservation of the DNA, without cooling, with little storage space and low expenses. No 
additives for the preservation are required, which could potentially interfere with the PCR. The 
samples can be delivered to the laboratory weeks after collection without any loss of quality. 
Filter paper has been used previously for the preservation of peripheral blood spots (Osman et 
al., 1997; Campino et al., 2000), dermal scrapings (Harris et al., 1998; Färnert et al., 1999) and 
different kinds of aspirates (El Tai et al., 2000). 
It has been shown in this study that the filter paper samples were stable for more than one year.  
The rodent samples had been stored at room temperature for more than one year before they 
were processed. The amplifications have been very efficient and no loss of quality was observed. 
A comparative study on Leishmania positive tissue on filter paper, which had been stored at 
different temperatures (-20°C, 4°C, 20°C) for more than one year, has shown that the DNA was 
conserved equally well at all temperatures. It can be assumed that humidity affects the stability 
of the DNA, but this has not been examined here. Freezing of filter paper samples may be 
preferred in humid climates. (Campino et al., 2000). Färnert et al., (1999) have found that blood 
samples stored at 4° and at 20° C lost some sensitivity after a period of 30 days, whereas blood 
samples on filter paper were stable for several months at 4° and at 20° C. For the storage of 
blood samples the choice of anticoagulant is relevant. Färnert et al., (1999) found inhibition in 
samples extracted from heparin-blood and equally efficient amplification from EDTA- and 
citrate-blood. Heparin is known to inhibit PCR. EDTA is also known to inhibit PCR, but the 
amount used for anticoagulation is small enough not to interfere with the reaction. By using filter 
paper also for peripheral blood (diagnosis of VL), the problem of PCR inhibition by 
anticoagulatory agents can be avoided. 
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4.1.4. Classical preservation methods: 
It was demonstrated that samples differently preserved can be processed as well: Paraffin 
embedded biopsies (after deparaffinization, see passage 2.2.4.2.) and Giemsa-stained smears 
were extracted with the phenol-chloroform extraction and successfully amplified. An eventual 
loss of sensitivity can not be excluded but was not further examined. The formalin-fixed jackal 
spleens were all negative, either due to true negativity, to DNA degradation prior to the 
extraction or to inhibition. The biopsied material had not been preserved well, judging from the 
outer appearance. Formalin-fixed biopsies have been used previously for the diagnosis of 
leishmaniasis with good success by Mimori et al., (1998). The positive results with paraffin 
embedded biopsies and Giemsa-stained smears in this study show that samples other than dermal 
skin scrapings may also be proceeded (if received from other hospitals). This shows that the 
same methods can be employed for retrospective studies (Laskay et al., 1995). 
 
4.2. Discussion of DNA extraction methods: 
Several different extraction methods have been employed, ranging from thorough purification to 
very simple and crude methods. All extraction methods were successful, each of them having 
advantages and disadvantages. Two objectives had to be pursued, one being the best possible 
purification with elimination of inhibitory factors, the other being the highest possible yield of 
DNA. A good balance had to be found between the two requirements. Thorough purification was 
achieved only through many single steps, always implying a loss of template to a certain extent 
and an increased risk of sample cross-contamination. Crude extractions did not eliminate 
inhibiting factors sufficiently (additives can circumvent the problem). Besides, it was important 
to develop a method, which would readily be accepted in terms of practicability and cost 
effectiveness (time and material) in a clinical laboratory. Avoidance of hazardous chemicals is 
another criteria, which might be considered for routine diagnosis. 
  
4.2.1. Phenol-chloroform-extraction: 
The phenol-chloroform extraction is a very efficient and thorough purification method, which is 
comparatively hazardous and time consuming. Many steps of lysis, digestion, extraction and 
washing require much opening and closing of the 1.5 ml tubes, implying an increased risk of 
sample cross-contamination. The phenol-chloroform extraction is highly efficient in removing 
inhibiting factors, such as hemoglobin. It therefore proved to be reliable also for samples with a 
higher blood content. All samples that were conserved differently (formalin-fixed, paraffin-
embedded biopsies and Giemsa stained smears) were proceeded with this method because it had 
the highest potential to remove inhibitory substances. Apart from that, phenol inactivates other 
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infective agents (eg. HIV), which may be a major consideration in some regions (eg. south-
western Europe). Proteinase-K digestion with subsequent phenol-chloroform extraction is the 
best known classical extraction method, which was successfully employed also in many previous 
studies on clinical samples (Smyth et al., 1992; Ashford et al., 1995; Andresen et al., 1996; 
Osman et al., 1997; Mimori et al., 1998; Färnert et al., 1999; Campino et al., 2000). 
 
4.2.2. Guanidine-extraction: 
The guanidine extraction was efficient and reliable as well. It is especially efficient in the 
recovery of traces of DNA. The guanidine extraction proved to be less reliable on samples with a 
high blood content. The procedure is shorter and less steps are required than with the phenol-
chloroform-extraction. The centrifugation steps are short (seconds) and a micro-centrifuge 
suffices. An advantage is also that the reagents are less hazardous than the ones used for the 
phenol-chloroform extraction. Besides, the samples are only once transferred to fresh 1.5 ml 
tubes, in contrast to 4 sets of fresh tubes needed during the phenol-chloroform extraction 
(contamination risk!). The guanidine extraction is a classical method in molecular biology, 
especially for forensic applications. Only few groups have employed this method in the field of 
leishmaniasis, also with good results (Noyes et al., 1998). An interesting study has been 
conducted by Lachaud et al., (2001) who compared the phenol-chloroform extraction with the 
guanidine extraction. In contradiction they found that the guanidine method was slightly more 
sensitive when whole blood (!) was used, whereas the phenol-chloroform method was superior 
when buffy coats were extracted. The difference was mainly that the phenol-chloroform 
extracted buffy coats produced stronger signals, the sensitivity was practically the same.  
 
4.2.3. Chelex-extraction: 
The Chelex-extraction was by far the shortest procedure. After over night digestion, heating for 
10 minutes and a short centrifugation the supernatant was directly submitted to PCR. Results 
were obtained already in the early afternoon of the following day. Using the more thorough 
extraction methods, PCR-results could only be obtained by the evening of the day after the over 
night incubation. Furthermore, it was shown that an incubation of only 1 hour is sufficient for 
successful amplification, but the yield might not be maximal. The fact that the samples stay in 
the same Chelex-suspension from the beginning to the end of the procedure, without opening 
and closing of the tubes, reduces the risk of sample cross-contamination. Besides, no material is 
lost during the procedure as it is the case with the phenol-chloroform extraction, in which a small 
part of the original sample is naturally lost in every transfer of the upper phase. Other 
experiments with crude extractions have clearly indicated that hemoglobin residues may inhibit 
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the PCR. A relatively high tissue content and a low blood content (= sample quality with highest 
success rate) of the skin scrapings reduces the risk of inhibition. The results on the Psammomys 
ear scrapings have proved the high efficiency of this method, as it has been found as well in 
previous studies on human samples (Harris et. al., 1998; Belli et. al., 1998; 1999). An extensive 
study on dermal scrapings in 232 patients with American CL has shown that the Chelex 
extraction was suitable for reliable PCR diagnosis. Using primers 13A/13B, 205 patients were 
PCR-positive (85%) (Belli et al., 1999). Especially for larger studies, the Chelex extraction is a 
very convenient and time saving method. The superior qualities of the Chelex method are: low 
risk of contamination, saving of labour and material, combined with good sensitivity. For routine 
use in a clinical laboratory, the employment of the Chelex method could reduce the costs for the 
PCR-diagnosis of leishmaniasis enormeously. Several hours of bench work can be avoided and  
laboratory supplies can be spared (pipette tips, 1.5 ml tubes and chemicals). The Chelex method 
is limited in its capacity if inhibitory substances are present (has to be evaluated yet). For the 
diagnosis of VL it can be suggested to use the buffy coat (also spotted on filterpaper). 
 
4.2.4. Crude extraction methods: 
It has been shown that proteinase-K digestion and boiling (5 minutes) in a water bath was 
sufficient for successful PCR-amplification from dermal scrapings. These experiments were 
performed in the beginning of the study, when primers Uni21/Lmj4 were tested for their 
sensitivity on clinical samples. The fact that results were obtained with the least sensitive 
primers employed in this study is promising for diagnosis with the more sensitive primers. After 
the Chelex extraction was found to work well, experiments on other crude preparations became 
obsolete for this study. Crude DNA-preparations have been tested previously by others, also with 
good success (Rodriguez et. al., 1994; Laskay et al., 1995; Harris et al., 1998; Belli et al. 1998). 
There are more variations and combinations, which would be worth-while to test, as for example 
proteinase-K digestion in 5% Chelex. Lopez et al., (1993) have used DNAse I digestion prior to 
PCR in order to expose more kDNA minicircles of the catenated network. The sensitivity was 
clearly increased when compared to non-digested samples (not tested in this study). 
 
4.2.5. Extraction methods related to different types of specimens: 
It was repeatedly observed that the quality of the results appeared to depend on the extraction 
method chosen for a certain type of sample. In a cooperative study (Mattheson and Anders, 
submitted 2001) a series of 7 different specimens were submitted to several different extraction 
methods in order to find the optimum extraction method for each different type of sample. 
Primers specific for the cytochrome b gene of the mitochondrial DNA were employed to detect 
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mammalian DNA. As expected, different extraction methods performed differently, depending 
on the types of specimens. The phenol-chloroform extraction was superior with the blood 
containing samples (1 drop of whole blood and of EDTA blood on filter paper, 500 µl of whole 
blood). The guanidine extraction was more efficient than the phenol-chloroform extraction with 
macerated raw tissue. The chelex method was almost as efficient as the phenol-chloroform 
extraction with blood spots on filter paper but it was much less efficient with larger amounts of 
blood and raw tissue. This comparative study showed that it is worth-while to select the 
extraction method according to the amount and type of sample.  
 
4.2.6. Storage of extracted samples: 
The extracted DNA was usually resuspended in ddH2O. The samples were directly submitted to 
PCR for best results. At 4°C the DNA degraded within days. Therefore aliquots of the extracted 
DNA were stored at -20°C, in case additional reactions were necessary. Usually good results 
were obtained also after one round of freezing and thawing. It was considered to use TE buffer 
(pH 8) instead of ddH2O, in order to stabilize the DNA. It was not used here because only small 
amounts of template would have been tolerated in the PCR-reaction due to the inhibitory activity 
of the EDTA present in the buffer. Since the phenol-chloroform extracted samples were 
resuspended in a much smaller volume than the guanidine- and Chelex-extracted samples, TE 
could be used for the phenol-chloroform extracted samples without any problems (advantage). 
The DNA is evidently more concentrated and less amounts of template are required for 
successful amplification, the inhibitory activity of EDTA is negligible then. When a small 
amount of TE-buffer (eg. 5µl) was added to extracted samples the PCR was not inhibited but the 
possibly higher stability of the DNA has not been examined yet. 
 
4.3. Reliability of the employed PCR-methods: 
4.3.1. Sensitivity: 
The kinetoplast specific primers have been selected because of their potential for high 
sensitivity. The aim of the direct PCR diagnosis was the detection of single parasites from 
clinical material. Studies on purified DNA of reference strains have confirmed the high 
sensitivity of primers 13A/13B and MPL1/MP3H up to less than single parasites (Rodgers et al., 
1990; Lopez et al., 1993). Experiments with serial dilutions of DNA within this study have 
found sensitivities with primers 13A/13B up to 10 fg, primers Uni21/Lmj4 up to 1 pg (25 fg 
DNA with Gels Star staining) and up to 1 pg with primers LITSRn/L5.8S (ITS-1). Even though 
primers Uni21/Lmj4 were theoretically capable of detecting single parasites it was often not 
seen. When clinical samples are examined less sensitivity is expected due to inhibitory agents. 
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Rodgers et al., (1990) found the sensitivity to be 10-100 fold less with clinical samples, 
compared to purified DNA from cultured strains (inhibition). Similar observations have been  
made repeatedly during this study. This fact could not be evaluated in a quantitative way since 
the intracellular amastigotes of a clinical sample would have to be compared with defined 
amounts of purified DNA which is practically impossible. A comparison between purified DNA 
and a defined number of promastigotes in peripheral blood is certainly the best possible 
comparative approach as recently performed by Dinse et al., (2001). The factor of cell lysis 
necessary to release the intracellular amastigotes in a real sample is not considered. Furthermore, 
dermal scrapings can not be standardized, every new sample has a different consistency (eg. 
amount of hemoglobin), which greatly influences the outcome. In order to assess the quality of 
the PCR in a more realistic way,  results were compared with the results of the corresponding 
smears. The study with primers 13A/13B on desert rodents (Chelex-extracted) has clearly 
demonstrated a sensitivity which is unlikely to be surpassed. Primers MPL1/MP3H amplified 
even a smaller part of the kinetoplast minicircles (70 bp) and were therefore expected to have a 
similar sensitivity on clinical samples as primers 13A/13B. This was confirmed in the 6 patients 
who had contracted CL in Tuiji (Bolivia). The ITS-1 primers LITSRn/L5.8S were found to be 
highly sensitive on clinical samples since they were able to amplify many samples, which had 
been positive by primers 13A/13B and/or MPL1/MP3H earlier. This can be stated since the 
samples had been extracted earlier and had to be defreezed for this PCR. Freezing may lead to 
deterioration of the DNA quality. 
In other studies, the sensitivity of PCR was always superior to the sensitivity of microscopy 
(Belli et al., 1998; Andresen et al., 1996; Rodriguez et al., 1994). PCR was also found to be 
more sensitive (100%) than serology (63%) (Ashford et al., 1997). It has been repeatedly shown 
that the potential sensitivity of PCR reached the detection of single parasites (Rodgers et al., 
1990; Lopez et al., 1993; Noyes et al., 1998; Harris et al., 1998).  
 
4.3.2. False negatives/ inhibition: 
It was observed repeatedly that an increase of template (DNA, lysate or supernatant) in the 
reaction mix did not necessarily lead to a better result. On the contrary, it became obvious that 
beyond a certain amount of template DNA the amplification was inhibited. This applied also for 
well purified samples. In the first attempt to apply the direct PCR diagnosis on the 23 patient 
samples from Wadi Albethan 10 µl of template (10 µl out of 100 µl extracted, resuspended 
DNA) were used resulting in only 12 positives. In the repeat PCR (performed by Kefaya Azmi) 
only 2 µl were used resulting in 23 positives (100%). Several experiments showed that the 
inhibition can be controlled by adding either BSA (eg. 5 µl of a 10mg/ml solution) or DMSO 
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(2.5%) together with formamid (1%) to the reaction. Using these additives, the PCR tolerates 
more µl of template DNA, which is of interest especially for the less sensitive PCR 
(Uni21/Lmj4). Inhibition especially with crude samples was observed by others as well. Belli et 
al., (1998) circumvented the problem by diluting the samples up to 10-fold. Since the employed 
primers (13A/13B and MP3H/MPL1) were highly sensitive, the template in the diluted samples 
sufficed. With sensitive primers a small amount of template DNA (1-2 µl) is sufficient to ensure 
amplification.  
The volume of the resuspension is also a factor worth to consider: A smaller volume is of 
advantage because the extracted DNA is more concentrated and therefore more stable. Only with 
the phenol-chloroform extraction could the volume be reduced to 25 µl. With the other methods 
the volume could not be reduced for technical reasons. The guanidine extracted samples were 
resuspended in a higher volume (100 µl) to allow the silica beads to be completely in suspension, 
in order to release the attached DNA into the solution. The Chelex extraction required at least 
200 µl of 5% Chelex, otherwise the filter paper would not have been covered completely during 
the incubation.  
False negative samples could be also due to uneven distribution of Leishmania DNA in an 
extracted patient sample, eg. if a sample contains only 1-10 parasites not every single µl of the 
resuspended DNA contains necessarily enough template to support amplification. It can be 
considered to amplify different amounts of one sample at the same time to avoid false negativity. 
Another possibility is to include an inhibition control, using primers which target human DNA. 
Human DNA is present in excess in all clinical samples and PCR-amplification can thus be 
controlled.  
 
4.3.3. False positives/ contamination: 
The main problem of sensitive PCR methods is the risk of contamination, leading to false 
positive results. Contamination was monitored by including at least two negative controls in 
every extraction series. A piece of plain filter paper was used also as a control of the filter paper 
itself. A human blood sample on filter paper was used to rule out any non-specific amplification 
of human DNA. For the Psammomys samples ear tissue was used from a negative laboratory 
animal. The amplification was controlled for any contamination related to the PCR itself 
(reaction mix without template).  
It appeared that contamination occurred mostly during the extraction, with negative extraction 
controls being positive and negative PCR controls being negative. For this reason several series 
of extractions (Hadassah patients) had to be excluded from the study. The risk of sample cross-
contamination was minimized, by following a number of precautions: Bleaching and UV-
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radiating of surfaces and pipettes were the most important measures to avoid contamination. 
After these measures were followed strictly, the problem was controlled and extraction controls 
as well as PCR controls were then negative. The risk of contamination is known to be the main 
problem of PCR, which has been discussed also by others in relation to PCR-diagnosis of 
leishmaniasis (Adhya et al., 1995; Wilson , 1995; Belli et al., 1998). 
 
4.3.4. Reproducibility of PCR-results: 
In repeated extraction and PCR (13A/13B) from single drops of the same blood samples (4 dogs 
with CVL) the same intensities of bands were reproduced. This concordance suggested a high 
correlation between the parasitic load and the amount of amplified product. A positive 
correlation between the intensity of bands and the number of parasites seen by microscopy was 
also found by Andresen et al., (1996). The distribution of amastigotes within a lesion is not 
homogenous. One experiment with three dermal scrapings which had been collected as a series  
from three different areas of the same lesion, showed great differences in the intensities of 
amplified bands. It is therefore also possible that the smear contains amastigotes and the filter 
paper not, or reversely. Also the relative amount of blood influences the results. Bloody samples 
often contain less parasites, since the blood does not necessarily originate from the lesion itself. 
If parasites are equally distributed in the sample, as it is the case in peripheral blood of VL 
patients the PCR seems to be reproducible to a high extent..  
 
4.4. Discussion of PCR results: 
4.4.1. Results with primers Uni21/Lmj4: 
The PCR using the kDNA primers Uni 21/Lmj4 was found to be useful to distinguish between 
L.major and L.tropica infections. The PCR on purified DNA and on cultured organisms proved 
to be reliable, yielding always a 680 bp product in L.major typed strains and a product of 820 bp 
in L.tropica typed strains. Non-leishmanial Kinetoplastidae did not amplify. The sensitivity with 
purified DNA (from cltured promastigotes) was promising, with regard to the potential use for 
direct diagnosis. Harris et al. (1998) estimated that 1 pg of DNA is equal to 10 parasites. The 
potential sensitivity of primers Uni21/Lmj4 therefore was corresponding to the DNA of 1/4 
parasite. Nevertheless, the primer pair Uni21/ Lmj4 was often not sensitive enough to detect 
single parasites from clinical samples. Efforts have been made to optimize the sensitivity by 
making the following changes:  
1.  DMSO and formamid or BSA were added to the PCR in order to block inhibitory 
activity. Thus more µl of extracted template were tolerated in the reaction. 
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2.  The choice of the polymerase influenced the outcome to a great extent: the Promega Taq 
polymerase often failed to amplify the 680-850 bp sequence from clinical samples. The 
TaKaRa Ex Taq and the Fermentas Taq polymerase proved to be more reliable.  
3.  It was hoped the sensitivity would be improved under less stringent PCR-conditions. A 
lower annealing temperature (50°C instead of 60°C) yielded also good results. Since 
occasionally non-specific PCR products of different sizes appeared the original annealing 
temperature (60°C) was finally adapted as the standard annealing temperature. 
4.  A higher number of cycles (45 instead of 35) was an alternative option to increase the 
sensitivity. 
5.  The staining with Gel Star stain instead of ethidium bromide staining clearly increased 
the sensitivity. Bands which were nearly invisible with ethidium bromid were distinct 
and clear when stained with Gel star stain. 
 
The PCR with primers Uni21/Lmj4 showed primarily good results with dermal scrapings on 
filter paper, and appeared to be a suitable method for direct diagnosis and simultaneous 
differentiation of L.major and L.tropica. Even on crude extractions (from dermal scrapings on 
filter paper), samples were amplified successfully (lysis with NET-buffer and proteinase K 
digestion). At the beginning, the results were very promising, but later this PCR often failed to 
produce results, even on microscopically confirmed patients.  Nevertheless, whenever the PCR 
succeeded the results were valuable and very helpful. The results were collected during the 
developmental stage when conditions of extraction and PCR were often modified. No 
amplification was probably often due to sub-optimal conditions (too much template eg.). A 
statistical analysis was therefore not possible. In 6 out of 24 PCR-positive patients the diagnosis 
was made by PCR only, since smear and culture had been negative.  
 
Specific cases diagnosed with kinetoplast primers Uni21/Lmj4: 
1. The case of the patient with the severe nose infection and a possible double infection will 
be discussed in the following section: controversial results.  
2. The diagnosis of L.major in the couple from Holon was important to exclude any other 
causative species. The area is not endemic for leishmaniasis and the source of the 
infection remained unclear. The couple claimed they had not travelled in- or outside the 
country since more than one year. The ecology (city, close to the Mediterranean) did not 
suggest a new focus of L.major. The only conclusive hypothesis was that the neighbour 
had imported infected sandflies in his car. The couple reported the neighbour was going 
frequently to the Jordan valley by car. The source of the infection remained unclear. 
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3.  The correct identification of L.major from a lesion caused by a L.major vaccination strain 
confirmed the specificity of the primers (patient No. 24 in Table No. 6). 
4.  The results from 4 skin scrapings collected from Psammomys ears show that the kDNA 
PCR with the primer pair Uni21/Lmj4 can be used for detecting infections in reservoir 
animal species as well. 
5.  In the case of the infected sandfly from Kfar Adumim L.tropica was confirmed with 
primers Uni21/Lmj4 as soon as promastigotes were discovered in the medium. This case 
demonstrated the usefulness of primers Uni21/Lmj4 on newly collected strains. 
Differentiation between L.major and L.tropica can be achieved long before the normal 
harvesting of cultures in the stationary phase of growth. Kfar Adumim is a known focus 
of Leishmania tropica (Klaus et al., 1994). It is no contradiction that Kfar Adumim 
residents were found to be infected with L.major as well. Transmission of L.major within 
the settlement Kfar Adumim has not been proven, but it can also not be excluded. The 
fact that both, L.major and L.tropica were diagnosed from residents of Kfar Adumim 
(L.tropica also from sandfly derived cultures), emphasizes the necessity of species 
distinction, even within one settlement. The Jordan Valley (Jericho) as the main 
transmission area of L.major in the country, is very close, the Wadi Kelt being in a 
distance of less than 1 km. The Bedouins in the area are familiar with CL. The exact 
limits of L.major transmission are not known in the Judean Desert, where Wadis directly 
connect with the Jordan Valley.  
6.  A cultured strain obtained from Costa Rica (via Lionel Schnur, Kuvin Center), yielded a 
PCR-product of 800 bp. Since the L.braziliensis- as well as the L.mexicana-complex are 
not amplified with primers Uni21/Lmj4 the only possible New World species amplified 
with these primers, is L.d.chagasi. The fact that the strain was derived from a patient with 
VL who is living in an area endemic for L.d.chagasi, corroborated the diagnosis. The 
same case has been reported as the first case of VL in Costa Rica by Carrillo et al, 
(1999), L.d.infantum/chagasi has been identified by isoenzyme analysis. This 
demonstrates that the primers Uni21/Lmj4 may be useful in the New World too. 
L.d.chagasi infections could be identified and distinguished from all other New World 
species. This may be of interest especially for the diagnosis of “atypical CL“ in the New 
World caused by L.d.chagasi (Ponce et al., 1991). 
Controversial results: 
In the patient with the severe infection of the nose, the direct PCR diagnosis revealed an 
infection with L.tropica from one lesion, and possibly a double infection (L.major/L.tropica) 
from the other lesion. The PCR on the culture of the same patient some weeks later revealed a 
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band of 680 bp (L.major). The EF performed on the culture identified this isolate as being 
L.major. A contamination of the filter paper extraction is presumably not the cause, since all 
controls were as expected and all other patient samples in the same series produced the smaller 
fragment of 680 (L.major). The more conclusive explanation is a mixed infection with two 
species. The origin of the patient (Hemdat) in the bordering area of the northern Jordan Valley 
and the hilly slopes of Samaria (West Bank) is indeed an area, where both species (L.major and 
L.tropica) may occur. Foci of L.major (Jordan Valley) and the newly identified focus of 
L.tropica in the hilly area (Wadi Albethan) are both very close. Klaus et al. (1994) made similar 
observations in two patients who had been infected in Kfar Adumim: the PCR (with primers 
Uni21/Lmj4) had revealed L.tropica from the early cultures. The culture had been re-examined 
after some time, and L.major had been identified. It has been observed that the initial growth of 
the culture was very slow, whereas the later culture was thriving well. The most probable 
explanation was a mixed infection with two species. It is a known fact that some species thrive 
better than others in culture. Strejan (1963) observed that different species of Leishmania require 
a different nutritional medium in order to grow well. In a mixed culture one species is therefore 
gradually outgrowing the other. Harris et al., (1998) reported that L.major outgrows L.tropica, as 
L.mexicana outgrows L.braziliensis in mixed cultures. This implies that diagnostic methods 
based on cultured parasites (isoenzyme electrophoresis, analysis of the EF, other PCR-methods) 
might be misleading in the case of double infections. As it was the fact in this patient the 
classical methods would have missed the more problematic causative agent (L.tropica), which 
requires medical intervention. A concurrent infection with L.major and L.donovani has been 
reported from Kenya (Mebrahtu et al., 1991). It can be assumed that double infections were 
greatly underreported in the past because diagnosis relied mostly on culture-based techniques. 
The presented case clearly demonstrates the relevance of direct diagnosis. 
It can not be excluded that some strains have characteristics of two species: Oren et al., (1991) 
reported about a 21 year old Israeli with VL, who came from the area south of the Sea of Galilee. 
A strain was isolated which was typed as L.tropica by EF whereas isoenzyme analysis had 
revealed characteristics from both, L.donovani and L.tropica. 
The PCR with primers Uni21/Lmj4 can not discriminate between L.tropica and L.d.infantum. A 
PCR-product of 800 bp was attributed to L.tropica, but theoretically it could be also due to 
L.d.infantum. There is no record of cutaneous L.d.infantum strains in Israel and the PA so far, but 
since it has been reported from other countries (Lebanon, Italy, Tunisia, Iran) it has to be 
considered (Nuwayri-Salti et al., 1994; Gramiccia et al., 1989; 1991; Hatam et al., 1997, 
respectively). Endemic areas of L.tropica and L.d.infantum are partly overlapping in the Jenin 
district, which makes the differentiation relevant. An attempt to overcome the limitation in 
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species discrimination with primers Uni21/Lmj4 was performed by Kefaya Azmi and Obeida 
Yussuf (students of the Al Quds-University, Jerusalem, laboratory work performed at the Kuvin 
Center), who tested many restriction enzymes for RFLP- analysis of the PCR product and were 
able to differentiate the species according to their patterns. 
 
4.4.2. Results with the genus specific kDNA-primers 13A/13B: 
The genus specific primer pair 13A/13B proved to be highly sensitive, up to 10 fg (1 pg = 10 
parasites, Harris et al., 1998) and was able to detect probably every single infection. The high 
sensitivity of the PCR with primers 13A/13B had been also found in previous studies (Rodríguez 
et al., 1994). This PCR proved to be an excellent screening method for the presence of 
Leishmania DNA, directly from dermal scrapings. Noyes et al., (1998) discussed, that the 
amplification of the conserved part (120 bp) of the kDNA minicircles is often sufficient because 
the species is already known (eg. screening of Psammomys). Primers 13A/13B amplified also 
non-leishmanial Kinetoplastidae, such as Trypanosoma, which has to be considered if infections 
are contracted in areas co-endemic with the Chagas disease or sleeping sickness 
(trypanosomiasis). 
The PCR with primers 13A/13B was introduced as a screening method. It has been successfully 
employed on several sample groups, after the contamination problems were controlled. The 
specific results will be discussed in extra sections: the results from the Tel Hashomer patients 
(New World leishmaniasis) will be discussed together with the corresponding results with 
primers MP3H/MPL1 in the following section, the results from the new L.tropica focus Wadi 
Albethan (West Bank) will be discussed in section 4.5., the animal samples will be discussed in 
section 4.6. 
 
4.4.3. Results with L.braziliensis specific primers MP3H/MPL1: 
Since New World leishmaniasis is occasionally seen in Israeli travellers it was important to 
establish also PCR-diagnosis for the Leishmania species of the New World. Because of the risk 
of mucocutaneous leishmaniasis (MCL, Espundia) later in the case of L.braziliensis-infections, 
the major goal was to identify the infections caused by the L.braziliensis complex. The diagnosis 
of L.mexicana species was also desired but of secondary relevance. Primers MP3H/MPL1 were 
selected because they met the two requirements, being able to distinguish between the 
L.braziliensis and the L.mexicana complex and also to detect single parasites (Lopez et. al., 
1993). The primers MP3H/MPL1 had been previously employed also on dermal scrapings and 
had been proved to be more sensitive than microscopy (Belli et. al., 1998). When tested on 
reference strains the species of the L.braziliensis complex (L.braziliensis, L.guyanensis, 
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L.panamensis) were amplified very efficiently. L.mexicana and the species of the Old World 
(L.major, L.tropica, the L.donovani complex) were not amplified, thus confirming the species-
specificity of the primers. The sensitivity of the primers were evaluated empirically on dermal 
scrapings, in relation to the corresponding results with primers 13A/13B. Anyhow it was 
important to examine the returners with both primer pairs, since they could have contracted the 
disease also in Israel, either before or after the journey to America (Table 6, patients 11 and 12!). 
All 6 patients who had contracted CL in Bolivia were diagnosed with L.braziliensis directly from 
lesion scrapings. One patient had visited Guatemala and was negative with the L.braziliensis 
specific primers but positive with the genus specific primers (13A/13B). This finding suggested 
an infection by species of the L.mexicana complex. L.d.chagasi was another possibility since it 
would have reacted identically with primers MP3H/MPL1 and primers 13A/13B. So far, 
“atypical” CL caused by L.d.chagasi has been reported from Costa Rica, Honduras (Ponce et al., 
1991) and from Nicaragua (Harris et al., 1998; Belli et al., 1999). The other 4 patients who were 
treated at the Tel Hashomer Hospital had been infected in the Old World. All 4 were negative 
with the L.braziliensis specific primers and positive with the genus-specific primers, as expected.  
Repeated sampling and PCR,  before, directly after and again months after treatment showed that 
the PCR signal became fainter or even disappeared after healing in most cases. In two patients 
who were suffering from a clinical relapse (patients 1 and 7, Table 8), the previously faint 
signals became more intense again. This was interpreted as a confirmation of the relapse, 
requiring another 3 weeks course of systemic pentostam. Not every PCR-positivity months after 
completion of the treatment should be regarded as a sign of a relapse. Due to the high sensitivity 
of the PCR a tiny remnant of DNA may easily be amplified, especially if the targeted sequence is 
as small as 70 bp. A weak amplification was seen in most of the cases after treatment and 
progressive healing. The clinical appearance needs to be judged primarily and the PCR-results 
are usually helpful to confirm the clinical findings. One has to be careful to draw conclusions on 
the variable quantity of the PCR-product. The reproducibility especially from lesion scrapings is 
limited, as discussed earlier. The amount of collected tissue was not standardized and was 
different in every new sample. Nevertheless, a constant decrease of PCR-amplification after 
completion of the treatment is certainly a good indication for cure. A study conducted by 
(Nuzum et al., 1995) has in fact shown that 12 out of 13 previously PCR-positive VL patients 
were PCR-negative 6 months after treatment and cure.  
Only recently we learned that a follow up study with repeated dermal scrapings and PCR, as it 
was performed here, may not be advisable due to increased risk of reactivation. This applies 
especially for L.braziliensis infections, which tend to recidivate (personal communication with 
Palmira Guevara, University of Venezuela, Caracas, Venezuela). 
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4.4.4. Results with ITS-1 primers and RFLP-analysis: 
The ITS-1 amplification combined with RFLP-analysis was published only recently (Schönian et 
al., 2000; El Tai et al., 2000), otherwise it would have been adopted as the standard 
methodology of this thesis from the beginning, due to its species specificity and good sensitivity.  
With purified DNA it had attained the same sensitivity as with primers Uni21/Lmj4 (1 pg).  This 
PCR method allows species specific diagnosis of all Old World species and all New World 
complexes. The different species of the L.braziliensis complex appear identical, the species of 
the L.mexicana complex (L.mexicana and L.amazonensis) can be differentiated. 
In this study the ITS-1-PCR was applied on already extracted clinical samples which had been 
stored at -20°C. The restriction of the PCR-product with the enzyme BsuRI (Hae III) showed the 
expected patterns, allowing for species specific diagnosis. The results of the pre-diagnosed 
samples were all confirmed. The ITS-1-amplification in combination with RFLP analysis is 
clearly superior to the other PCR methods presented here. The additional step of about 2 hours 
incubation and an additional gel electrophoresis run is a negligible disadvantage in relation to the 
benefits. Most PCR-systems found in the literature achieve either high sensitivity or species 
specificity. Only a few are sensitive and also species specific for very few species 
simultaneously. With this method nearly every Leishmania species can be identified with high 
sensitivity. 
 
4.5. Wadi Albethan, a newly identified focus of L.tropica in the West Bank: 
A new focus of L.tropica has been identified in Wadi Albethan, an Arab village east of Nablus. 
Probably the whole mountain range west of the Jordan Valley is prone to be endemic with 
L.tropica. The area has not been systematically investigated yet. One soldier reported about  
several other soldiers being infected with CL in a military camp on the same longitudinal line 
some kilometers south (personal communication). Kfar Adumim is also on the same longitudinal 
line as Tiberias in the north (both L.tropica foci). The outbreak of CL in Wadi Albethan was 
confirmed as being caused by L.tropica with primers Uni21/Lmj4 from the 2 successfully 
cultured strains, RFLP analysis of the PCR-product (performed by Kefaya Azmi), ITS-1 
amplification and RFLP analysis and the PPIP-PCR (performed by Carol Eisenberger, Kuvin 
Center, Jerusalem). It proved to be very difficult to retrieve sufficient template DNA from 
dermal scrapings for the amplification with primers Uni21/Lmj4. The ITS-1-PCR had not been 
published at that time, which would have been the superior method. 
The microscopical examination of the 23 smears was sensitive to 39 %. This confirmed the 
findings of many other studies, in which the microscopical detection rate did not exceed the 
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sensitivity of PCR. Four smears of this study group, as well as many others seen during the study 
period, had to be classified as negative, even though the microscopical picture was highly 
suggestive of a leishmanial infection. Cell like structures in the size of amastigotes were often 
seen in groups either intracellularly in macrophages or extracellularly. Nuclei and kinetoplasts 
could not be identified. In most of these cases patients had been treated previously either with 
intralesional pentostam or liquid nitrogen. It was assumed that the described structures were 
destroyed amastigotes. The smears showed a picture of successful destruction of the parasite, 
which is expected under treatment as well as during a natural healing process.  
 
4.6. Discussion of PCR results from animals: 
Desert rodents: 
The study on 30 ear scrapings of Psammomys was performed in order to approve the reliability 
of the direct PCR diagnosis. Besides, it was an interesting field study which revealed a high 
percentage of Leishmania infections in the Psammomys of the Qziot area in the Negev. The fact 
that all positive smears (20) were also positive by PCR confirmed the specificity of the PCR (no 
false negatives). The sensitivity by PCR (28) was far higher than by microscopy (20), as 
expected. The screening of ear tissue from other desert rodents from the Qziot area revealed a 
Leishmania infection in a rodent species (Gerbillus dasyarus), which was not known previously 
to host the parasite. A new reservoir host species has been identified by PCR. The faint bands of 
120 bp indicated the presence of leishmanial DNA. The result was confirmed by one amastigote 
found in one of the smears. So far, the findings can only prove the infection of this gerbil 
species; the question if this species is in fact functioning as a reservoir has yet to be elucidated. 
 
Canids: 
The peripheral blood from four examined dogs suffering from CVL was PCR-positive with 
primers 13A/13B. This small study showed that one drop of blood can be sufficient for diagnosis 
of VL. It can be assumed that VL could be diagnosed equally well also from human blood 
(discussed later in the section on diagnosis of VL). Thus suitable laboratory tools have been 
established for the diagnosis of VL too. As mentioned earlier infantile kala azar is occasionally 
seen in the West Bank and many dogs are infected in Israel (only poor data of dogs in the West 
Bank) which shows the relevancy. 
All jackal ears (of 20 animals) were negative. Most of the western-blot results of the same 
animals had been either negative or only borderline positive (according to Gad Baneth, 
Veterinary School, Hebrew University, Rehovot). The examination of the ears had a low chance 
for positive PCR-results, but it was considered worth-while to try because of the great relevancy 
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to identify infections in jackals (see Introduction). The jackal spleens in formalin were all 
negative by PCR. The tissue was not preserved well, which questioned the quality of the 
extracted DNA anyhow, as mentioned before. Other possible reasons for the negativity could be 
either due to inhibition of the PCR by remnants of formalin or to the fact that the animals were 
not infected with Leishmania.  
 
Hyraxes as a reservoir of L.tropica?: 
The examined hyrax tissue (nose, skin and bone tissue of the parched hyrax and the ear biopsy of 
a living animal) was negative. One hyrax was parched and it was not certain if DNA could be 
recovered at all. The other hyrax was not exactly from a known endemic area. It was obvious 
that systematic trapping of hyraxes in a highly endemic area would be necessary in order to 
detect potential infections. Wadi Albethan would be an excellent study area since it is hyper-
endemic for L.tropica and hyraxes are abundant. Due to the recent political developments this 
study can not be carried out presently but the methodology is available now in the laboratory to 
conduct these studies in the future. 
Hyraxes (Photo 19) were observed close to Kfar Adumim (L.tropica focus, Photo 13) in the 
Judean Desert and in Korazim, a settlement on the northern slope of the lake of Galilee, which is 
one other new L.tropica focus in the country (patient 5, Table 8, Photo 3). Also in Jordan,  
hyraxes were observed in the three major foci of L.tropica, and were therefore highly suspected 
to be the reservoir (Saliba et al., 1997). Previous findings have supported the hypothesis: 
L.tropica has been identified in a hyrax in Kenya (Sang et al., 1992). Hyraxes were observed in a 
new focus of L.tropica in Kenya (Sang et al., 1994). Hyraxes have been found infected with 
L.aethiopica in Ethiopia (Ashford et al., 1973). The cultured parasites had not been characterized 
at the time of publication. Since L.tropica has been isolated from dogs in Morocco (Dereure, 
1991) and was also found in a rat (Aljeboori and Evans, 1980), both animal species have to be 
considered as being a potential reservoir as well. It has to be clarified if dogs or rodents are only 
accidental hosts or if they are functioning as reservoir.  
 
4.7. Choice of treatment on the basis of PCR-results: 
Species- or at least complex-specific identification is essential for the selection of the appropriate 
treatment. Early differentiation of L.braziliensis and L.mexicana infections can help to avoid 
unnecessary hospitalization and treatment of patients infected with L.mexicana. If these patients 
still require treatment, ambulant care would be sufficient and drugs (ketokonazol eg.) could be 
administered orally (Rodriguez et al., 1994). Several patients in Israel might be spared from 
toxic and costly treatment every year. A three weeks course of intravenous pentostam in Israel 
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sums up to about $ 10,000 for hospitalization and 500 $ for the treatment (20 mg/kg/day 
pentostam for 20 days) (personal communication with Dr. Eli Schwartz, Tel Hashomer Hospital, 
Tel Aviv). 
Infections with L.mexicana and the L.braziliensis complex were found to respond differently to 
certain drugs (Navin et al., 1992). 90 % of patients with L.braziliensis-infections responded well 
to sodium stibogluconate whereas only 57% of L.mexicana infections showed improvement. 
Using ketoconazol 89% of patients with L.mexicana infections responded well compared to only 
30% of the patients infected with L.braziliensis. The PCR results with primers Uni21/Lmj4 can 
also give a direction for the choice of the adequate therapy. If L.major is diagnosed (680 bp), 
usually no treatment is required. If a >800 bp product is found the patient needs to be treated 
(L.tropica, L.donovani complex). The ITS-1 amplification combined with restriction is evidently 
a suitable method for species specific diagnosis and therefore provides the information necessary 
to treat a patient adequately. 
 
4.8. PCR diagnosis in VL: 
This study focused on CL because VL is rare and most cases occur in the West Bank (Photo 14), 
where the access to doctors and hospitals is complicated. Even if there were single cases in the 
past two years they were not necessarily referred to our laboratory. The methodology which has 
been successful for the diagnosis of CL can be applied as well for the diagnosis of VL. As the 
small study on 4 infected dogs has shown, VL can be diagnosed directly from peripheral blood. 
It is of great importance that these methods are available in the country, especially for the 
diagnosis of human (infantile kala azar) in the West Bank but also for epidemiological studies in 
canids. The methods are suitable for a clinical laboratory, which is equipped with a PCR 
machine. Osman et al., (1997 a) evaluated PCR-diagnosis on peripheral blood spots from 
confirmed and suspected VL patients in Sudan. The PCR was positive in 70% of the confirmed 
and in 19% of the suspected cases. In the same study, also different clinical specimens were 
compared for their detection rate by PCR. Lymph node aspirates, bone marrow aspirates and 
peripheral blood (finger-prick-blood) of microscopically confirmed VL cases in Sudan were 
collected on filter paper and extracted with phenol-chloroform. The PCR revealed positivity in 
100% of the bone marrow aspirates, in 87% of the lymph node aspirates and in 70% of the 
peripheral blood samples. Even though the detection rate from blood was the least, as expected, 
it is an excellent method for first line screening in suspected cases of VL. Thus many patients 
could be spared from the more invasive diagnostic methods, such as bone marrow- and splenic 
aspirations. Also Campino et al., (2000) have found a good detection rate with peripheral blood 
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spots on filter paper. Out of 20 immunocompromised and previously diagnosed VL patients 15 
were confirmed by PCR (SSU-rRNA primers).  
The use of the buffy coat (Lachaud et al., 2001) or separated peripheral blood mononuclear cells 
(PBMC) (Nuzum et al., 1995 and Belli et al., 1998) may be even more promising since the 
parasites are concentrated in these cells. The cells (PBMC) were separated from peripheral blood 
and only crudely prepared (lysis in a buffer, digestion with proteinase K and boiled for 15 
minutes). Belli et al., (1999) found 7 out of 9 VL patients to be positive by PCR. Adya et al., 
(1995) compared the sensitivity of PCR, ELISA and microscopy in Indian patients with 
symptoms suggestive of VL. Out of 22 patients 17 were positive by PCR, 14 by ELISA and 7 by 
smears which had been prepared from spleen aspirates.  
Since the reservoir and the vector for VL are prevalent in many places in Israel and in the West 
Bank, CVL is increasingly seen in domestic dogs in Israel, outbreaks in humans could occur as 
well at any time. It is therefore good to be technically prepared for reliable diagnosis. Serology is 
available, but antibodies are not necessarily found in the beginning of the disease. Diagnosis  
from spleen or bone marrow aspirates is also very sensitive, but can be left for the PCR-negative 
cases (from peripheral blood). 
 
4.9. Guidelines for future applications: 
4.9.1 Sampling, preservation and extraction: 
As a result of the observations made during the whole study period and the findings of the 
comparative study (with Carney Mattheson, not included in this thesis), the following proceeding 
can be recommended for a clinical laboratory: Dermal scrapings on filter paper are very suitable 
samples which can be highly recommended for the PCR-diagnosis of CL. For the diagnosis of 
VL, the buffy coat of peripheral blood appears to be the best specimen, which can be spotted 
onto  filter paper as well. Bone marrow aspirations (more sensitive but also more invasive) can 
be preserved as second line diagnostic measures.  
Filter paper samples consisting mostly of tissue and only of a small amount of blood can be 
extracted with the Chelex method with excellent results. If specimens contain a larger amount of 
blood (eg. also dermal scrapings on filter paper, which accidently consist mainly of a drop of 
peripheral blood) or are conserved differently (fixed in formalin, paraffin embedded, Giemsa 
stained) the phenol-chloroform extraction should be used. The guanidine method can not offer 
more than the Chelex method and may be preserved for exceptional samples (bone powder, 
macerated tissue). It may be considered for samples in which a certain degree of purification is 
necessary and a loss of material (as it can not be avoided with the phenol-chloroform extraction) 
would be critical. 
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The problem of inhibition has to be considered. Inhibition is influenced by the original sample 
size in relation to the volume of lysis, extraction and DNA resuspension and also by the amount 
of template DNA used in the PCR. It is self-evident that the way of preservation plays an 
important role as well as the removal of inhibitory substances during DNA extraction, which 
depends mainly on the employed extraction method. In the case of dermal scrapings on filter 
paper in the size of about 0.5 cm in diameter all three methods are efficient (phenol-chloroform, 
guanidine and chelex). 
 
4.9.2. Recommended approach for PCR diagnosis in the future: 
The amplification of the ITS-1 region should be the method of first choice. No other system has 
been found in the literature so far which is simultaneously as sensitive and species specific for 
the whole spectrum of Leishmania species. It is of great benefit especially for a country like 
Israel, where 3 species are endemic and any species may be imported. Therefore any Leishmania 
species can potentially be encountered in Israel. In countries where only one species is known to 
be endemic it would be sufficient to amplify the ITS-1 region for a genus specific result without 
consecutive RFLP-analysis. RFLP-analysis could follow if the disease was imported from 
another country. If a laboratory prefers to concentrate only on genus specific diagnosis, 
kinetoplast primers 13A/13B should be favoured due to the higher sensitivity. These primers 
may be employed for the same reason in cases of negativity with the ITS-1 primers. With the 
advent of the ITS-1 primers the L.braziliensis specific primers MPL1/MP3H can be replaced as 
well. If the ITS-1 amplification is negative, they may be used in a second attempt (higher 
sensitivity). The ITS-1 primers are superior in New World leishmaniasis because they can 
identify also L.mexicana infections, whereas the L.braziliensis primers can positively identify 
only species of the L.braziliensis complex. 
Kinetoplast primers Uni21/Lmj4 can be replaced by ITS-1 primers due to the higher sensitivity 
of the latter. There may be still applications where primers Uni21/Lmj4 are benefitial: Whenever 
a distinction between L.major and L.tropica is required and enzyme digestion (with the ITS-1 
method) is not wanted or not possible the kinetoplast primers can be employed. It can be 
assumed that primers Uni21/Lmj4 could have a high success rate if the best conditions 
(discussed earlier) are chosen on a regular basis. 
 
 
4.10. Leishmaniasis in non-endemic areas with particular regard to Germany: 
In Germany leishmaniasis is occasionally seen in travellers and immigrants. The incidence of 
leishmaniasis is not known since the disease is not reportable. Due to tourism the number of 
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cases is increasing. According to the "Deutsches Ärzteblatt" (Harms-Zwingenberger and 
Bienzle, 2000) patients are either treated by local physicians or in hospitals. Diagnosis relies on 
microscopy, culturing, serology and PCR. Rarely cases of infantile kala azar have been 
diagnosed in the past. One interesting case was reported recently: an infant of 15 months was 
diagnosed with VL, who had never left Germany except for a short visit to Holland (Bogdan et 
al, 2001). After 6 months of fever and hepatosplenomegaly kala azar was finally diagnosed. The 
parents reported the family had spent holidays at a campsite in southern Germany (Füssen) in the 
previous summer, where many returners from the Mediterranean use to camp on their way back 
to Germany. One hypothesis suggested that an infected sandfly might have been imported in a 
car. It was also suggested that autochthonous foci could possibly emerge in central Europe. This 
is indeed worth-while to consider as a realistic possibility since sandflies have been identified 
recently in south-west Germany along the upper Rhine valley. The identified sandfly species, 
Phlebotomus mascittii Grassi 1908, belongs to a subgenus responsible for transmission of VL in 
the Mediterranean (Naucke and Pesson, 2000). The prospect of a warmer climate in Europe may 
create conditions for endemic leishmaniasis in central Europe (Kuhn, 1999).  
Dogs are much more frequently diagnosed with CVL in Germany than humans with VL. 
According to Gothe et al., (1997) 236 dogs were diagnosed with leishmaniasis between 1993 and 
1995. The dogs were either imported from Mediterranean countries or had been travelling with 
their owners. It can not be excluded that infected dogs could potentially introduce L.d.infantum 
and function also as a reservoir in an emerging focus.  
Individual cases have shown, that it is worth-while to search for leishmaniasis in patients with 
fever of unknown origin (FUO) and splenomegaly, even if the patient history does not suggest 
kala azar. Unusual ways of transmission have been reported as for example congenital 
transmission (Meinecke et al., 1999), blood transfusion (Le Fichoux et al., 1999) and possibly 
also liver transplantation (Grimm et al., 1996). Furthermore, one has to be aware that 
immunosuppressed persons (eg. HIV-infected persons, transplant recipients, patients with 
chronic diseases) are at risk to contract VL during visits to Mediteranean countries. It should be 
also seriously considered to screen transplant organs routinely by PCR if they come from 
endemic countries in Europe. As transplantation is increasingly organized centrally in Europe 
this measure could help to prevent cases of “autochthonous VL” in non-endemic European 
countries. Another interesting fact should be notified: it has been shown by Le Fichoux et al., 
(1999) and it has been dicussed also by Kubar et al., (1997) that the rate of subclinical infections, 
even with parasitemia, can be considerably high in endemic areas of kala azar (eg. southern 
France, Nice area). This is a relevant issue with regard to blood transfusion in these areas. Out of 
565 blood donors who were screened for the presence of antibodies (by western blot) 76 were 
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found to be seropositive. The buffy coats of the positive samples were cultured and 
promastigotes were detected in 9 cultures. Grogl et al, (1993) have studied the survivability of 
Leishmania parasites in human blood products under blood bank conditions. It was found that 
the parasites survive the conditions up to at least 25 days and also retain their infectivity. Also 
tourists to the Mediterranean could contract subclinical infections, and could become 
symptomatic after years, eg. in a state of immune suppression. The same applies for residents 
who come from Mediterranean or Middle Eastern countries (eg. Turks, Iranians, Arabs) In non-
endemic countries physicians are often not aware of leishmaniases and diagnosis is usually 
delayed, especially in the serious cases of kala azar with unusual histories. Since infections can 
theoretically be caused by all Leishmania species the identification at the species level is 
mandatory. Sensitive direct PCR diagnosis has the same relevancy as in endemic regions and 
should be favoured as the first diagnostic measure in suspected cases of VL and should be 
routinely performed in cases of CL in addition to microscopy. Culture based methods and 
serology can be performed as well but should be second line diagnostic measures. Invasive 
diagnostic measures, such as skin biopsies (CL) or bone marrow aspirations (VL), can be 
preserved for the case that the primary PCR on dermal scrapings (CL) or peripheral blood/ buffy 
coat (VL) is negative and symptoms still support the diagnosis. 
 
4.11. Concluding remarks: 
As leishmaniasis is not defeated but is rather a health threat more than ever before, improved 
diagnosis is of crucial importance for any attempt to control the disease. Diagnostic methods 
have to be simple and cheap enough to be used also in developing countries, and they have to be 
suitable for field work too. Endemic areas are not confined to the developing world, as most of 
the classical tropical diseases are. Also the developed world has to be prepared to see more 
patients with leishmaniasis, mostly due to endemicity in many countries with a warmer climate, 
travelling, but also as an opportunistic disease in HIV-infected patients. PCR is a very powerful 
tool for sensitive and specific diagnosis. The benefits of the PCR-methodology are undoubtedly 
enormous. This work has focused on PCR-diagnosis of leishmaniasis in Israel and the West 
Bank, where the methods have been established and are ready now for routine use. This study  
has been also exemplary for other endemic or non-endemic countries, where direct PCR 
diagnosis of leishmaniasis is planned to be introduced. The methods can be adopted, benefits of 
different extraction- and PCR-methods can be estimated with the help of this research and the 
best combination of methods can be selected for different settings in other countries. 
 
 




In Israel and the West Bank, three species of Leishmania are prevalent: L.major, L.tropica and 
L.donovani infantum (L.d.infantum). Cutaneous leishmaniasis (CL) is mostly caused by L.major 
in the Negev and the Jordan Valley. Its ecoepidemiology has been studied thoroughly in the past. 
CL due to L.tropica is more sporadic, but new foci have been emerging in recent years in the 
northern, more hilly parts of the country. The epidemiology is only poorly understood because 
only very few of the L.tropica foci within Israeli territory have been investigated so far. Only 
few data are available on L.tropica foci within the West Bank. The transmission is highly 
suspected to be zoonotic, but the reservoir animal species has not been identified yet. Since L. 
tropica infections may visceralize or become chronic (lupoid leishmaniasis) they need to be 
distinguished from L.major infections. Any emerging focus of CL therefore requires species 
specific identification. 
L.d.infantum causes visceral leishmaniasis (VL) in humans and in canids in Israel and the West 
Bank. Human disease is mostly seen in infants in the West Bank (Jenin district). It is not 
frequently diagnosed but it poses a serious life threat, and outbreaks are theoretically possible at 
any time. In Israel, the disease predominantly affects dogs. Canine visceral leishmaniasis (CVL) 
is diagnosed more frequently than ever before in the country. It is an emerging disease, which is 
spreading in central Israel and is also a potential danger for humans. In the northern West Bank, 
L.tropica and L.d.infantum foci are overlapping. Since strains of L.tropica were reported to 
visceralize and L.d.infantum strains may be dermatotropic, it is obvious that the differentiation of 
the two species would be of clinical and epidemiological importance.  
Apart from the endemic forms of leishmaniasis, imported forms, especially from the New World, 
are occasionally seen in Israel. Many young Israelis travel to Central and South America, and a 
few of them contract CL every year. Species-specific diagnosis is of great importance especially 
in these patients since only L.braziliensis infections require hospitalization and intravenous 
therapy with antimonal drugs.  
The aim of this work was to establish field applicable methods for the diagnosis of leishmaniasis 
directly from clinical material. Furthermore, it was important to introduce species-specific 
diagnosis for the above-named reasons. Apart from improved diagnosis of patients, screening 
methods for epidemiological studies were needed. Dermal scrapings were collected from 
cutaneous lesions of patients and of rodents. The samples were preserved on sterile filter paper. 
Several DNA extraction methods were compared, ranging from thorough to crude purification. 
Apart from dermal scrapings, various other clinical specimens were successfully proceeded 
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(Giemsa stained smears and paraffin embedded biopsies). This showed that Giemsa stained 
smears and paraffin embedded biopsies are suitable for retrospective studies, if required. For 
skin scrapings from desert rodents, the chelex-extraction yielded excellent results. For the 
screening of many samples, the work can be facilitated to a great extent by using chelex-
extraction instead of the phenol-chloroform or the guanidine extraction method. It was found that 
samples with a relatively high tissue and a low blood content yielded excellent results with the 
chelex method. If samples were bloody, the phenol-chloroform extraction was superior. 
Furthermore it was shown that inhibition of the PCR by interfering factors (predominantly 
hemoglobin) could be circumvented by using additives in the PCR, such as bovine serum 
albumin (BSA), formamide and dimethoxysulfoxid (DMSO). The DNA was subjected to 
different polymerase chain reactions (PCR), which targeted the kinetoplast minicircle DNA 
(kDNA) and later also another region, the intergenic transcribed spacer (ITS-1) within the 
ribosomal operon. The study primarily focused on primers Uni21/Lmj4, which amplified whole 
kDNA minicircles of the Old World species of Leishmania. These primers had never been tested 
systematically and the sensitivity was not known. L.tropica/L.infantum and L.major infections 
were distinguished by species-specific sizes of the minicircles. This PCR method was useful for 
the direct diagnosis of cutaneous leishmaniasis in individuals, but was not reliable enough to be 
employed for routine diagnosis. The genus-specific kDNA primer pair 13A/13B, which 
amplifies a conserved sequence of 120 bp, was highly sensitive and was successfully employed 
as a screening method in humans and in reservoir animals. Primers MP3H/MPL1 amplified a 70 
bp sequence specific for the L.braziliensis complex. L.braziliensis infections were diagnosed in 7 
patients using these primers. The course of the disease was monitored by PCR over several 
months. Only recently has species-specific diagnosis by restriction fragment length 
polymorphism (RFLP) analysis of the amplified ITS-1 region (~300 bp) been published (El Tai 
et al., 2000) and was adopted in our laboratory. It provided sensitive and species-specific 
diagnosis of both the Old World and New World species, and therefore covered all the 
requirements simultaneously.  
During the study, a new focus of L.tropica was identified in the West Bank, in Wadi Albethan, a 
village east of Nablus. A survey of desert rodents trapped in the Negev revealed a new rodent 
species (Gerbillus dasyarus) as a possible host for Leishmania parasites. The diagnosis of 
L.braziliensis infections was achieved for the first time in the country. Species-specific diagnosis 
directly from clinical samples is now available in Israel. The methods are ready to be introduced 
in other laboratories in the country or elsewhere, and have been adapted for possible routine use 
in clinical laboratories. They are suitable for diagnosis as well as for epidemiological studies. 
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Zusammenfassung 
Die Leischmaniose ist endemisch in Israel und in den palästinensischen Gebieten (West Bank). 
Drei Arten von Leishmanien kommen in Israel vor, L.major, L.tropica und L.donovani infantum 
(L.d.infantum), welche im wesentlichen zwei Krankheitsbilder verursachen: Die kutane 
Leischmaniose, oder auch Orientbeule, wird überwiegend von L.major verursacht, und eher 
seltener, jedoch in zunehmendem Maße auch von L.tropica. Die viszerale Leischmaniose, oder 
auch Kala Azar, wird in Israel von L.d.infantum hervorgerufen.  
Die Epidemiologie von L.major, der häufigsten und auch harmlosesten Spezies im Land, ist 
weitgehend erforscht. L.major ist vor allem in den Wüstengegenden des Landes verbreitet 
(Negev, Arava), im besonderen auch in Jericho („Jerichobeule“) und im Jordantal. L.major 
kommt als eine Zoonose vor, Wüstennagetiere wie z. B. die fette Sandratte (Psammomys obesus) 
dienen als Reservoir. L.tropica ist vergleichsweise wenig erforscht. Diese Spezies kommt eher 
sporadisch im nördlichen, höher gelegenen Teil des Landes vor (Galiläa, Samaria, 
Westjordanland). Immer wieder sind in den letzten Jahren neue Ausbrüche aufgetreten, von 
denen die meisten noch wenig erforscht, geschweige denn mit Sicherheit identifiziert worden 
sind (vor allem im Westjordanland). Es wird angenommen, daß es sich auch bei den L.tropica 
Infektionen um eine Zoonose handelt (im Unterschied zur bekannten Anthroponose bei L.tropica 
in den größeren Städten des Nahen Ostens), jedoch ist das tierische Reservoir bislang nicht 
bekannt. Da L.tropica Infektionen insgesamt schwerwiegender sind, in seltenen Fällen auch zu 
einer viszeralen Manifestation, oder auch in eine chronische, lupoide Form führen können, 
müssen sie von L.major Infektionen differenziert werden. Insbesondere ist es wichtig, daß neu 
auftretende Foci spezies-spezifisch identifiziert werden.  
Die viszerale Leischmaniose ist ebenfalls ein ernstzunehmendes Problem im Land: Die 
Erkrankung ist tödlich, wenn sie nicht rechtzeitig diagnostiziert und therapiert wird. Vor allem 
sind Kleinkinder im nördlichen Westjordanland betroffen. Die Inzidenz ist nicht hoch, jedoch 
gibt es offensichtlich einen funktionierenden Infektionszyklus, der die Voraussetzung ist für  
mögliche Ausbrüche der Erkrankung in der Zukunft. In Israel sind bislang nur sehr wenige Fälle 
von Kala Azar aufgetreten, doch ist in den letzten Jahren deutlich geworden, daß die viszerale 
Leischmaniose bei Hunden weit verbreitet ist und daher auch für den Menschen eine potenzielle 
Gefahr besteht. Da das klinische Bild nicht eindeutig auf den Errerger hinweist (L.d.infantum 
kann sich in seltenen Fällen kutan, und L.tropica kann sich viszeral manifestieren), ist auch hier 
eine spezies-spezifische Diagnostik geboten.  
Neben den endemischen Formen der Leishmaniose kommen mit zunehmender Häufigkeit auch 
eingeschleppte Leishmaniosen aus Zentral- und Südamerika vor. Es ist üblich, daß junge Israelis 
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nach ihrer Entlassung aus der Armee für einige Monate reisen (als Rucksacktouristen). Mit 
besonderer Häufung werden Infektionen aus dem bolivianischen Regenwald (L.braziliensis) 
beobachtet. Da die Infektionen durch L.braziliensis mit einem besonderen Risiko verbunden sind 
(mögliche spätere mukokutane Leischmaniose, Espundia), müssen diese Patienten für drei 
Wochen systemisch mit Pentostam behandelt werden (wie bei Kala Azar). Dies ist 
selbstverständlich mit hohen Kosten verbunden (Hospitalisierung), außerdem ist die Therapie 
nebenwirkungsreich. Bislang wurden alle Reiserückkehrer aus Amerika, bei denen eine kutane 
Leischmaniose aufgetreten war, ohne eine spezies-spezifische Diagnostik vorsichtshalber 
therapiert.  
 
Ziel der vorliegenden Arbeit war es, eine sensitive und spezies-spezifische PCR Diagnostik der 
Leishmaniose im Land zu etablieren. Neben einer verbesserten Diagnostik bei Patienten war es 
wichtig, auch Methoden für epidemiologische Studien (z.B. screening von Reservoirtieren) zur 
Verfügung zu stellen. Für die PCR-Diagnostik wurden vor allem Wundabstriche aus Läsionen 
(von Patienten und auch Tieren) mithilfe einer sterilen, chirurgischen Klinge gewonnen und auf 
Filterpapier konserviert. Daneben wurden auch andere Proben bearbeitet und für ihre Eignung 
zur PCR-Diagnostik geprüft, z. B. Giemsa gefärbte Abstriche, Paraffin eingebettete Biopsien 
(für eventuelle retrospektive Studien in der Zukunft). Auch wurde peripheres Blut von 
erkrankten Hunden untersucht (1 Tropfen auf Filterpapier), um gleichzeitig auch die Diagnostik 
der viszeralen Leischmaniose voranzutreiben. 
Um die Diagnostik zu vereinfachen (Anpassung für ein nicht forschungsorientiertes Labor), 
wurden verschiedene Extraktionsmethoden ausprobiert und ihre Eigenschaften näher untersucht. 
Alle getesteten Methoden (Phenol-Chloroform, Guanidin, Chelex, „Crude“) waren erfolgreich, 
d.h. PCR-Resultate wurden direkt von klinischem Material gewonnen. Interessanterweise 
wurden gerade mit einer sehr einfachen und schnellen Methode (Chelex) exzellente Resultate 
erzielt (28 von 30  Psammomys-Ohr-Proben waren positiv). In diesem Falle waren jedoch auch 
die Proben ideal (überwiegend Gewebe und wenig blutig). In anderen Fällen zeigte sich, daß 
PCR-Inhibition ein wesentliches Problem sein kann und daher differenziert werden muß, welche 
Proben einer gründlichen Aufreinigung bedürfen (Phenol-Chloroform-Extraktion). Es wurden 
Versuche unternommen, die PCR-Hemmung zu verhindern, indem zusätzliche Substanzen der 
Reaktion beigefügt wurden (Bovines Serumalbumin, Dimethylsulfoxid, Formamid). Dadurch 
konnten störende Substanzen, wie z.B. Hämoglobin, tatsächlich effektiv abgefangen werden, 
sodaß dann die PCR-Reaktionen auch bei grob zubereiteten Proben (z.B. nur Proteinase-K-
Verdau plus Lyse) durchaus möglich war.  
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Für die PCR wurden verschiedene Oligonukleotid-Paare eingesetzt. Zunächst wurde das 
Problem der Differenzierung von L.major und L.tropica angegangen, da dies eine vorrangige 
Aufgabe war. Zu diesem Zweck wurden die eigens dafür entwickelten Primer Uni21/Lmj4 
(Eresh et al., 1993) getestet. Diese Primer amplifizieren ganze „Minicircle“ der Kinetoplasten-
DNA (kDNA), die in 10.000 Kopien pro Organismus vorkommen, und daher potenziell als sehr 
sensitiv eingestuft wurden. Diese Primer-Paar konnte tatsächlich Leischmania-DNA direkt aus 
klinischem Material amplifizieren, die Sensitivität war jedoch insgesamt nicht zuverlässig genug 
für eine mögliche Einführung als Routinemethode. Für epidemiologische Anwendungen wurde 
das genus-spezifische Primer Paar (13A/13B, ebenfalls kDNA-Primer, Rodgers et al., 1990) 
verwendet, welches sich als hoch sensitiv erwies, jedoch keine spezies-spezifische Diagnostik 
leisten konnte.  
Die Diagnostik der importierten Leischmaniosen aus der Neuen Welt erforderte den Einsatz 
eines weiteren Primer-Paares. Um eine hohe Sensitivität zu gewährleisten wurde dafür ebenfalls 
ein kDNA-Primerpaar eingesetzt (MP3H/MPL1, Lopez et al., 1993), welches die Spezies des 
L.braziliensis-Komplexes spezifisch amplifizieren, daneben jedoch keine andere Spezies 
erkennt. Dadurch konnten mehrere L.braziliensis-Infektionen bei Reiserückkehrern identifiziert 
werden. Um gleichzeitig auch die Infektionen zu erfassen, die nicht durch L.braziliensis 
verursacht waren, wurden dieselben Patientenproben auch mit den genus-spezifischen Primern 
untersucht. Gegen Ende der experimentellen Arbeit wurde eine vierte Methode eingeführt (El 
Tai et al., 2000), die eine sowohl sensitive als auch gleichzeitig spezies-spezifische Diagnostik 
für fast alle Spezies ermöglichte. Diese Primer (LITSRn/L5.8S) amplifizieren eine 300 bp 
Sequenz des ribosomalen Operons (Intergenic transcribed spacer, ITS-1). Diese Sequenz besteht 
aus konservierten und variablen Anteilen. Die konservierten Anteile ermöglichen eine  
Amplifikation aller Spezies (genus-spezifisch). Die variablen Anteile der Sequenz (spezies-
spezifisch) werden für die spezies-spezifische Diagnostik genutzt, mithilfe von Restriktions-
Fragment-Längen-Polymorphismen (RFLP-Analyse). Zwar ist der Restriktionsverdau des PCR-
Produktes ein zusätzlicher Schritt, doch wird dieser durch die Überlegenheit der Methode völlig 
gerechtfertigt.  
 
Während der experimentellen Phase sind „nebenbei“ recht interessante Ergebnisse erzielt 
worden: Es wurde ein neuer L.tropica–Fokus identififiziert. In einem palästinensischen Dorf in 
der Nähe von Nablus (Wadi Albethan, Westjordanland) wurde ein Neuausbruch der kutaner 
Leischmaniose beobachtet, von dem ein großer Teil der Bevölkerung betroffen war (keine 
genauen epidemiologischen Daten). Die PCR von Wundabstrichen auf Filterpapier bewährte 
sich in dieser ersten realen Feldstudie.  
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In einer umfangreicheren Studie an Wüsten-Nagetieren (Ohr-Wundabstriche auf Filterpapier) 
wurde eine neue Tierspezies als mögliches Reservoir gefunden, die vorher nicht als solche 
bekannt war (Gerbillus dasyarus). Die genus-spezifische PCR war schwach positiv bei mehreren 
Individuen, 1 amastigoter Parasit wurde in einem Giemsa gefärbten Ausstrich nachwiesen 
(Bestätigung der PCR-Ergebnisse). 
Direkte (d.h. von klinischem Material, nicht von Kulturen), spezies-spezifische PCR-Diagnostik  
der Leischmaniasis ist in Israel zum ersten Mal durchgeführt und jetzt etabliert worden, 
L.braziliensis Infektionen sind zum ersten Mal spezies-spezifisch im Land nachgewiesen 
worden. Die Erfahrungen aus dieser Forschung können helfen, geeignete Konservierungs-, 
Extraktions- und PCR-Methoden für die Diagnose der Leischmaniose auch in anderen Labors zu 
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